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Chapter ι 
Rheumatoid arthritis 
Rheumatoid arthritis (RA) is a heterogeneous, chronic inflammatory disease that 
significantly impacts patients' quality of life. The occurrence of the disease varies 
among different ethnicities and areas of the world, implicating the involvement of 
genetic and environmental factors in disease development . In developed countries 
it affects 0.5 - 1.0% of the adult population and incidence increases with age. 
Although its exact etiology is not fully understood, loss of self-tolerance, triggering 
an antigen-driven autoimmune response, plays a pivotal role in the initiation and 
progression of the disease . Despite many years of research aimed at identifying 
potential therapeutic targets and the tremendous effort undertaken to develop safe 
and effective drugs, a treatment that fully prevents or cures this disease is still not 
available. 
The course of the disease can range from mild to very severe and is characterized by 
persistent inflammation in multiple joints and concomitant destruction of cartilage 
and bone (Figure 1). These processes are regulated by cells of the immune system, 
such as monocytes/macrophages, neutrophils, lymphocytes, and dendritic cells, as 
well as local resident cells, like fibroblasts, osteoclasts, and chondrocytes. At the site 
of inflammation immune cells massively infiltrate the synovium, producing 
cytokines, chemokines, and alarmins upon activation by immune complexes (ICs), 
which further drive inflammation. The synovial lining layer becomes hyperplastic and 
transforms into pannus tissue that invades and destroys the articular cartilage and 
bone via the production of proteolytic enzymes, including matrix metalloproteinases 
(MMPs), aggrecanases, and cysteine proteases . 
Autoantibodies and immune complexes in rheumatoid arthritis 
Antibodies or immunoglobulins (Ig) are the primary mediators of the humoral 
immune response against foreign pathogens. They are produced in response to an 
encounter with its specific antigen and can be classified into five distinct isotypes 
(IgA, IgD, IgE, IgG, and IgM) . When the immune system fails to discriminate self 
from non-self, an immune response to self-antigens can lead to the development of 
n 
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autoimmune diseases, which are characterized by the serological presence of 
autoantibodies5. Rheumatoid factors (RF), first discovered by Waaler in 1940 , are 
autoantibodies directed against the Fc domain of IgG and they are classically 
associated with RA. Although RF are detected in the majority of patients, their 
sensitivity and specificity for RA is low because RF can also be found in patients with 
other autoimmune diseases or chronic infections, and even in healthy individuals . 
Nowadays, a wide spectrum of autoantigens targeted by autoantibodies have been 
described in RA, including cartilage components, stress proteins, enzymes, nuclear 
proteins, and citrullinated proteins . Testing for anti-citrullinated protein antibodies 
(ACPA) has become a commonly accepted and crucial part of RA diagnosis, since 
ACPA are more specific and sensitive for diagnosis than RF, and they are also useful 
for discriminating erosive from non-erosive RA . 
Healthy joint Arthritic joint 
Bone 
^>· 
Articular cartilage 
Synovial lining 
Synovial fluid 
Synovial hyperplasia 
and inflammation 
Osteophyte formation 
Cartilage destruction 
Bone erosion and 
pannus formation 
Figure 1: Schematic view of an arthritic joint versus a healthy joint 
Antibodies associate with their respective antigens to form immune complexes, 
which have a broad effect on cells and tissues in the body. Large amounts of IgG-
containing immune complexes are present in the serum and synovial joints of RA 
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patients and they are thought to play a crucial role in RA pathogenesis Mice 
deficient for autoantibody-producmg Β cells are protected against the development 
of collagen-induced arthritis (CIA) Additionally, experimental arthritis m mice can 
be induced by the passive transfer of anti-collagen type II antibodies or anti-
glucose-6-phosphate isomerase antibodies 13, as well as by mtra-articular deposition 
of lysozyme-anti-lysozyme complexes The magnitude of the immune complex 
response is dependent on the size of the complex, which is determined by the ratio 
of antibody to antigen 15 Cellular activation by immune complexes can be induced 
via binding of complement components, thereby activating the classical or 
alternative complement pathway , or by ligation of immune complexes to their 
associated receptors 
Fey receptors: expression and signal transduction pathways 
The receptor family for the Fc domain of immunoglobulins is well conserved among 
different species and for each antibody isotype a specific Fc receptor (FcR) exists 
23
 The human genome contains eight genes encoding receptors for IgG-containmg 
immune complexes, also called Fey receptors (FcyRs) These are FcyRI (FcyRIA/IB/IC), 
FcyRII (FcyRIIA/B/C), and FcyRIII (FcyRIIIA/B) 2* In mice, four different FcyR classes 
have been described, which correspond to their human counterparts FcyRI (CD64), 
FcyRIIB (CD32), FcyRIII (CD16), and FcyRIV 2 5 2 6 FcyRs are expressed on the cell 
surface of a broad range of innate immune cells of hematopoietic origin, including 
monocytes, macrophages, neutrophils, Β cells, and dendritic cells (DCs) Cellular 
activity is regulated through balanced signaling via activating and inhibitory FcyRs 
FcyRI, FcyRIII, and FcyRIV are activating receptors that depend on the 
immunoreceptor tyrosme-based activation motif (ITAM)-bearing Fc receptor y 
subunit (FcRy-cham) for their cell surface expression and intracellular signal 
transduction Binding of immune complexes induces receptor cross-linking and 
phosphorylation of the FcRy-cham by Src family kinases, leading to the recruitment 
of Syk family kinases that subsequently activate phosphatidylmositol 3-kinase (PI3K) 
(Figure 2) 2131 Downstream activation of Bruton's tyrosine kinase (BTK) and 
phospholipase C-y (PLCy) eventually results in activation of mitogen-activated 
protein kinase (MARK) pathways and Ca + mobilization Additional activation of 
MARK pathways occurs through activation of the SOS-Ras-Raf cascade by Syk kinases 
Immune complex-mediated triggering of activating FcyRs initiates a range of 
biological responses that include phagocytosis, oxidative burst, antibody-dependent 
cellular cytotoxity, and regulation of cytokine and chemokme production " The only 
inhibitory FcyR, FcyRIIB, mediates its downstream signaling through phosphorylation 
13 
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of the Immunoreceptor tyroslne-based inhibitory motif (ITIM), thereby recruiting the 
hematopoietic-restricted protein Src homology 2-contalnlng Inositol 5'-phosphatase 
(SHIP) 35. This adaptor protein counter-regulates the activation signals of activating 
FcyRs or other ITAM-bearing receptors by Interfering with the PI3K and SOS-Ras-Raf-
MAPK pathways (Figure 2)36;37. 
FcyRIIB 
Ca"' mobilization 
MARK (ERK, p38, JNK) 
Phagocytosis 
Cytokine/chemoktne production 
Oxidative burst 
ADCC 
Figure 2: Fey receptor signaling pathways 
Fey receptors in rheumatoid arthritis 
Fey receptors as regulators of inflammation 
The generation of FcyR knockout mice has considerably facilitated In elucidating 
their role in the regulation of immune responses. Mice deficient for the FcRy-chain 
lack functional expression of all activating FcyRs. As a result, these animals are 
almost completely protected against arthritis development Induced by either active 
or passive immunization, despite normal cellular and humoral Immunity 16:38-40 Using 
mice lacking either FcyRI or FcyRIII revealed that In most arthritis models FcyRIII Is 
the dominant mediator for development of inflammation 16,41;42 Only in the antigen-
'4 
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induced arthritis (AIA) model, FcyRI and FcyRIII were shown to be functionally 
redundant The role of FcyRIV in the initiation and progression of experimental 
arthritis has remained unclear for a long time Strong indications for a role in disease 
pathology were obtained by investigating arthritis development in a wide range of 
FcyR double knockout mice Λ5 Recently, a FcyRIV" " mouse was developed, which 
displays reduced clinical signs of arthritis in the immune complex-mediated K/BxN 
serum transfer arthritis model Arthritis development m mice deficient for the 
inhibitory FcyRIIB is characterized by earlier onset of disease, increased antibody 
titers, reduced clearance of immune complexes, and enhanced disease severity 
40 42 44 47 p u r | : | i e r m o r e ) p a s S | V e transfer of human RA-associated antibodies can also 
induce arthritis m these mice , and FcyRIIB deficiency renders otherwise resistant 
C57BL/6 mice susceptible to CIA development 
Although cell type-specific FcyR knockouts are not yet available, the prominent 
presence of FcyR-bearmg cells m the inflamed synovium of RA patients and data 
obtained from a wide range of experimental models further supports assumptions 
on their central role m RA pathogenesis Macrophages and neutrophils are an 
important source of cytokines, chemokmes, oxygen radicals, and proteolytic 
enzymes Selective macrophage depletion from the synovial lining in established 
experimental arthritis reduces the severity of inflammation and cartilage 
destruction, whereas disease development is almost completely prevented upon 
macrophage depletion prior to arthritis induction In other arthritis models it 
was demonstrated that neutrophils can also substantially contribute to the incidence 
and severity of disease 54 56 
Studies of Β cell and DC function in humans and mice have implicated numerous 
roles for these cell types in the development of autoimmune diseases 5 7 5 9 Both Β 
cells and DCs play a pivotal role m orchestrating Τ cell immunity and tolerance by 
their ability of antigen presentation and cytokine production 5 9 6 1 In Β cells, 
activating signal transduction by the Β cell receptor is negatively regulated by the 
inhibitory FcyRIIB, thereby providing a suppressive feedback mechanism for 
activation, antigen presentation, proliferation, and antibody production of Β cells 62 
The absence of this feedback mechanism in FcyRIIB mice leads to enhanced 
antibody production upon immunization , whereas Β cell-deficient mice, on the 
other hand, are protected against CIA development The successful use of Β cell-
targeting therapies in the treatment of RA, e g , Rituximab, has provided proof of 
concept of its therapeutic potential in disease treatment Experimental evidence 
for a direct pathogenic role of DCs in arthritis development is limited A study from 
Leung and colleagues showed that presentation of collagen type ll-denved peptides 
15 
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by mature bone marrow-derived DCs can induce arthritis in the joints of susceptible 
DBA/1 mice, suggesting the involvement of DCs in the CIA model 
Fey receptors and cartilage destruction 
One of the main target tissues for destruction in RA is the articular cartilage covering 
the bony surface of joints. Cartilage is a complex living tissue providing the strength 
and flexibility needed for smooth joint movement. Within the extracellular cartilage 
matrix, which is composed of a dense network of collagen fibers and proteoglycans 
(PG), low numbers of chondrocytes are embedded. Chondrocytes are essential for 
the production and maintenance of the extracellular matrix . Because cartilage is 
a tissue with poor regenerative capacity, damage, successively progressing from 
reversible PG depletion towards irreversible degradation of the collagen network 
and chondrocyte death, will lead to erosion of the cartilage and concurrent loss of 
joint function 
Degradation of the cartilage matrix is mediated by proteolytic enzymes such as 
aggrecanases and MMPs . Chondrocyte homeostasis is closely linked to cartilage 
matrix integrity. As a result, chondrocyte death can be induced by loss or 
perturbation of the extracellular matrix, but also by excessive levels of reactive 
oxygen species, loss of growth factors, or mechanical injury 71'75. Pro-inflammatory 
cytokines like interleukin-1 (IL-1), tumor necrosis factor alpha (TNFct), and IL-17 are 
strongly produced during joint inflammation and are known for their detrimental 
effect on the integrity of articular cartilage through inhibition of PG synthesis and 
induction of nitric oxide and MMPs 76. However, matrix-degrading MMPs are 
synthesized and secreted in a proenzyme form. Proteolytic cleavage of their N-
terminal pro-domain is required for their full activation . Although cytokines can 
induce the production and secretion of latent MMPs, their activation was shown to 
be dependent on the expression of FcyRs, which also play an important role in the 
mediation of chondrocyte death and cartilage erosions. VDIPEN expression, a MMP-
induced neoepitope, chondrocyte death, and cartilage erosions were absent during 
AIA and immune complex-mediated arthritis (ICA) in FcRy-chain"'" and FcyRI/ll/llf7" 
mice . FcyRI was shown to be the dominant receptor mediating cartilage 
destruction in the AIA model, as destruction parameters were unchanged in FcyRIM 
mice, but significantly decreased in FcyRI"7- animals AA. In the ICA model, FcyRI and 
FcyRIM are equally important m mediating severe cartilage destruction 42. 
The inhibitory FcyRIIB acts as an important negative regulator of joint destruction. 
In both AIA and ICA, FcyRIIB-7- mice display strongly enhanced VDIPEN expression, 
chondrocyte death, and cartilage erosion 42'44. Furthermore, we have observed that 
16 
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FcyRs are expressed on the cell surface of chondrocytes. However, expression levels 
are very low and not regulated by cytokines, nor do chondrocytes appear to be 
affected by direct stimulation with immune complexes (unpublished observations). 
Fey receptors and bone erosion 
Bone remodeling is a continuous, highly coordinated process that involves the 
resorption of bone by osteoclasts and the formation of new bone by osteoblasts. 
The tight balance between removal and repair of damaged bone is crucial for the 
maintenance of skeletal integrity and mineral homeostasis. Bone erosions are a 
common feature of RA, resulting from a shift in this balance towards enhanced 
formation and activity of osteoclasts in the affected joints ' 
Osteoclasts are multinucleated cells unique in their ability to resorb mineralized 
tissues like bone. They are formed by fusion of mononuclear progenitors of the 
monocyte/macrophage lineage. Macrophage colony-stimulating factor (M-CSF) and 
receptor activator of nuclear factor-κΒ ligand (RANKL) are two critical factors needed 
for osteoclastogenesis. M-CSF is a cytokine that mediates the survival, proliferation, 
and differentiation of hematopoietic progenitors into mature phagocytes and 
osteoclasts . The TNF superfamily member RANKL induces commitment to the 
osteoclast lineage through its receptor RANK and its genetic ablation causes 
osteoclast-deficient osteopetrosis 80'82. In addition to M-CSF and RANKL, co-
stimulatory signaling via ITAM- and ITIM-bearing adaptors and receptors is of crucial 
importance for the regulation of osteoclastogenesis . Osteoprotegerin (OPG) is a 
soluble decoy receptor for RANKL that strongly suppresses osteoclastogenesis both 
in vitro and in vivo . The RANKL:OPG ratio in serum is often used as a marker for 
osteoclast activation, since the amount of bone resorption is regulated by the 
balance between RANKL and OPG levels . Activation of osteoclasts is induced upon 
its attachment to the bone matrix, leading to internal rearrangements that prepare 
the osteoclast to resorb bone. The actin cytoskeleton reorganizes and a sealing zone 
between the basal membrane of the osteoclast and the bone surface is formed 88. 
The acidic milieu within the sealed compartment provides an optimal environment 
for the cathepsin Κ enzyme that degrades the underlying bone 
The research area of osteoimmunology, combining osteoclast biology and 
immunology, has contributed significantly to the understanding of bone loss in RA. 
The inflamed synovium is an active site of interplay between immune and bone cells 
and therefore plays an important role in bone pathology . Activated Τ cells and 
macrophages produce pro-inflammatory cytokines and chemokines that can, 
respectively, stimulate osteoclast differentiation and function, and attract 
17 
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mononuclear progenitors to the site of inflammation Thus far, research has 
focused predominantly on the regulation of osteoclastogenesis by Τ cells and pro­
inflammatory cytokines Little is known about the involvement of activating and 
inhibitory FcyRs in the differentiation and function of osteoclasts, even though they 
are highly expressed by myeloid progenitor cells 9 1 9 2 In psoriatic arthritis patients 
increased numbers of circulating CD14+CD16+ monocytes are present and enhanced 
CD16 expression on monocytes is associated with increased bone resorptive activity 
of osteoclasts in vitro The human osteoclast inhibitory peptide-1 (OIP-1) can 
inhibit osteoclastogenesis of murine bone marrow precursors via the inhibitory 
FcyRIIB 9 4 These studies clearly point towards a direct role for FcyRs m osteoclast-
mediated bone erosions m RA 
Dysregulation of Fey receptor expression in arthritis 
Activating and inhibitory FcyRs are co-expressed and function m concert to generate 
a well-balanced immune response 9 5 Disruption of this functional balance either 
leads to hyperactivity or unresponsiveness towards foreign and/or self-antigens, as 
is often observed in autoimmune diseases and infections Normally, the expression 
of FcyRs is tightly regulated by inflammatory stimuli and cytokines Activating FcyRs 
are up-regulated by the bacterial endotoxin lipopolysacchande (LPS), complement 
component C5a, and Τ helper 1 (Thl) cytokines mterferon-y (IFNy) and TNFa The 
inhibitory FcyRIIB, on the other hand, is down-regulated upon stimulation with these 
inflammatory mediators 2 6 9 6 9 9 The Th2 cytokines IL-4, IL-13, and transforming 
growth factor-ß (TGF-ß), as opposed to Thl cytokines, down-regulate activating 
FcyRs and up-regulate the inhibitory FcyRIIB " 1 0 1 
Τ cells are not only essential for effective host defense, but they are also key 
players in autoimmunity In arthritis models the chromcity of joint inflammation and 
degradation are markedly amplified by the presence of a Τ cell component 
One of the prominent activities of Τ cells in joint pathology is to modulate effector 
cell functions via secretion of cytokines that regulate FcyR expression For many 
years RA was considered a Thl driven disease, characterized by increased local 
production of IFNy and inadequate production of Th2 cytokines Neutrophils 
isolated from the synovial fluid of RA patients express high levels of FcyRI, as 
opposed to neutrophils derived from the blood of these patients, which do not 
express FcyRI Additionally, FcyRI induction by RA synovial fluid on neutrophils of 
healthy controls can be blocked by addition of an anti-IFNy antibody In mice, local 
overexpression of IFNy during ICA aggravates the severity of joint destruction 107 
This does not result from a change in total cell mass, but is rather due to enhanced 
expression levels of FcyRI m the inflamed synovium m conjunction with an increased 
18 
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activation state of macrophages. The deleterious effect of IFNy is only observed in 
the presence of immune complexes and FcyRs, and in FcyRf ~ mice, levels of 
cartilage destruction remain low . Furthermore, even though the initiation of 
inflammation at ICA onset was shown to be mediated by FcyRIII , local 
overexpression of IFNy can bypass this FcyRIII dependency by induction of FcyRI 
expression in the synovium 
Discovery of the Thl7 cell, named after its production of the pro-inflammatory 
cytokine IL-17, has refined the Τ cell paradigm in arthritis. Elevated IL-17 levels have 
been found in the synovium of RA patients 109, and evidence for its pathogenic role in 
the regulation of inflammation, cartilage, and bone destruction is growing . We 
have found that IL-17 amplifies cartilage destruction, particularly in immune 
complex-mediated arthritis models, but whether direct regulation of FcyR expression 
is involved is unclear 1 1 3 ' m . 
In the non-T cell-mediated ICA model it was shown that local triggering of Toll-like 
receptor 4 (TLR4) by the cationic antigen lysozyme, used for ICA induction, 
potentiates early onset of inflammation and cartilage destruction through up-
regulation of FcyR expression . TLR4 is a member of the Toll-like receptor family, 
which function as gatekeepers of innate and adaptive immunity. Aberrant regulation 
and/or activation of TLRs is strongly associated with the development of 
autoimmune diseases. TLR4 recognizes exogenous pathogen-associated molecular 
patterns (PAMPs) or endogenous damage-associated molecular patterns (DAMPs), 
leading to inflammatory responses . In addition, TLR4 was shown to contribute to 
spontaneous arthritis development in IL-1 receptor antagonist (IL-IRa) mice by 
modulating Thl7 cells and IL-17 production , while TLR4 inhibition suppresses the 
development of inflammation and joint destruction in CIA mice . The expression of 
TLR4 in RA synovium is elevated and various TLR4 ligands are present within the 
joints 120'121. However, which ligands play a dominant role in the initiation and 
progression of the disease remains to be elucidated. 
Fey receptors and alarmins in rheumatoid arthritis 
DAMPs, also referred to as alarmins, are endogenous molecules rapidly released or 
secreted in response to cellular stress, tissue injury, inflammation, and necrotic cell 
death. They serve to alarm the innate and adaptive immune system and share 
several characteristics with cytokines1 2 2"1 4. A growing body of evidence implicates a 
role for alarmins such as the calgranulins, heat shock proteins, and high mobility 
group box 1 (HMGB-1) in the pathogenesis of autoimmune diseases 
19 
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Calgranulins, comprised of calgranulm A (S100A8, myeloid-related protein 8 [MRP8]), 
calgranulm Β (S100A9, MRP14), and calgranulm C (S100A12), are the most up-
regulated proteins present in RA synovial fluid 1 2 8 S100A8 and S100A9 were initially 
described as markers of inflammation, but their expression strongly correlates with 
arthritis severity and joint destruction as well 1 2 9 1 3 0 . in addition, studies on 
experimental arthritis m FcyR knockout mice have identified a strong association 
between the expression of FcyRs, the expression of S100A8 and S100A9, and disease 
activity n 4 7 1 0 7 Macrophages in inflamed knee joints of FcyRI/IM and FcyRllf mice 
lack expression of S100A8 and S100A9, whereas enhanced expression of these 
proteins is detected in macrophages of FcyRIIB"" animals. A direct role m joint 
destruction is suggested by the fact that S100A8- and S100A9-expressing 
macrophages are found m close proximity of the cartilage surface , as well as 
that they are an important source of IL-1 and oxygen radicals under inflammatory 
conditions 1 3 1 1 3 2 . S100A12 is a sensitive biomarker for disease activity in arthritis, 
inflammatory bowel disease, and acute vasculitis, and can induce synovial 
inflammation m CIA mice 
Regulation and function of SlOO proteins 
The calgranulins form a subgroup of proteins within the SlOO protein family, of 
which more than 20 members have been described thus far. S100 proteins are low 
molecular weight proteins (9-14 kDa) characterized by two Ca2+-binding EF-hand 
motifs S100A12 is exclusively expressed m granulocytes and, in contrast to 
S100A8 and S100A9, is not expressed in rodents 1 3 9 1 < , 0 it forms homodimers, is 
secreted by activated neutrophils, and displays potent chemotactic activity W 1 1 4 2 . 
S100A8 and S100A9 are abundantly expressed m the cytosol of granulocytes, 
monocytes, in early stages of macrophage differentiation, and even in bone and 
cartilage cells Although they are not expressed by resident tissue 
macrophages, they are strongly induced during acute and chronic inflammation 1K 
Their expression is regulated by various pro-inflammatory stimuli such as LPS, IFNy, 
TNF, and IL-1 1 4 6 1 4 β Usually, S100A8 and S100A9 are co-expressed and form a non-
covalent heterodimer complex (S100A8/A9) In heterodimer formation S100A8 
functions as the bioactive component, whereas S100A9 stabilizes S100A8 to prevent 
its degradation Targeted deletion of the S100A9 gene results m loss of both S100A8 
and S100A9 protein expression, probably due to rapid degradation of S100A8 as its 
binding partner S100A9 is absent Besides heterodimers, homodimers can be 
formed as well, which may exert other functions than the heterodimer complex 
S100A8 and S100A9 are implicated in various intra- and extracellular functions 
Intracellular homeostasis is maintained upon calcium binding, thereby regulating the 
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differentiation of myeloid cells, organization of the cytoskeleton, production of 
reactive oxygen species, and Ca2+-homeostasis 1 5 0 1 5 3 . S100A8 and S100A9 are 
actively secreted by cytokine-activated phagocytes via a protein kinase C (PKC) and 
tubulin dependent pathway 154. This secretory mechanism deviates from the classical 
endoplasmic reticulum-Golgi secretion route and is suggested to be typical for DAMP 
molecules . After secretion they stimulate the production of pro-inflammatory 
cytokines and adhesion molecules resulting in attraction and activation of leukocytes 
156 158 s e c r e t j o n by activated phagocytes, together with the chemo-attracting and 
cytokine-like functions of S100A8 and S100A9, culminates m a positive feedback 
mechanism promoting further recruitment and activation of leukocytes. This 
provides a plausible mechanism by which S100A8 and S100A9 may function as 
amplifiers of inflammation in RA. 
S100 proteins and signaling 
Sensing of DAMPs occurs through pattern recognition receptors (PRRs) like TLRs, 
NOD-like receptors, scavenger receptors, and the receptor for advanced glycation 
end products (RAGE). S100A12 exerts its chemotactic and pro-inflammatory 
activities via interaction with RAGE . Based upon its close homology with other 
S100 family members it was then assumed that all S100 proteins would act via RAGE, 
which seems rather oversimplified these days. A schematic overview of putative 
receptors and signaling pathways for S100A8 and S100A9 is given in Figure 3. 
Promotion of tumor cell growth and cardiomyocyte dysfunction induced by 
S100A8/A9 were indeed shown to be mediated by RAGE and downstream activation 
of nuclear factor-κΒ (NF-κΒ) 160'161. However, in murine phagocytes S100A8 was 
demonstrated to signal via TLR4, activating the canonical myeloid differentiation 
factor 88 (MyD88) dependent pathway, thereby promoting lethal endotoxin-induced 
shock . TLR4 activation sets off an intracellular chain of reactions, mediated by 
adaptor proteins and kinases, wherein downstream activation of the transcription 
factors activator protein-1 (AP-1) and NF-κΒ eventually results in the expression of 
pro-inflammatory cytokines and chemokines . More recently, Loser and colleagues 
have shown that S100A8 and S100A9 play a crucial role in the development of 
autoreactive CD8+ Τ cells, which was also mediated by TRL4 164. 
Besides a role for TLR4 in RA pathogenesis, there are also strong indications that 
RAGE might be involved. Blockade of RAGE suppresses the clinical and histological 
evidence of inflammation and joint destruction in CIA mice, and the prevalence of a 
polymorphism within the ligand-binding domain of RAGE was found to be increased 
in RA patients 136. Which of these two receptors is most dominant in S100A8 and/or 
S100A9 induced pathology in arthritis remains to be clarified. 
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IRAKI IRAK4 
TRAF6 
ERK1/2 P38 
NF-kB AP-1 
Figure 3: Putative receptors and signaling pathways for S100A8 en S100A9 
Aim and outline of this thesis 
The general aim of this thesis was to broaden our understanding of FcyR-mediated 
joint destruction in experimental arthritis and to further explore their association 
with the expression and function of the alarmins S100A8 and S100A9. 
In Chapters 2 and 3, we investigated the role of FcyRs in osteoclast-mediated bone 
destruction in experimental arthritis. First (Chapter 2), we elicited antigen-induced 
arthritis in the knee joints of FcyRIIB'^, FcyRI/ll/llf7", and FcRy-chain-7' mice, after 
which bone erosion levels and the expression of osteoclast regulatory factors were 
analyzed. In Chapter 3, we further explored the direct role of FcyRs and their 
response towards immune complexes in osteoclast differentiation and function in 
vitro using bone marrow-derived osteoclast precursors from FcyRIIB" and FcRy-
chain'7" mice. 
Because disruption of the coordinated expression of activating and inhibitory FcyRs 
is an important determinant of joint destruction in arthritis, it is essential to identify 
the factors present within the inflamed joint that can modulate this expression 
balance, and to gain further insight into their underlying destructive mechanisms. In 
Chapter 4, we therefore compared the mechanisms by which IL-17 and IFNy amplify 
Chapter ι 
FcyR-mediated cartilage destruction In vitro, we studied the ability of these 
cytokines to regulate FcyR expression on macrophages and neutrophils In vivo, we 
examined the modulation of inflammation and cartilage destruction by local, 
adenoviral overexpression of IL-17 or IFNy during immune complex-mediated 
arthritis (ICA) m FcRy-chain~/" mice 
In addition to cytokines, it was shown that TLR4 activation can influence FcyR 
expression. Given the strong association in experimental arthritis between the 
expression of FcyRs and the expression of S100A8 and S100A9, ligands of TLR4 
and/or RAGE, we investigated whether these S100 proteins can directly modulate 
FcyR expression on macrophages and neutrophils {Chapter 5) In addition, we 
assessed the contribution of TLR4 m SlOO-mediated signal transduction by 
stimulation of TLR4"/" macrophages. In Chapter 6, we explored the active 
involvement of S100A8 and S100A9 m the development of inflammation and 
cartilage destruction during antigen-induced arthritis m S100A9" " mice, which also 
lack S100A8 protein expression. Potential mechanisms of S100A8-mediated cartilage 
destruction were studied into more detail in Chapter 7 Here, we examined the 
effect of S100A8 on the production and activation of aggrecanases and MMPs by 
murine chondrocytes, and compared it with the effects of IL-1 because IL-1 is known 
to be a dominant cytokine in stimulating MMP production In Chapter 8, we 
investigated the role of S100A8 and S100A9 m the regulation of osteoclast-mediated 
bone destruction Onset and progression of bone destruction were studied in 
arthritic knee joints of S100A9" " mice (AIA) In addition, we determined the 
contribution of S100A8 and S100A9, and that of their putative receptors RAGE and 
TLR4, in the formation and bone resorptive capacities of bone marrow-derived 
osteoclasts 
In the final chapter (Chapter 9) the results described m this thesis are summarized 
and discussed. 
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Chapter 2 
Abstract 
Objective To determine the relationship between synovial inflammation and the 
concomitant occurrence of cartilage and bone erosion during conditions of variable 
inflammation using various Fey receptor knockout (FcyR '") mice 
Methods Antigen-induced arthritis (AIA) was introduced in the knee joints of various 
FcyR"7" mice and wild type controls Joint inflammation, cartilage destruction, and 
bone erosion levels were determined by histological analysis Cathepsm K, RANKL, 
and osteoprotegerm (OPG) levels were detected by immunolocalization 
Results In FcyRIIB mice, which lack the inhibitory Fey receptor MB, levels of joint 
inflammation, cartilage destruction, and bone erosion were significantly higher 
(infiltrate 93%, exudate 200%, cartilage 100%, and bone 156%) AIA in mice lacking 
activating FcyR types I, III, and IV, but not the inhibitory FcyRIIB (FcRy-cham ' mice), 
prevented cartilage destruction completely In contrast, levels of bone erosion and 
joint inflammation were comparable with wild type controls Of great interest, m 
arthritic mice lacking FcyR types I, MB, and III, but not IV (FcyRI/ll/lll '" mice), levels of 
joint inflammation were highly elevated (infiltrate and exudate, 100% and 188%, 
respectively) Cartilage destruction levels were decreased by 92%, whereas bone 
erosion was increased by 200% Cathepsm K, a crucial mediator of osteoclasts, 
showed a strong correlation with the amount of inflammation, but not with the 
amount of activating FcyRs, which were low in osteoclasts RANKL, but not OPG, 
levels were higher in the inflammatory cells m arthritic knee joints of FcyRI/ll/lll / 
mice versus wild type mice 
Conclusion Activating FcyRs are crucial in mediating cartilage destruction 
independently of joint inflammation In contrast, activating FcyRs are not directly 
involved in bone erosion Indirectly, activating FcyRs drive bone destruction by 
regulating joint inflammation 
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Cartilage and bone erosions are characteristic features of rheumatoid arthritis (RA). 
During experimental antigen-induced arthritis (AIA), severe cartilage and bone 
erosions develop that resemble human disease. During AIA, large amounts of 
inflammatory cells, mainly macrophages, migrate into the synovial layer . These 
macrophages become activated, thereby releasing mediators that regulate both 
severe cartilage and bone destruction. Macrophages may regulate cartilage 
destruction directly by releasing cytokines such as interleukin-1 (IL-1), tumor 
necrosis factor (TNF), and matrix metalloproteinases (MMPs). Moreover, they may 
also indirectly mediate cartilage destruction by activating synovial fibroblasts, which 
are the main producers of MMPs 
Bone destruction is thought to be mediated mainly by osteoclasts, whose precursors 
stem from the monocyte/macrophage lineage ' . Within the synovium these 
precursors, but also mature macrophages, differentiate into functional osteoclasts 
under the influence of factors like receptor activator of NF-κΒ ligand (RANKL) 6. 
Osteoclasts secrete enzymes, such as cathepsin K, which mediate bone erosion by 
degrading type I collagen, the main component of bone. Synovial macrophages 
produce cytokines involved in differentiation and activation of osteoclasts, thereby 
aggravating bone erosion . Moreover, macrophages are important producers of 
MMPs, which may also play a part in the preparation of the bone surface for 
osteoclast attachment . 
Prominent triggers of macrophages are immune complexes (ICs) that contain IgG. 
These ICs are found in large amounts in both synovial and cartilage layers, as well as 
in the joint fluid of many RA patients 9'10. In earlier studies, we found that severe 
cartilage destruction and surface erosion in particular developed in the presence of 
ICs . Bone destruction, however, seemed to develop in all models tested. In IC-
mediated arthritis, synovial macrophages are dominant players in the induction of 
severe cartilage destruction u . 
ICs that contain IgG communicate with macrophages using Fey receptors (FcyRs). 
Binding of ICs to FcyRs causes activation of macrophages. Macrophages express 4 
classes of FcyRs 13"15 and previous studies in our laboratory have shown that the 
absence of activating FcyRI, FcyRIII, and FcyRIV completely abrogated severe 
cartilage destruction during experimental arthritis . Thus, macrophage activation 
by FcyRs is an important event in the onset of cartilage destruction. 
In the present study, we investigated the relative contribution of FcyRs in the 
generation of severe cartilage and bone destruction during AIA. We studied the 
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relationship between synovial inflammation and the concomitant occurrence of 
cartilage and bone erosions during conditions of variable inflammation m a range of 
FcyR"'" mice. We found that activating FcyRs are crucial in mediating cartilage 
destruction independently of joint inflammation In contrast, activating FcyRs are not 
directly involved in bone erosion Indirectly, however, the presence of ICs can drive 
joint inflammation, thereby causing bone erosion. 
Materials and methods 
Animals 
FcyR"7" mice were generated as previously described 1 6 1 8 The FcyR knockout mice 
were backcrossed onto the C57BL/6 background for 15 generations and C57BL/6 
mice (The Jackson Laboratory, Bar Harbor, ME) were used as controls In some 
experiments, FcyR-7" mice of intercross progeny (C57BL/6 χ 129Sv) were used with 
their proper controls (FcyRI/ll/IM mice) All mice were housed under specific 
pathogen-free conditions during breeding and experiments. Mice received 
autoclaved chow and acidified water ad libitum Only mice that were healthy were 
used in the experiments, and they were matched by age (10-20 weeks) and sex for 
each set of experiments All experiments were approved by local authorities of the 
Animal Care and Use Committee (DEC 98 22) and were performed by personnel 
certified by the Dutch Ministry of Health. 
Induction of Antigen-Induced Arthritis 
Mice were immunized with 100 μg of methylated bovine serum albumin (mBSA, 
Sigma, Zwijndrecht, the Netherlands) emulsified in 100 μΙ of Freund's complete 
adjuvant (CFA) Injections were divided between the flanks and the footpads of the 
front paws. Heat-killed Bordetella pertussis (RIVM, Bilthoven, the Netherlands) was 
administered mtrapentoneally as an additional adjuvant One week later, 2 
subcutaneous booster injections with 50 μg of mBSA/CFA were administered in the 
neck region Three weeks after these injections, arthritis was induced by intra­
articular injection of 60 μg of mBSA m 6 μΙ phosphate buffered saline (PBS) into the 
knee joint, resulting in chronic arthritis. 
Histology of arthritic knee joints 
Mice were killed 7 days after arthritis onset Knee joints were decalcified, 
dehydrated, and embedded m paraffin. Tissue sections (7 μιτι) were stained with 
hematoxylin and eosm (H&E) Seven sections, spaced 120 μιτι apart, representing the 
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whole knee joint were measured to get a statistically justified result. Histopathologic 
changes were scored using the following parameters. Inflammation, defined as the 
influx of inflammatory cells into the synovium and joint cavity, was graded on a scale 
of 0 (no inflammation) to 3 (severely inflamed joint). Cartilage destruction was 
measured as chondrocyte death and surface erosion and was determined in various 
cartilage layers (medial and lateral femur and tibia) m total knee joint sections that 
were stained with H&E Chondrocyte death was determined as the percentage of 
cartilage area containing empty lacunae in relation to the total area Cartilage 
surface erosion was determined as the amount of cartilage lost m relation to the 
total cartilage area. All experiments were scored separately and independently of 
each other Data were expressed as the mean of all cartilage layers measured Bone 
destruction was determined m 10 different well-defined areas of the total knee joint 
section. Destruction was graded on a scale of 0 (no damage) to 3 (complete loss of 
bone structure) 
Immunohistochemical detection of cathepsm K, RANKL, and OPG 
Whole knee joint sections were fixed, decalcified, and embedded m paraffin, as 
described above Tissue sections (7 μπι) were treated with 3% H2O2 for 10 minutes at 
room temperature Sections were incubated for 2 hours with 10 mM citrate (pH 6.0), 
and thereafter incubated for 1 hour with the primary antibody directed against 
F4/80 (rat anti-mouse F4/80, Serotec, Oxford, UK), a murine macrophage membrane 
antigen, rabbit anti-RANKL (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-
OPG (Santa Cruz Biotechnology), or rabbit anti-cathepsin Κ (a kind gift of Professor 
Hideaki Sakai, Nagasaki, Japan). Rat IgG or Rabbit IgG antibodies (Dako, Carpmtena, 
CA) were used as a control. After rinsing, sections were incubated for 30 minutes 
with biotm-conjugated rabbit anti-rat IgG or biotm-conjugated swine anti-rabbit IgG 
and streptavidm-peroxidase (all Dako). Development of the peroxidase staining was 
performed with diaminobenzidme (Sigma) Counterstammg was done with Mayer's 
hematoxylin (Merck, Darmstadt, Germany) Sections were coded and randomly 
analyzed by 2 independent observers (EL and ABB) Staining of F4/80 and RANKL on 
inflammatory cells was scored using a grid at 400x magnification. Thereby, the ratio 
of stained cells was expressed as a percentage of the total cell number counted 
within the joint cavity (exudate) and m the synovium (infiltrate) in 2 random high-
power fields, both to the left and to the right of the patella. 
Osteoclasts and macrophages 
Culture of osteoclasts and macrophages was performed as previously described 19 
Briefly, tibiae from C57BL/6 mice were removed and ground m a mortar with culture 
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medium (α-Minimum Essential Medium, Gibco, Paisley, UK) supplemented with 5% 
fetal calf serum (Myelone, Logan, UT), 100 units/ml penicillin, 100 μg/ml 
streptomycin, 250 ng/ml amphotericin Β (antibiotic/antimycotic solution, Sigma), 
and heparin (170 lU/ml, Leo Pharmaceutical Products, Weesp, the Netherlands) The 
cell suspension was aspirated through a 21-gauge needle and filtered over a 100 μιη 
pore size Cell Strainer filter (Becton Dickinson, Franklin Lakes, NJ) Cells were washed 
twice m culture medium, centrifuged at 200g for 5 minutes, and plated in 96-well 
flat-bottomed tissue culture treated plates (Costar, Cambridge, MA) at a density of 
IxlO 5 cells per well Cells were cultured in 150 μΙ culture medium containing 30 
ng/ml recombinant murine macrophage colony-stimulating factor (M-CSF, R&D 
Systems, Minneapolis, MN) with or without 20 ng/ml recombinant murine RANKL 
(RANKL-TEC, R&D Systems) Tartrate-resistant acid phosphatase (TRACP)-negative 
mononuclear cells were cultured when adding M-CSF alone, whereas TRACP-positive 
multinucleated cells were cultured in the presence of M-CSF and RANKL Culture 
media were replaced after 3 days After 5 days of culture, wells were washed with 
PBS and either fixed for 5 minutes in 4% PBS-buffered formaldehyde for TRACP 
staining or dissolved in RNA lysis buffer from the RNeasy Mini kit (Qiagen, Hilden, 
Germany) and stored at -80oC (for RNA isolation) 
RNA isolation and real-time polymerase chain reaction 
RNA from cultured cells was isolated using the RNeasy Mini kit (Qiagen) according to 
the manufacturer's instructions RNA was measured with the RiboGreen kit 
(Molecular Probes, Eugene, OR) RNA (100 ng) was used in the RT reaction, which 
was performed using a complementary DNA synthesis kit (Fermentas, Vilnius, 
Lithuania), using both oligo(dT)18 and D9N6 primers Quantitative real-time 
polymerase chain reaction (PCR) was performed using the ABI Prism 7000 Sequence 
Detection system (Applied Biosystems, Foster City, CA) for quantification using SYBR 
Green Master Mix (Applied Biosystems) and melting curve analysis Primer 
sequences for GAPDH, FcyR types I, MB, III, and IV, and cathepsm Κ were used PCR 
conditions were as follows 2 minutes at 50oC and 10 minutes at 95°C, followed by 
40 cycles of 15 seconds at 950C and 1 minute at 60°C, with data collection during the 
last 30 seconds The concentration of primers (Biolegio, Maiden, the Netherlands) 
was 300 nmoles/liter All PCRs were performed m a total reagent volume of 25 μΙ 
Relative quantification of the PCR signals was performed by comparing the threshold 
cycle (Ct) value of the gene of interest in each sample with the Ct value of the 
reference gene GAPDH (ACt) Then, messenger RNA (mRNA) levels m osteoclasts 
were corrected for those found in macrophages (AÛCt) Quantitative PCR analysis of 
each sample was performed in duplicate 
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Statistical analysis 
Mann-Whitney U test was performed to determine statistical significance between 
experimental groups. Ρ values less than 0.05 were considered significant. 
Results 
Relationship between cartilage destruction and joint inflammation 
Earlier studies revealed FcyR involvement in severe cartilage destruction during AIA 
16
"
18
. Table 1 summarizes the findings regarding MMP-mediated cartilage 
destruction, matrix erosion, and their relationship with joint inflammation in various 
FcyR knockout mice. In the absence of FcyRI, FcyRIIB, and FcyRIII (FcyRI/ll/llf'" mice), 
MMP-mediated cartilage destruction was completely abolished 1 week after arthritis 
induction despite the presence of florid joint inflammation. FcyRI appeared to be 
pivotal for the mediation of severe cartilage destruction and the lack of correlation 
with joint inflammation was striking (Table 1). 
Table 1: Role of various Fey receptors (FcyRs) in mediating cartilage destruction on day 7 after induction 
of antigen-induced arthritis 
MMP-mediated Cartilage matrix 
cartilage destruction erosion Inflammation 
wild type ++ + 
FcRy-cham-'" 
FcyRI"' + 
FcyRIII"'" ++ + 
FcyRIIB"'" +++ ++ 
FcyRI/ll/lll"'" 
Tissue sections were stained with anti-VDIPEN antibodies or hematoxylin and eosm to determine matrix 
metalloprotemase (MMP)-mediated VDIPEN expression and erosion of the cartilage matrix, respectively 
VDIPEN expression was graded using an arbitrary score from 0-3 (0 = no expression, 1 = minor, 2 = 
marked, 3 = maximal within the experiment). In FcRy-cham"'" and FcyRI/ll/IH"'" mice, MMP-mediated 
cartilage destruction and matrix erosion were completely prevented, indicating that both FcyRI and 
FcyRIII may be the dominant activating FcyRs In the absence of only FcyRIII, no differences were found 
compared with controls, whereas in the absence of only FcyRI, MMP-mediated cartilage destruction and 
matrix erosion were partially prevented 
++ 
++ 
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We decided to explore the synovial inflammation in more detail, paying particular 
attention to the number of inflammatory cells in synovial tissue and joint exudate. 
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Figure 1. Effect of Fey receptors (FcyRs) on joint inflammation (cell mass in the joint cavity [exudate] and 
in the synovial layer [infiltrate]) 7 days after the induction of antigen-induced arthritis in FcRy-chain"'- (A), 
FcyRIIB"^ (B), and FcyRI/ll/lll '" (C) mice, and their wild type controls. Data were graded using an arbitrary 
scale of 0-3 (0 = no cells, 1 = few cells, 2 = moderate, 3 = maximal within the experiment). The number of 
macrophages was determined by immunolocalization of F4/80 (inset in E) and expressed as a percentage 
of the total cell influx. Levels of joint inflammation were significantly higher in arthritic FcyRIIB and 
FcyRI/ll/lir'" mice compared with controls. Values are the mean ± SD of at least 8 animals per group. * = Ρ 
< 0.05 by Mann-Whitney U test. Histologically, knee joints of arthritic FcvRI/ll/lll mice (E) showed 
strongly increased levels of joint inflammation compared with wild type controls (D). Original 
magnification xlOO in D and E; x400 in inset. 
Since FcyRI in mice is predominantly expressed on macrophages, their numbers were 
specified using immunodetection of the macrophage antigen F4/80. In the absence 
of the inhibitory FcyRIIB (FcyRIIB^ ' mice), levels of joint inflammation on day 7 of AIA 
were significantly higher (infiltrate 93% and exudate 200% higher) than those in wild 
type controls {Figure IB). In arthritic knee joints of mice lacking all activating FcyRI, 
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III, and IV, but not the inhibitory FcyRIIB (FcRy-cham mice), comparable levels of 
joint inflammation were found (Figure 1A). In FcyRI/ll/llf'- mice, levels of joint 
inflammation were significantly elevated (infiltrate and exudate by 100% and 188%, 
respectively) as compared with their controls, probably due to inefficient clearance 
of ICs 18 (Figure 1C). The number of F4/80-positive cells (macrophages) was 
expressed as a percentage of the total number of inflammatory cells in the joint 
cavity (exudate) and synovium (infiltrate) (Figures 1A-C) The increased cellular influx 
when only FcyRIIB was absent, or when FcyRI, MB, and III, but not FcyRIV, were 
absent was particularly due to polymorphonuclear cells (PMNs). The latter was 
confirmed by immunodetection of the PMN-specific NIMP-R14 antigen (results not 
shown) 
Involvement of activating FcyRs not seen in bone destruction during AIA 
We then investigated whether bone erosion is FcyR-dependent and/or coupled to 
joint inflammation For that purpose, 10 well-defined areas along the bone surface 
of total knee joint sections were graded for bone erosion using an arbitrary scale 
from 0-3. Results were expressed as the sum of all 10 areas. Bone erosion was most 
pronounced at the medial femur and tibia of the knee joint. In FcyRIIB"'" mice, levels 
of bone destruction were significantly elevated (156%), suggesting that activating 
FcyRs may be involved in bone destruction (Figure 2B) In FcyRI/11/ΙΐΓ " mice, levels of 
bone erosion were increased by 200% (Figures 2C, J, and K). The severity of bone 
erosion was correlated with the amount of cell influx, implying that bone erosion 
may still be regulated directly by FcyRIV, or indirectly by enhanced cellular influx 
However, m the knee joints of FcRy-cham" mice with AIA, levels of bone erosion 
(Figure 2A) and joint inflammation were not significantly different from those m their 
wild type controls, indicating that bone destruction is not directly regulated by 
FcyRs, but is more likely to be regulated by the number of inflammatory cells 
Cartilage destruction and bone erosion uncoupled 
To compare bone erosion with cartilage destruction, we quantified chondrocyte 
death, cartilage surface erosion, and bone erosion in the same sections. In FcyRIIB" " 
mice, chondrocyte death was significantly elevated on day 7 after AIA induction 
(156%) and correlated with elevated joint inflammation (Figure 25). When arthritis 
was induced in the knee joints of FcyRI/ll/llf/" mice, cartilage destruction levels 
(chondrocyte death) were 92% lower than in the arthritic knee joints of wild type 
controls, although joint inflammation was significantly elevated (Figure 2F) This 
implies that FcyRIV is not involved m mediation of cartilage destruction at this time 
point and that cartilage destruction is not coupled to joint inflammation. 
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Chondrocyte death Surface erosion 
Figure 2. Effect of Fey receptors (FcyRs) on bone erosion and cartilage destruction 7 days after the 
induction of antigen-induced arthritis in FcRy-chain-'" (A, D, and G), FcyRIIB^" (B, E, and H), and 
FcyRI/ll/lir'- (C, F, and I) mice, and wild type (WT) controls. Bone erosion was determined in 10 different 
well-defined areas of the total knee joint section and graded on a scale of 0-3, ranging from no damage to 
complete loss of bone. Cartilage destruction was measured as chondrocyte death or surface erosion. In 
FcRy-chain''" mice, no cartilage destruction was observed, whereas levels of bone destruction were not 
different from levels in wild type controls (D and G versus A). In FcyRI/ll/lir ' mice, cartilage destruction 
was also completely absent, whereas levels of bone destruction were elevated and correlated with the 
severity of inflammation (F and I versus C). In FcyRIIB mice, levels of both cartilage and bone erosion 
were elevated (E and H versus B). Values are the mean ± SD of at least 8 animals per group. * = Ρ < 0.05 
versus wild type controls, by Mann-Whitney U test. In FcvRI/ll/lll mice, bone erosion was very severe, 
and a direct connection between synovial inflammation and bone marrow was observed (J; arrow). Bone 
erosion in wild type controls was less severe (K; arrow). Insets show bone erosion at a higher 
magnification. Chondrocyte death (F) was absent in FcyRI/ll/llf'' mice (J) and prominent in wild type 
controls (K; see empty lacunae; arrowheads). Hematoxylin and eosin stained knee joint sections; original 
magnification x250 in J and Κ; x400 in insets. 
Since the development of bone erosion continued within these mice (Figures 2B and 
C) this further indicated that there is also an uncoupling between cartilage and bone 
destruction. Further proof that cartilage and bone destruction are not coupled was 
obtained from FcRy-chain- ' mice. Levels of joint inflammation were not significantly 
different between FcRv-chain~/~ mice and their wild type controls. Although cartilage 
destruction (chondrocyte death) on day 7 was completely absent in arthritic FcRy-
chain' ~ mice (Figure 2D), the development of bone erosion continued and its 
4S 
Chapter 2 
severity was not different from controls (Figure 2A). Similar trends were found when 
cartilage surface erosion was scored (Figures 2G, H, and /). 
Osteoclast cathepsin Κ not directly dependent on FcyR expression and activation 
Osteoclasts produce large amounts of cathepsin K, a dominant enzyme that 
mediates the degradation of bone matrix. Immunostaining of cathepsin Κ was found 
almost exclusively in well-defined osteoclast-containing areas at sites adjacent to 
bone erosion (Figures 3D and f) . In arthritic knee joints of FcRy-chain" mice, 
cathepsin Κ levels were reduced by 28%, although this difference did not reach 
significance (Figure 3A). In the absence of only FcyRIIB (FcvRIIB"/_ mice), cathepsin Κ 
staining was significantly elevated by 200% and correlated with enhanced joint 
inflammation (Figure 3B). In FcyRI/ll/llf ' mice, cathepsin Κ staining areas were again 
elevated, by 121%, and correlated with enhanced joint inflammation, implying that 
the amount of cellular influx is correlated with the presence of cathepsin Κ (Figures 
3C-E). 
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Figure 3. Immunolocalization of cathepsin Κ in inflamed knee joints of FcRv-chain-'- (A), FcyRIlB''- (Β), and 
FcyRI/M/iir ' (C) mice. The area expressing cathepsin Κ was evaluated using image analysis. Levels of 
cathepsin K-positive multinucleated cells were significantly increased in the inflamed joints of FcyRI/ll/llf'' 
mice (C and E) or FcyRIIB"'" mice (B), whereas much less staining was detected in the arthritic controls (B-
D). Values are the mean ± SD of at least 8 mice per group. * = Ρ < 0.05 versus control, by Mann-Whitney U 
test. Arrows in D and E represent cathepsin K-positive multinucleated cells. Original magnification x250. 
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Down-regulation of FcyR expression during differentiation into osteoclasts 
ICs may directly activate osteoclasts by binding to their FcyRs. To investigate the 
relative expression of FcyRs in osteoclasts compared with that of macrophages, 
murine bone marrow cells were cultured in the presence of M-CSF (macrophages) 
and M-CSF and RANKL (osteoclasts), respectively. The latter combination 
differentiated bone marrow cells into multinucleated osteoclasts (Figures 4A and 8), 
in which the mRNA level for cathepsin K, a marker of osteoclasts, was raised by more 
than 1,000-fold as measured by real-time PCR (Figure 4C). Although FcyR mRNA 
levels are expressed by osteoclasts, the levels of all activating FcyRs (FcyR types I, III, 
and IV) were significantly reduced (16, 8, and 4 times, respectively) compared with 
macrophages. Interestingly, FcyRIIB expression levels were comparable with those 
found in macrophages. This resulted in a much lower ratio of activating to inhibitory 
FcyRs, suggesting that osteoclasts are less sensitive to direct activation by ICs. 
FcvRI FcyRIIB FcvRIII Fc-.RIV cathepsin Κ 
Figure 4. Fey receptor (FcvR)expression by osteoclasts. Bone marrow cells were cultured for 5 days with 
(A) M-CSF (macrophages; arrow) or (B) M-CSF and RANKL (osteoclasts; arrow). Original magnification 
χ400. (C) RNA was isolated from these cells and messenger RNA (mRNA) levels of FcyRI, FcyRIIB, FcyRIII, 
FcyRIV, and cathepsin Κ were determined using quantitative real-time polymerase chain reaction. First, 
differences in mRNA levels of FcyRs or cathepsin Κ were corrected for GAPDH (ACt). Then, mRNA levels in 
osteoclasts were corrected for those found in macrophages (AûCt). Levels of mRNA for cathepsin Κ were 
strongly increased, whereas activating FcyR types I, III, and IV mRNA levels were significantly down-
regulated. 
Determination of RANKL and OPG expression by inflammatory cells 
Since joint inflammation levels were correlated with the number of cathepsin K-
producing osteoclast-like cells along the bone surface, we additionally determined 
the levels of RANKL and OPG, a soluble decoy receptor for RANKL competing against 
RANK. Immunolocalization of RANKL and OPG showed that mainly mononuclear cells 
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(macrophages and lymphocytes) and not polymorphonuclear cells stained positive 
(Figures 5E and F). In FcyRI/ll/IH mice, RANKL-positive cells were increased in the 
exudate (114%) (Figure 5C), whereas no significant differences were found in the 
number of OPG-positive cells between FcyRI/ll/lll mice and wild type controls 
(Figure 5D), suggesting that more osteoclast differentiation factors may be released 
within these joints. In FcRy-chain"' mice, the number of RANKL-positive cells was 
67% lower in the exudate (Figure 5A). The number of OPG-positive cells in the 
infiltrate was also down-regulated, by 56% (Figure 5B). These differences, however, 
did not reach statistical significance. 
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Figure 5. RANKL and osteoprotegerin (OPG) expression by inflammatory cells on day 7 after the induction 
of antigen-induced arthritis in FcRy-chain^ (A and B), FcyRI/ll/llf'" mice (C and D), and wild type controls. 
RANKL and OPG expression were determined by immunolocalization. The percentage of positive cells 
present within the cellular mass in the joint cavity (exudate) and in the synovial layer (infiltrate) was 
determined using a microscopy caliper. Five microscopic fields (400χ) were counted, and positive cells 
were expressed as a percentage of total inflammatory cells. Values are the mean ± SD of at least 8 animals 
per group. * = Ρ < 0.05 versus controls, by Mann-Whitney U test. Only macrophages, and not 
polymorphonuclear cells, expressed RANKL and OPG (E and F). Original magnification χ400. 
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Discussion 
In the present study, we found that FcyRs are crucial in directly mediating cartilage 
destruction but not bone erosion However, FcyRs may indirectly drive bone erosion 
by regulating joint inflammation Mostly, a clear correlation was found between 
cartilage destruction and the number of inflammatory cells present within the joint 
However, in the arthritic knee joints of FcyRI/ll/lll ' mice, a clear uncoupling was 
found between joint inflammation and cartilage destruction, indicating that FcyRs 
are crucial in directly mediating cartilage destruction As a parameter of cartilage 
destruction we investigated chondrocyte death, which, together with the breakdown 
of the type II collagen network, is the ultimate change towards irreversible cartilage 
destruction In earlier studies, we found that FcyRI, in mice predominantly expressed 
by synovial macrophages, is responsible for chondrocyte death m the AIA model 
Binding of ICs to FcyRI on synovial macrophages leads to activation of NADPH 
oxidase and the production of oxygen radicals, cytokines like TNF, and enzymes such 
as MMPs, and may be responsible for inducing chondrocyte death 
In contrast to cartilage destruction, bone erosion is not directly regulated by FcyRs 
since the development of bone erosion continued m the absence of all 3 activating 
FcyRs (FcRy-cham"7" mice) In FcyRI/ll/lll mice, levels of bone erosion were 
substantially higher on day 7 after AIA induction as compared with wild type 
controls However, bone erosion m these mice strongly correlated with joint 
inflammation and since the latter is FcyR-dependent, this indicates that bone erosion 
is indirectly related to FcyRs Earlier studies have shown that FcyRIIB strongly inhibits 
joint inflammation during AIA This may be a result of suppressing activating FcyRs or 
by increasing the phagocytosis of ICs 18 In FcyRI/ll/llf " mice, the capacity of 
macrophages to phagocytose ICs is strongly reduced, which may lead to increased 
complement activation, driving the severe inflammation within the arthritic joints 
Bone erosion is predominantly regulated by osteoclasts These cells differentiate 
from precursor cells and migrate to the bone surface Targeting osteoclasts with 
zoledromc acid, resulting in their mactivation, was shown to prevent bone 
destruction m collagen-induced arthritis Osteoclasts highly and quite selectively 
express cathepsm Κ ^ This enzyme is activated intracellularly and secreted into the 
resorption area 24 and can efficiently degrade native type I collagen and several 
other proteins of the bone matrix In the present study, we found a significant 
elevation of the number of cathepsm K-positive cells along the bone surface in 
arthritic knee joints of FcyRI/11/ΙΐΓ " mice This may be due to increased 
differentiation of stem cells into osteoclasts, or it may be because resident 
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osteoclasts become more activated. More inflammation may lead to an elevated 
influx of hematopoietic stem cells, which also differentiate into osteoclasts. 
Concomitantly, more inflammation may attract more resident osteoclasts to the 
bone surface. 
The FcRy-chain is associated with the osteoclast-associated receptor, which is 
critical for osteoclast differentiation 26. However, arthritic FcRy-chain" " mice showed 
bone erosion levels similar to those in wild type controls, implying that cathepsin K-
producing cells other than osteoclasts may be involved in mediating bone erosion in 
this model. 
ICs may activate osteoclasts directly by binding to their FcyRs. Although low amounts 
of FcyRs are present in osteoclasts, we found that expression of the activating FcyR 
types I, III, and IV is significantly down-regulated in in v/iro-generated osteoclasts 
compared with in w'tro-generated macrophages. Expression of the inhibitory FcyRIIB 
on the other hand, was comparable to that found in macrophages. Since the ratio of 
activating to inhibitory FcyRs was much lower in osteoclasts than in macrophages, 
the direct activation of osteoclasts by ICs may be of minor importance. In contrast, 
activation of inflammatory cells that highly express activating FcyRs may lead to the 
release of cytokines involved in differentiation of monocytes into osteoclasts. 
However, the development of bone erosion continued in the knee joints of 
FcyRI/ll/lir7" mice, while the infiltrated cells still became highly activated, as 
indicated by the expression of activation markers such as MRP14 . This suggests 
that non-FcyR-regulated production of mediators stimulates monocyte-derived 
osteoclast formation. 
M-CSF and RANKL have been shown to be sufficient for the differentiation of bone 
marrow-derived hematopoietic precursor cells into bone-resorbing osteoclasts 
RANK, RANKL, and OPG, the decoy receptor of RANKL, are clearly expressed during 
experimental arthritis 28. RANK/RANKL pathways are of crucial importance in 
osteoclastogenesis and the development of bone erosion. RANKL knockout mice 
express an osteopetrotic phenotype, including the complete absence of osteoclasts 
29 
, whereas the decoy receptor OPG is an important negative regulator of 
osteoclastogenesis and bone resorption 30'31. Mononuclear cells, which are clearly 
present in AIA, dominantly expressed RANKL and OPG. Although the percentage of 
mononuclear cells expressing RANKL was lower in FcRy-chain" " mice, there was still 
significant expression of RANKL. The latter finding indicates that, in this model, 
mononuclear cells become activated to produce RANKL by non-FcyR pathways. 
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The number of RANKL-producing mononuclear cells may have a crucial impact on 
differentiating osteoclasts Activated Τ cells are well-known producers of RANKL 32 
and induction of apoptosis in activated Τ cells resulted in significant suppression of 
osteoclastogenesis 33 Osteoclastogenesis is thereby further regulated by Τ cell-
derived cytokines, such as IL-17 34 and IL-18 35, and macrophage-denved cytokines, 
such as IL-1 3 6 and IL-6 37 In the present study, we found that a large number of the 
mononuclear cells expressing RANKL were also F4/80 positive Although monocytes 
normally do not express RANKL 38, this suggests that activated macrophages may 
also contribute to RANKL production 
The most important inhibitor of RANKL is OPG, which prevents RANK-RANKL 
interaction, resulting m the inhibition of osteoclastogenesis OPG is highly 
expressed by fibroblasts 39, which may substantially contribute as an inhibitor of 
RANKL The balance of the expression levels between RANKL and OPG is critical for 
osteoclast formation and the RANKL OPG ratio acts independently of cathepsm K, 
since impaired bone resorption in cathepsm K-deficient mice is partially 
compensated by an increased RANKL OPG ratio 4 0 A decreased concentration of 
OPG was detected m synovial fluid from RA patients ',1 We found that the ratio of 
RANKL- to OPG-producmg cells was somewhat higher in mononuclear cells present 
within knee joints of arthritic FcyRI/ll/lll '' mice, which may explain the elevated 
osteoclast formation 
NIMP-R14-positive PMNs appeared predominantly within the inflamed synovium 
and were mainly responsible for the increase in joint inflammation in arthritic 
FcyRIIB"7 and FcyRI/ll/lll ' mice However, these cells did not express RANKL or 
OPG, which suggests that PMNs are probably not involved in osteoclast 
differentiation via the RANKL/OPG pathway However, large amounts of PMNs may 
significantly contribute to the production of cytokines, such as IL-1 i2 A study by Ma 
et al showed that IL-1, but not TNF, dramatically up-regulates osteoclastogenesis 
in the presence of M-CSF and RANKL 
The present study clearly shows that activation of FcyRI and FcyRIII is crucial m 
directly mediating cartilage, but not bone, destruction However, indirectly FcyRs 
may also drive bone destruction by regulating joint inflammation 
Immunomodulation leading to a decrease of activating FcyRs and an increase of the 
inhibitory FcyRIIB may directly ameliorate cartilage destruction, and indirectly 
ameliorate bone erosion by down-regulating joint inflammation Thus, interference 
of FcyRs may be an important therapeutic target 
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Abstract 
Objective The aim of the present study was to investigate the role of Fey receptors 
(FcyRs) in osteoclastogenesis and osteoclast function 
Methods Bone destruction was analyzed m arthritic knee joints of FcyRIIB-deficient 
mice, FcRy-cham mice (lacking expression of all activating FcyRs), and wild type 
mice Osteoclast precursors were differentiated in vitro towards osteoclasts in the 
absence or presence of immune complexes (ICs) Additionally, mature osteoclasts 
were stimulated with ICs Experiments were analyzed for the expression of FcyRs 
and osteoclast markers, osteoclast formation, and resorption pit formation on bone 
Results Bone destruction was significantly enhanced in arthritic knee joints of 
FcyRIIB-deficient mice Compared with wild type macrophages, the levels of 
activating FcyRs on mature osteoclasts were significantly lower, whereas FcyRIIB 
expression was comparable Osteoclast precursor cells were found to express high 
levels of activating FcyRs IC stimulation of mature osteoclasts neither affected their 
number nor their bone resorptive capacity However, differentiation of bone marrow 
precursors in the presence of ICs resulted in significant inhibition of osteoclast 
formation and function Osteoclast precursors of FcyRIIB"7" mice developed normally 
into functional osteoclasts, but m the presence of ICs differentiation of FcyRIlB"7" 
precursors into osteoclasts was significantly inhibited In contrast, ICs present during 
osteoclastogenesis of FcRy-cham precursors did not inhibit osteoclast formation or 
resorption pit formation 
Conclusion Despite strong expression of FcyRIIB, ICs do not affect the function of 
mature osteoclasts Osteoclastogenesis in the presence of ICs is strongly inhibited via 
activating FcyRs, which are highly expressed on precursor cells 
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Rheumatoid arthritis (RA) is characterized by chronic inflammation and joint 
destruction. Disturbance of the delicate balance between bone formation and bone 
resorption in favor of the latter, resulting from activation of resident osteoclasts and 
differentiation of infiltrated precursor cells ' , leads to functional disability ' 
Osteoclasts are unique in their ability to resorb mineralized tissues like bone. They 
are derived from hematopoietic precursors of the monocyte/macrophage lineage 
and differentiate into multinucleated osteoclasts under the influence of macrophage 
colony-stimulating factor (M-CSF) and receptor activator of NF-κΒ ligand (RANKL)5. 
In addition to M-CSF and RANKL, recent studies have demonstrated that co-
stimulatory signaling via immunoreceptor tyrosine-based activation motif (ITAM)-
bearing adaptors is essential for osteoclastogenesis. The Fc receptor y subunit (FcRy-
chain) is required for signal transduction of the osteoclast-associated receptor 
(OSCAR). DNAX-activation protein 12 (DAP12) is a molecule that associates with 
triggering receptor expressed on myeloid cells 2 (TREM-2). Both OSCAR and TREM-2 
are important regulators of osteoclastogenesis 6'7. In addition, FcRy-chain~ " mice 
display a normal skeletal phenotype, whereas DAP12"/" mice display mild 
osteopetrosis. In contrast, DAP12/FcRy-chain double knockout mice exhibit a very 
severe osteopetrotic phenotype due to a complete lack of osteoclast differentiation, 
suggesting functional redundancy between these two adaptors . 
Regulation of ITAM-mediated signaling is mediated by immunoreceptor tyrosine-
based inhibitory motif (ITIM)-mediated signaling. The balance between these 
signaling pathways determines the magnitude of the response. Recent studies have 
demonstrated inhibition of osteoclast formation or activity by ITIM-bearing 
receptors such as PIR-B, SIRPa, and PECAM-1, via recruitment and activation of the 
protein tyrosine phosphatase SHP-1 9'11. In contrast, Ly49Q, another ITIM-bearing 
receptor induced on osteoclast precursors upon RANKL stimulation, was found to 
positively regulate osteoclast differentiation, which was suggested to result from 
competition between ITIM-bearing receptors for binding SHP-112. In 2002, Takeshita 
et al. have identified the hematopoietic-restricted protein Src homology 2-containing 
inositol 5'-phosphatase (SHIP) as an important regulator of osteoclast formation and 
function. It was demonstrated that SHIP"''" mice develop severe osteoporosis due to 
increased numbers of hyper-resorptive osteoclasts, which resulted from a prolonged 
life span and an increased sensitivity of osteoclast precursors to M-CSF and RANKL13. 
Interestingly, SHIP was found to play a central role in the regulation of bone 
destruction in the immune complex-mediated K/BxN serum transfer arthritis model 
, in which Fey receptors (FcyRs) also play a crucial role 15'16. 
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Immune complexes (ICs), composed of antibodies bound to its specific antigen, are 
abundantly present in the sera and joints of RA patients and play an important role 
in mediating inflammation and joint destruction 17 ICs regulate immunogenic and 
tolerogenic responses via binding to FcyRs, a family of highly conserved 
transmembrane receptors, expressed on cells of hematopoietic origin such as 
monocytes, macrophages, neutrophils, dendritic cells, and Β cells Four different 
FcyR classes have been identified m mice FcyRI, FcyRIII, and FcyRIV are activating 
receptors signaling through the ITAM-bearmg FcRy-cham The inhibitory FcyRIIB 
mediates its downstream signaling through ITIM phosphorylation, thereby recruiting 
SHIP and counteracting the activation signals of activating FcyRs or other ITAM-
bearmg receptors 
The experimental antigen-induced arthritis (AIA) model, wherein IC formation is a 
major element of the disease, is characterized by rapid development of 
inflammation and severe cartilage and bone erosions upon triggering with the 
antigen, and shows great resemblance to human RA pathogenesis Using this model, 
we have previously demonstrated that the activating FcyRI and FcyRIII play a crucial 
role in matrix metalloprotemase (MMP)-mediated cartilage destruction FcyRIIB was 
shown to be an essential inhibitory factor m the regulation of cartilage destruction, 
bone degradation, and joint inflammation by controlling the influx of mononuclear 
cells 2 1 2 2 However, the molecular association between IC-mduced activation of the 
ITIM-bearmg FcyRIIB and the regulation of osteoclast-mediated bone destruction has 
not been investigated thus far The aim of the present study was to investigate the 
role of FcyRIIB in IC-stimulated osteoclast differentiation and activation 
Materials and methods 
Mice 
FcyRIIB" " mice were recently generated by Dr Verbeek using C57BL/6-derived 
embryonic stem cells FcyRI/11/ΙΐΓ and FcRy-cham mice were generated as 
previously described Wild type C57BL/6J mice were purchased from Charles 
River (Sulzfeld, Germany) Mice were housed m filter-top cages and a standard diet 
and water were provided ad libitum All animal studies were approved by the Local 
Animal Experimentation Committee 
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Induction of Antigen-Induced Arthritis 
Mice were immunized with 100 μg of methylated bovine serum albumin (mBSA, 
Sigma-Aldnch, St Louis, MO), emulsified in 100 μΙ Freund's complete adjuvant (CFA, 
Difco Laboratories, Detroit, Ml) Injections were divided over both flanks and 
footpads of the front paws Heat-killed Bordetella pertussis (RIVM, Bilthoven, the 
Netherlands) was administered mtrapentoneally as an additional adjuvant Two 
subcutaneous booster injections with in total 50 μg mBSA/CFA were given m the 
neck region 1 week after the initial immunization Three weeks after these 
injections, AIA was induced by injecting 60 μg of mBSA in 6 μΙ phosphate buffered 
saline (PBS) directly into the knee joint, resulting m chronic arthritis 
Histological analysis 
Seven days after AIA induction total knee joints were isolated, fixed m 4% formalin 
for 4 days, decalcified in formic acid, dehydrated, and embedded in paraffin Frontal 
sections of 7 μπι were prepared and stained with hematoxylin and eosm to study 
bone erosion, which was graded on a scale ranging from 0 (no erosion) to 3 
(complete bone loss) Osteoclast activity was visualized by immunohistochemistry 
for the osteoclast activity marker cathepsm Κ Sections were deparaffmized, 
rehydrated, and treated with 3% H2O2 in methanol for 15 minutes Subsequently, 
sections were pre-incubated with 10% casein m PBS for 30 minutes and thereafter 
incubated for 1 hour with the primary antibody rabbit anti-cathepsm Κ (Abl9027, 
Abeam, Cambridge, UK) As a control, sections were incubated with normal rabbit 
IgG Additionally, sections were incubated with the secondary antibody, biotmylated 
goat anti-rabbit IgG and binding was detected using the ABC-HRP kit (Elite kit. Vector 
Laboratories, Burlmgame, CA) Peroxidase was developed with diammobenzidme 
(DAB) and sections were counterstamed with hematoxylin for 1 minute For 
immunolocahzation of IgG sections were pre-treated with hyaluromdase ABC and 
additionally stained with goat anti-mouse peroxidase, which was subsequently 
developed with DAB and sections were counterstamed with hematoxylin for 1 
minute 
Bone marrow isolation and in vitro cell culture 
Bone marrow was isolated from femurs and tibiae by flushing the marrow cavity 
with culture medium (ot-Mimmum Essential Medium, Invitrogen, Carlsbad, CA) 
supplemented with 5% FCS, 100 U/ml penicillin, and 100 μg/ml streptomycin) Bone 
marrow cells were plated into 96-well plates at a density of IxlO5 cells per well m 
150 μΙ culture medium containing 30 ng/ml recombinant murine M-CSF (R&D 
Systems, Minneapolis, MN) with (osteoclasts) or without (macrophages) 40 ng/ml 
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recombinant murine RANKL (RANKL-TEC, R&D Systems). Additionally, cells were 
seeded on 650 μιτι thick bovine cortical bone slices. Culture media were replaced 
every 3 days. Either from day 0 or day 5 of cell culture, ICs (heat-aggregated gamma 
globulins) were added in a final concentration of 100 μ§/ηηΙ for activation of FcyRs. 
ICs were obtained by heating 10 mg/ml rabbit IgG (Sigma-Aldrich) at 630C for 30 
minutes. After heating, the solution was centrifuged (10 min, 12.000g), and the IC 
concentration in the supernatant was determined by absorbance reading at 280 nm. 
As a control, monomeric rabbit IgG (m-IgG) without heat treatment was used. 
MCS analysis 
Six bone marrow subsets were analyzed by two-color flow cytometric analysis as 
previously described 25. Biotinylated ER-MP12 and FITC-conjugated ER-MP20 were a 
kind gift of Dr. P.J.M. Leenen (Erasmus University Medical Center, Rotterdam, the 
Netherlands). Briefly, freshly isolated bone marrow cells were washed and labeled 
with biotinylated ER-MP12, recognizing CD31. After washing, cells were labeled with 
fluorescein isothiocyanate (FITC)-conjugated ER-MP20, recognizing Ly-6C, and 
streptavidin-PE conjugate (Biolegend, San Diego, CA). To determine FcyR expression, 
cells were labeled with Alexa Fluor 647-labeled mouse anti-FcyRI (BD PharMingen, 
San Diego, CA), APC-labeled rat anti-FcyRII/lll (2.4G2; BD PharMingen), 
carboxyfluorescein-conjugated rat anti-FcyRIII (R&D Systems), or Alexa Fluor 647-
labeled Armenian hamster anti-FcyRIV (kindly provided by Dr. F. Nimmerjahn, 
University of Erlangen-Nuremberg, Erlangen, Germany). Cells were washed and 
fluorescence was analyzed using a fluorescence-activated cell sorter (FACSCalibur; 
BD Biosciences, San Jose, CA) and FlowJo software (Tree Star, Inc., Ashland, OR). 
Tartrate-resistant acid phosphatase staining and cell count 
After 6 days of culture the number of tartrate-resistant acid phosphatase-positive 
multinucleated cells (TRACP* MNCs) was determined. Cells were washed in PBS, 
fixed in 4% PBS-buffered formaldehyde for 10 minutes, and stained for TRACP 
activity using the leukocyte acid phosphatase kit according to the manufacturer's 
protocol (Sigma-Aldrich). Only cells with three or more nuclei were considered as 
osteoclast. Based on the number of nuclei per cell, each osteoclast was assigned to 
one of three groups: 3-5 nuclei, 6-10 nuclei, or >10 nuclei since the number of nuclei 
may reflect the maturity of the osteoclast 
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Osteoclast resorption assay 
To determine resorption pit formation by osteoclasts cultured on bone slices, cells 
were lysed m water and cell remnants were mechanically removed by sonicating the 
bone slices m 10% ammonia for 30 minutes The slices were thoroughly washed and 
incubated m a 10% saturated alum (KAI(S04)212H2O) solution for 10 minutes Finally, 
slices were washed again and the resorption pits were stained with Coomassie 
brilliant blue (PhastGel Blue R-350, GE Healthcare Bio-Sciences, Uppsala, Sweden) 
Five micrographs per bone slice from pre-determmed positions were taken with a 
digital camera mounted on an inverted light microscope. The percentage of resorbed 
bone area was quantified using the Qwm image analysis system (Leica Imaging 
Systems, Wetzlar, Germany) 
RNA isolation and quantitative real-time polymerase chain reaction 
Total RNA of cultured cells was isolated using TRIzol reagent and reverse transcribed 
into complementary DNA (cDNA) using Moloney murine leukemia virus reverse 
transcriptase, oligo(dT) primers, and dNTPs (Invitrogen). Quantitative real-time 
polymerase chain reaction (PCR) was performed using the ABI Prism 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA) PCR conditions were as 
follows: 2 minutes at 50oC, 10 minutes at 95°C, followed by 40 cycles of 15 seconds 
at 95°C and 1 minute at 60°C, with data collection during the last 30 seconds. 
Product specificity was confirmed by post-amplification dissociation curve analysis 
Quantitative real-time PCR was performed m a total volume of 20 μΙ, containing 4 μΙ 
cDNA, 1.2 μΙ forward primer (5 μΜ), 1 2 μΙ reverse primer (5 μΜ), 10 μΙ SYBR Green 
Master Mix (Applied Biosystems), and 3.6 μΙ distilled I-I2O Samples were normalized 
for the expression of GAPDH by calculating the delta Ct (ACt = Cttar6et gene - CtGApDH), 
and relative gene expression was calculated as 2"(ACt) 
Statistical analysis 
Statistics were performed using GraphPad Prism version 4 0 (GraphPad Software 
Ine , San Diego, CA) Differences between two groups were tested using the unpaired 
Student's t-test or Mann Whitney U test Multiple comparisons were tested using 
one-way ANOVA followed by Tukey's multiple comparison test, or Kruskal-Walhs test 
followed by Dunn's multiple comparison test. Ρ values less than 0 05 were 
considered significant. Results are expressed as the mean ± SEM unless stated 
otherwise. 
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Results 
Severe bone destruction in arthritic knee joints of FcyRIIB-deficient mice 
Previous work in our lab has identified that 7 days after AIA induction significantly 
elevated bone erosions and cathepsin K-positive osteoclast numbers are found in 
arthritic knee joints of FcyRIIB-deficient mice. In contrast, bone erosion levels of wild 
type and FcRy-chain~/" mice, lacking expression of all activating FcyRs, were 
comparable . These data are summarized in Table 1. 
In addition, we now demonstrate that immunolocalization of IgG, suggestive of ICs, 
displays the abundant presence of depositions at the site of bone erosion (Figures 1A 
and β). 
Table 1: Bone destruction in murine knee joints 7 days after induction of antigen-induced arthritis 
Cathepsin Κ 
Bone erosion levels 
immunolocalization 
wild type 0 6 + 0 2 + 
FcyRIIB' 1 6 ± 0 1t +++ 
FcyRI/ll/llf'" 1.7±0.6t +++ 
FcRy-cham"'" 0.4 ±0.3 + 
Bone erosion was graded on a scale from 0 (no erosion) to 3 (complete bone loss) Osteoclasts were 
visualized by cathepsin Κ immunolocalization. Note the enhanced bone erosion and osteoclast numbers m 
FcyRIIB-deficient mice Values are the mean ± SEM (η = at least 6 mice per group), t = ρ < 0 05 versus wild 
type by Mann Whitney U test 
FcyR expression on osteoclasts 
The FcyR levels expressed by bone marrow-derived osteoclasts were compared with 
the FcyR levels expressed by bone marrow-derived macrophages. The latter cells are 
known to express all activating and inhibitory FcyRs. The messenger RNA (mRNA) 
levels of the activating FcyRI, FcyRIII, and FcyRIV that were expressed by osteoclasts 
were significantly lower when compared with macrophages, whereas expression of 
the inhibitory FcyRIIB was comparable (Figure 2A). Flow cytometric analysis 
displayed high expression levels of all FcyR classes on the cell surface of 
macrophages (Figure 2B). 
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Figure 1. Immune complexes (ICs) are present at the site of bone erosion in arthritic knee joints. (A) 
Immunolocalization of IgG, suggestive of ICs, in knee joints of FcyRIIB mice 7 days after AIA induction. 
Note the clear presence of ICs at the site of bone erosion (indicated by arrows). (B) Isotype control. 
Original magnification «400. BM = bone marrow, Β = bone, S = synovium. 
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Figure 2. FcyR expression on macrophages and osteoclasts. Bone marrow cells were differentiated in vitro 
for 6 days towards macrophages (M-CSF) or osteoclasts (M-CSF + RANKL). (A) Relative mRNA expression 
levels of FcyRI, FcyRIIB, FcyRIII, and FcyRIV determined by quantitative real-time PCR analysis. (B) Mean 
fluorescence intensity (MFI) of FcyRI, FcyRII/lll, FcyRIII, and FcyRIV was measured by flow cytometry. 
Values are the mean ± SD, calculated from 3 independent experiments performed in triplicate. ** = Ρ < 
0.01, by Student's t-test. 
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In contrast, FcyR expression levels on osteoclasts were significantly lower (Figure 
28). Although the expression of FcyRIIB cannot be determined directly with the 
antibodies used in this study, comparing the expression levels of FcyRII/lll and FcyRIII 
suggests that the reduced expression of FcyRII/lll on osteoclasts is mainly caused by 
the strongly reduced expression of FcyRIII. This assumption is supported by the 
mRNAdata. 
Control IC 6 days IC 24 hrs 
Figure 3. Effect of IC stimulation on osteoclast differentiation and function. Bone marrow-derived 
osteoclast precursors, differentiated in vitro for 6 days, were stimulated either from day 0 of culture (6 
days) or day 5 (24 hrs) with 100 pg/ml ICs or monomeric IgG (m-IgG). Formation of TRACP* MNCs (A), 
relative mRNA expression levels of the osteoclast markers TRACP, CTSK, NFATcl, DC-STAMP, and CTR, and 
the monocyte/macrophage marker F4/80 (B), and bone resorption levels of IC-stimulated osteoclasts and 
controls (C). Data are expressed as the mean ± SEM (η = 6 mice). * = Ρ < 0.05, •* = Ρ < 0.01, by one-way 
ANOVA (A and B) or Kruskal-Wallis test (C). (D) representative images for TRACP staining and resorption 
pit formation. Original magnification x200. 
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IC stimulation of mature osteoclasts does not affect osteoclast function 
To investigate the effect of FcyR activation on mature osteoclasts, bone marrow 
precursors were differentiated with M-CSF and RANKL for 5 days prior to 24 hours of 
stimulation with ICs or control m-IgG IC stimulation of mature osteoclasts resulted 
m equal numbers of TRACP* MCNs and no differences were found m the average 
number of nuclei per osteoclast (Figures 3A and D). Moreover, no changes were 
detected m the mRNA expression levels of the osteoclast markers nuclear factor of 
activated Τ cells, cytoplasmic 1 (NFATcl), dendritic cell-specific transmembrane 
protein (DC-STAMP), calcitonin receptor (CTR), cathepsm Κ (CTSK), and TRACP. 
However, we noticed a strong induction of the monocyte/macrophage marker F4/80 
(Figure 3B) The bone resorptive capacity of osteoclasts was similar for unstimulated 
and IC-stimulated cells (F/gL/res3Cand D) 
IC incubation of osteoclast precursors inhibits their differentiation towards mature 
osteoclasts 
Next, we investigated the effect of FcyR activation on osteoclastogenesis of bone 
marrow precursors. Differentiation of bone marrow cells towards osteoclasts in the 
presence of ICs resulted in a significant reduction m the numbers of large (>10 
nuclei/cell) and intermediate-sized (6-10 nuclei/cell) TRACP* MNCs, whereas the 
number of TRACP* MNCs containing 3-5 nuclei/cell was not changed (Figures 3A and 
D) In addition, mRNA expression levels of NFATcl, DC-STAMP, CTR, CTSK, and TRACP 
were significantly down-regulated (Figure 3B) In contrast to the reduced expression 
of osteoclast markers, F4/80 was found to be significantly up-regulated (Figure 3B), 
suggesting a more macrophage-hke phenotype of IC-stimulated cells. Functional 
analysis revealed that resorption pit formation by osteoclasts that were 
differentiated m the presence of ICs was also significantly reduced (Figures 3C and 
D) Precursors differentiated m the presence of m-IgG displayed normal osteoclast 
formation and function, indicating that the inhibitory effects are specifically IC-
mediated (Figures 3A-C) 
IC-mediated inhibition of osteoclastogenesis is independent of Fey RH Β expression 
Osteoclast precursors residing within the bone marrow are present at various stages 
of maturity, and as a result thereof, differ in their potential to differentiate into 
osteoclasts The composition of bone marrow subpopulations m wild type and 
FcyRIIB"'" mice was analyzed based on the expression of CD31 and Ly-6C As 
depicted m Figure 44, the subsets prone to differentiate towards osteoclast were 
comparable in wild type and FcyRIIB"'" mice Additionally, no differences were found 
in the composition of the remaining subpopulations 
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Osteoclast precursors of both genotypes readily differentiated into TRACP+ MNCs. 
Comparable osteoclast numbers were formed and the average number of nuclei per 
cell was similar (Figure 48). In concordance with these findings, mRNA expression 
levels of osteoclast markers and resorption pit formation were found to be similar as 
well (Figures 4C and D). We next investigated the effect of IC stimulation on mature 
osteoclasts. For both wild type and FcyRIIB ^ osteoclasts, IC stimulation did not 
result in altered osteoclast numbers, changes in mRNA levels of osteoclast markers, 
or differences in bone resorption (data not shown). 
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Figure 4. IC-mediated inhibition of osteoclastogenesis is independent of FcyRIIB expression. Bone marrow 
precursors of FcyRIIB^ and wild type mice were differentiated in vitro for 6 days in the presence or 
absence of ICs (100 μΒ/ηηΙ). (A) Composition of 6 bone marrow subsets in FcyRIIB and wild type mice 
discriminated by ER-MP12/ER-MP20 staining and analyzed by flow cytometry. (B) Formation of TRACP* 
MNCs (B), relative mRNA expression levels of the osteoclast markers TRACP, CTSK, NFATcl, DC-STAMP, 
and CTR, and the monocyte/macrophage marker F4/80 (C), and bone resorption levels of IC-stimulated 
osteoclasts and wild type controls. Data represent the mean ± SEM (η = 6 mice). * = Ρ < 0.05, ** = Ρ < 
0.01, by one-way ANOVA (Β and C) or Kruskal-Wallis test (D). 
However, when ICs were present during the entire period of differentiation, the 
formation of large and intermediate-sized TRACP+ MNCs (>10 and 5-10 nuclei per 
cell, respectively) was significantly inhibited in both genotypes (Figure 4B). In 
contrast, no differences were found in the formation of osteoclasts containing 3-5 
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nuclei per cell Inhibition of osteoclastogenesis by ICs was also reflected by 
significantly decreased mRNA expression levels of NFATcl, DC-STAMP, CTR, CTSK, 
and TRACP (Figure 4C), and significantly reduced resorption pit formation on bone 
(Figure 4D). Because IC stimulation of mature osteoclasts did not sort any effect, 
regardless of the presence of FcyRIIB, further research was focused on investigating 
the inhibitory effects of ICs on osteoclastogenesis from precursor cells 
Activating FcyRs, highly expressed on osteoclast precursors, mediate IC-induced 
inhibition of osteoclastogenesis 
Since inhibition of osteoclastogenesis was observed m wild type as well as FcyRIIB' ~ 
precursors when ICs were present for the entire duration of osteoclast 
differentiation, we hypothesized that ICs exert their inhibitory effect via activating 
FcyRs m the early phase of osteoclastogenesis Although we have demonstrated that 
activating FcyRs are scarcely present on mature osteoclasts, their expression levels 
on precursor cells are unknown To investigate this, freshly isolated bone marrow 
cells were stained with ER-MP20 and ER-MP12 for identification of osteoclast 
precursor subpopulations Simultaneously, cells were stained with antibodies 
recognizing FcyRI, FcyRII/lll, or FcyRIV. Flow cytometric analysis revealed that each 
osteoclast precursor subset expressed very high levels of both activating and 
inhibitory FcyRs (Figure 5A). To further investigate our hypothesis, bone marrow 
cells from FcRy-cham" ~ mice, lacking expression of all activating FcyRs, and wild type 
controls were isolated and subsequently differentiated into osteoclasts Under 
unstimulated conditions, the size and number of TRACP* MNCs that were formed 
after 6 days of culture were similar for wild type and FcRy-cham- ~ cells and no 
differences were found m bone resorption (Figures 5B-D) However, for wild type 
precursors, addition of ICs during differentiation resulted m a significant inhibition m 
the formation of large and intermediate-sized TRACP* MNCs, as well as significantly 
reduced bone resorption levels In contrast, the number of osteoclasts and 
resorption pit formation on bone m IC-stimulated FcRy-cham cultures were not 
changed as compared to unstimulated controls (Figures 5B-D) 
Discussion 
Autoantibody formation and IC deposition in articular joints elicit local immune 
responses and play a crucial role in RA pathogenesis . The inflamed synovium is 
an active site of interplay between immune and bone cells Therefore, m the 
research area of osteoimmunology crosstalk is studied between the immune and 
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skeletal system . This has significantly contributed to the understanding of 
rheumatic bone loss, although it has mainly focused on the regulation of 
osteoclastogenesis by Τ cells and pro-inflammatory cytokines ' . 
~ 400η 
• 1 Early blasts 
^•Myeloid blasts 
I I Monocytes 
• • wild type 
Z^ wild type + IC 
d ] FcRy-chain-/-
• • FcRy-chain-/- + IC 
Resorption 
Figure 5. Lack of activating FcyRs abrogates IC-induced inhibition of osteoclastogenesis. Bone marrow 
precursors of FcRy-chain"'' and wild type mice were differentiated In vitro for 6 days in the presence or 
absence of ICs (100 μg/ml). (A) FcyR expression on osteoclast precursor subsets discriminated by ER-
MP12/ER-MP20 staining and analyzed by flow cytometry. Formation of TRACP* MNCs (B) and bone 
resorption levels of IC-stimulated osteoclast precursors and controls (C). Values are the mean ± SEM (η = 6 
mice per group). * = Ρ < 0.05, ** = Ρ < 0.01, by one-way ANOVA (Β) or Kruskal-Wallis test (C). (D) 
representative images for TRACP staining and resorption pit formation on bone. Original magnification 
x200. 
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In the present study we have shown that, during AIA, ICs are abundantly present at 
bone erosion sites. In arthritic knee joints of FcyRIIB-deficient mice bone destruction 
is significantly enhanced, which might be due to increased inflammation also present 
in these mice 22. FcRy-chain"/" mice displayed similar levels of bone destruction as 
wild type controls. In addition we have demonstrated in vitro that ICs strongly inhibit 
the differentiation of early bone marrow precursors into osteoclasts via activating, 
but not inhibitory FcyRs, whereas ICs do not affect the function of mature 
osteoclasts despite strong expression of FcyRIIB. 
FcyRIIB expression on osteoclasts was previously demonstrated by Shanmugarajan 
et al. 33. In the present study we showed that FcyRIIB expression on bone marrow-
derived osteoclasts is comparable with its expression on bone marrow-derived 
macrophages. The expression of activating FcyRs on osteoclasts is very low, 
suggesting that mature osteoclasts will most likely respond to IC stimulation via the 
inhibitory FcyRIIB. However, stimulation of mature osteoclasts with ICs did neither 
affect osteoclast numbers nor their function. This could be due to the lack of 
activating FcyRs on mature osteoclasts, which are normally co-expressed with, and 
required for co-crosslinking to the inhibitory FcyRIIB upon IC ligation, in order for 
FcyRIIB to exert an inhibitory effect ' 
Although it is known that both activating and inhibitory FcyRs are present on 
myeloid and lymphoid precursors early in development ' , characterization of their 
function on osteoclasts precursors has not been thoroughly investigated yet. Only 
recently it was found that the human osteoclast inhibitory peptide-1 (OIP-1), a 
glycophosphatidylinositol-linked membrane protein homologous to murine stem cell 
antigen-2, inhibits osteoclastogenesis of murine precursor cells via the inhibitory 
FcyRIIB B3. Furthermore, it was shown that osteoclast formation was inhibited only 
when OIP-1 was added at the proliferative stage (days 1-3) of bone marrow cultures. 
Additionally, Piper et al. have demonstrated that osteoclast maturity is reflected by 
the number of nuclei per cell, which is positively correlated to the volume of the 
resorption pit made 26. In concordance with these studies, we have demonstrated 
that IC stimulation of bone marrow precursors at the start of osteoclastogenesis 
strongly inhibited osteoclast differentiation. This is reflected by significantly 
decreased osteoclast numbers containing more than 5 nuclei/cell and reduced 
resorption pit formation on bone. It is important to note that inhibition was also 
observed when a different type of ICs were used (BSA:anti-BSA; results not shown). 
In this study heat aggregated IgG was used since we were mainly interested in the 
role of FcyRIIB, suggested to be the preferential receptor for this type of ICs37. 
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In contrast to the findings of Shanmugarajan et al., we found that ICs do not mediate 
their inhibitory effect via FcyRIIB since inhibition of osteoclastogenesis was still 
present when FcyRIIB precursors were used. Instead, we found that ICs mediate 
their inhibitory effect via activating FcyRs, as demonstrated by the absence of IC-
mediated inhibition of osteoclastogenesis using FcRy-chain precursors. Part of this 
contradictory finding may be explained by the observation that OIP-1 was found to 
exclusively bind and activate FcyRIIB with a binding affinity comparable to the 
binding affinity of ICs, whereas activating FcyRs did not seem to be involved . ICs on 
the other hand, bind to both activating and inhibitory FcyRs and the outcome of the 
response is dependent on the expression balance of these FcyR classes 
It remains to be elucidated why both activating and inhibitory FcyRs inhibit 
osteoclast differentiation from bone marrow precursors. For Ly49Q it was 
demonstrated that this inhibitory receptor positively regulates osteoclast 
differentiation as a result from competition with other ITIM-bearing receptors for 
binding SHP-112. A similar mechanism may apply for ITAM-bearing adaptor proteins. 
Keeping in mind that macrophages and osteoclasts are characterized by their specific 
function, this could also explain why activating FcyRs are rapidly down-regulated on 
osteoclasts precursors upon stimulation with M-CSF and RANKL. In macrophages, the 
ITAM-bearing FcRy-chain associates with activating FcyRs upon IC ligation to mediate 
phagocytosis and the release of cytokines and chemokines . However, during 
osteoclastogenesis the FcRy-chain is required for the cell surface expression of 
OSCAR and co-stimulatory signaling of this receptor upon ligation to its yet 
unidentified ligand is needed for normal osteoclast formation and function 8'39. This 
suggests that down-regulation of activating FcyRs might be beneficial for 
osteoclastogenesis by favoring OSCAR expression. 
Recently it was shown that distinct osteoclast precursor subsets in the bone marrow 
differ in their potential to differentiate into osteoclasts . An abnormal composition 
of these populations in the bone marrow may disturb osteoclastogenesis in vivo and 
could be a confounding variable accounting for the elevated bone erosions observed 
in arthritic knee joints of FcyRIIB" " mice. Analysis of freshly isolated bone marrow 
cells revealed that this composition was comparable between wild type and 
FcyRIIB~/~ mice, which is therefore unlikely to explain the observed differences in 
arthritic bone destruction in vivo. 
An explanation for the severe bone destruction in arthritic FcyRIIB animals is that 
in the absence of FcyRIIB negative regulation of activating FcyRs is lost. This enables 
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continuous IC-mduced activation of FcyR-bearmg inflammatory mediators resulting 
in sustained inflammation Activated macrophages produce chemokmes such as 
MlP-la, MCP-1, and RANTES 4 0 4 1 that attract mononuclear cells to the inflamed 
joint In addition they produce factors that stimulate osteoclast differentiation and 
function including the pro-inflammatory mediators IL-1 and TNFa, and the osteoclast 
differentiation factor RANKL42 *3 
As demonstrated, mature osteoclasts are not susceptible to IC regulation Therefore, 
resident osteoclasts present within the joint prior to arthritis onset, can be activated 
by RANKL, IL-1, and TNFa Osteoclastogenesis of infiltrated progenitors will be 
strongly inhibited by ICs via activating FcyRs, but differentiation will not be 
completely blocked, since our in vitro data show that differentiation into small bone 
resorbmg osteoclasts (3-5 nuclei/cell) is not inhibited by ICs Moreover, pro­
inflammatory cytokines and RANKL do not only activate mature osteoclasts, but also 
stimulate differentiation of precursors, thus the overall amount of osteoclasts within 
the joint will increase 
Strong induction of F4/80 suggests that IC-stimulated precursors acquire a more 
macrophage-like phenotype and therefore may be able to produce more 
chemokmes and cytokines, creating a self-perpetuating inflammatory loop that 
ultimately leads to severe bone destruction Additionally, even though ICs are 
important mediators of disease in the AIA model, it has also been demonstrated that 
Τ cells play an important role Blocking IL-17 during reactivation of AIA prevents joint 
inflammation and bone erosion and Thl7 cells are nowadays recognized to 
function as an osteoclastogemc Τ cell subset45 
The absence of severe bone destruction in arthritic FcRy-cham mice can be 
explained by the presence of FcyRIIB, inhibiting amplification of inflammation and 
thus inhibiting activation of resident osteoclasts and differentiation of infiltrated 
osteoclast precursors Ongoing development of bone erosions m FcyRI/ll/lll ' mice is 
probably caused by activation of FcyRIV, which is still present in these mice 46, 
whereas the absence of FcyRIIB enables the establishment of an amplifying 
inflammatory loop Although the exact role of FcyRIV remains unclear, comparing 
different arthritis models and various FcyR knockout mice clearly indicates that this 
receptor is important for the development of joint destruction 24 
In conclusion, our study demonstrates that, even though ICs strongly inhibit 
osteoclastogenesis, their effect on bone destruction in arthritis predominantly 
depends on the regulation of inflammation mediated by the coordinate expression 
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of activating and inhibitory FcyRs. We hypothesize that uncontrolled IC-mediated 
activation of macrophages leads to continuous production of osteoclast activating 
cytokines, which overrule the direct inhibitory effects of ICs on osteoclastogenesis. 
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Abstract 
Objective: Previously, we reported that interferon-y (IFNy) aggravates cartilage 
destruction in immune complex (IC)-mediated arthritis (ICA) via up-regulation of 
activating Fey receptors (FcyRs). Recently, we found that interleukin-17 (IL-17) also 
aggravates cartilage destruction in arthritis models wherein ICs are involved, but the 
underlying mechanism remains unknown. This study was undertaken to determine 
the role of IL-17 in FcyR-mediated cartilage destruction during ICA, and to compare 
its effect with that of IFNy. 
Methods: ICA was passively induced in FcRy-chain' ~ mice, which lack functional 
activating FcyRs, and in wild type controls. AdlL-17 or a control vector was injected 
into the knee joints 1 day prior to ICA induction. Knee joints were isolated for 
histological analysis, and synovium samples were obtained for real-time polymerase 
chain reaction (PCR). Macrophage cell lines (RAW 264.7) and polymorphonuclear cell 
lines (PMN; 32Dcl3) were stimulated with IFNy or IL-17 for analysis of FcyR 
expression using real-time PCR and fluorescence-activated cell sorting. 
Results: IL-17 overexpression prior to ICA induction significantly aggravated cartilage 
destruction and inflammation, characterized by a massive influx of PMNs, which 
adhered to the cartilage surface. Although IL-17 overexpression increased FcyR 
messenger RNA levels in the synovium, in vitro stimulation of macrophages and 
PMNs revealed that, in contrast to IFNy, IL-17 did not directly regulate FcyR 
expression. Despite similar inflammation in AdlL-17-enhanced ICA in FcRy-chain 
mice and wild type controls, severe cartilage destruction and PMN adherence were 
completely absent in FcRy-chain" " mice. 
Conclusion: Our findings indicate that IL-17-mediated aggravation of cartilage 
destruction during ICA is FcyR-dependent. However, in contrast to IFNy, which 
directly up-regulates FcyR expression on macrophages and PMNs, IL-17 enhances 
cartilage destruction by increasing the local amount of FcyR-bearing neutrophils. 
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Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic 
inflammation of the joints and destruction of cartilage and bone. Large amounts of 
IgG-containing immune complexes (ICs) are often found in the serum and joints of 
RA patients and are thought to play a crucial role in RA pathogenesis . ICs 
communicate with their effector cells via binding to Fey receptors (FcyRs), which can 
lead to phagocytosis, oxidative burst, and the production of cytokines and 
chemokines 2. FcyRs are predominantly expressed on hematopoietic cells, such as 
macrophages, polymorphonuclear cells (PMNs), dendritic cells, and Β cells3. 
In mice, four different FcyR classes have been identified. Three of these are 
activating receptors signaling through the immunoreceptortyrosine-based activation 
motif (ITAM)-containing FcRy-chain. These are the high-affinity FcyR type I (FcyRI; 
CD64), the low-affinity FcyRIII (CD16), and the recently identified intermediate-
affinity FcyRIV. The fourth receptor, the inhibitory, low-affinity FcyRIIB (CD32), is a 
single-chain receptor, which signals through the immunoreceptor tyrosine-based 
inhibitory motif (ITIM). FcyRIIB exerts its inhibitory effect upon co-ligation to the 
activating FcyRs, thereby inhibiting their cellular activation signals . 
Previously it was shown that the activating FcyRI and FcyRIII play a crucial role in 
mediating severe cartilage destruction in IC-mediated arthritis (ICA) ". In this model, 
severe, irreversible cartilage destruction results from proteolytic degradation of the 
extracellular cartilage matrix by matrix metalloproteinases (MMPs), thereby 
generating neoepitopes (VDIPEN) that can be detected by immunolocalization 5'6. 
MMPs are synthesized as inactive proenzymes, and proteolytic cleavage of the pro-
domain is required for their full activation. In arthritis the production of pro-MMPs is 
regulated by several different mediators, such as cytokines, chemokines, and growth 
factors ' . However, using FcyRI knockout mice, we have previously demonstrated 
that this receptor is crucial for full MMP activation, since MMP-mediated cartilage 
destruction is completely absent in these mice . 
FcyR-mediated cartilage destruction is more pronounced when, in addition to ICs, Τ 
cells are involved, as has been demonstrated with the murine model of antigen-
induced arthritis using various FcyR knockout mice . Although neither Thl nor Th2 
cytokines are present at high levels in the joints of RA patients, the Thl cytokine 
interferon-y (IFNy) consistently predominates over the Th2 cytokine interleukin-4 (IL-
4). Therefore, RA has been considered to be a Thl condition for many years 10'11. 
Furthermore, we have previously found that local overexpression of IFNy during ICA 
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leads to aggravation of MMP-mediated cartilage destruction via up-regulation of the 
activating FcyRI and FcyRIII 
Recently, a new Τ helper subset has been defined, which develops distinctively 
from Thl and Th2 cells 14 and is thought to play an important role in RA. This CD4+ Τ 
cell lineage has been named Thl7 for its production of the pro-inflammatory 
cytokine IL-17 . IL-17A, referred to hereinafter as IL-17, is the prototype member of 
a family consisting of 6 cytokines (IL-17A to IL-17F) and 5 receptors (IL-17RA to IL-
17RE). Although IL-17 production is limited, its receptor is ubiquitously expressed in 
virtually all cells and tissues 15'16. Elevated levels of this cytokine have been found in 
the synovium and synovial fluid of RA patients as compared with osteoarthritis 
patients and healthy controls . Furthermore, local overexpression of IL-17 leads 
to aggravation of cartilage destruction in collagen-induced arthritis, which is 
mediated by both a Τ cell-driven and an IC-driven component . Blocking IL-17 in 
this model causes a reduction in cartilage destruction , but the underlying 
mechanism of how IL-17 amplifies cartilage destruction remains unknown. 
The objective of the present study was to determine the role of IL-17 in FcyR-
mediated cartilage destruction during ICA, an arthritis model mediated solely by ICs, 
and to compare its effect with that of IFNy. We found that local overexpression of IL-
17 in ICA leads to aggravation of cartilage destruction and massive infiltration of 
PMNs. Although we found increased FcyR messenger RNA (mRNA) levels in the 
synovium after IL-17 overexpression, our in vitro studies showed that, in contrast to 
IFNy, IL-17 does not directly regulate FcyR expression on macrophages or PMNs. 
Using mice that lack functional, activating FcyRs (FcRy-chain"7" mice), we showed 
that the IL-17-mediated aggravation of cartilage destruction in ICA is FcyR-
dependent. These findings indicate that IL-17 enhances FcyR-mediated cartilage 
destruction during ICA by strongly elevating the local amount of FcyR-bearing 
neutrophils. 
Materials and methods 
Animals 
The FcRy-chain" " mice were generated as reported previously 22 and backcrossed to 
the C57BL/6 background. Control C57BL/6 mice were obtained from The Jackson 
Laboratory (Bar Harbor, ME). Mice were housed in filter-top cages and fed a 
standard diet and water ad libitum. All animal studies were approved by the local 
research ethics committee. 
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Adenoviral vectors 
AdlL-17 was provided by Dr J Κ Kolls (Children's Hospital of Pittsburgh, Pittsburgh, 
PA) and was constructed as described previously 23 The replication-deficient empty 
adenoviral vector AdDel70-3 was used as a control vector throughout the study 
AdlL-17 or AdDel70-3 (IxlO7 plaque-forming units m 6 μΙ of phosphate buffered 
saline [PBS] each) was injected mtra-articularly into the knee joints of mice 1 day 
prior to ICA induction and into the knee joints of naive mice (those without ICA), 
respectively 
Induction of IC-mediated Arthritis 
ICA was passively induced by mtra-articular injection of 3 μg of poly-L-lysme-coupled 
lysozyme in 6 μΙ of pyrogen-free saline into the knee joints of mice that had 
previously been injected intravenously with 0 2 ml of polyclonal antibodies directed 
against lysozyme The anti-lysozyme antibodies were raised in rabbits 
Histological analysis 
Total knee joints from mice were isolated 6 days after injection of the adenovirus 
For standard histological analysis, knee joints were fixed in 4% formalin for 4 days, 
decalcified m 5% formic acid, dehydrated, and embedded m paraffin Frontal 
sections of 7 μιτι were prepared and stained with hematoxylin and eosm (H&E) for 
evaluation of inflammation Infiltrate and exudate were scored separately on an 
arbitrary scale ranging from 0 (no inflammation) to 3 (severe inflammation) 
Infiltrate was defined as the number of inflammatory cells present m the synovial 
tissue, whereas exudate was defined as the number of inflammatory cells m the joint 
cavity Additionally, chondrocyte death was scored as the number of empty lacunae 
and expressed as the percentage of the total number of chondrocytes within the 
cartilage layers of the patella and femur Cartilage erosion was expressed as the 
percentage of impaired cartilage of the total cartilage surface For determination of 
proteoglycan (PG) depletion, sections were stained with Safranm 0 and 
counterstamed with Fast Green PG depletion was scored on an arbitrary scale 
ranging from 0 (fully stained cartilage) to 3 (complete loss of red staining) Scoring 
was done by 2 independent observers (LCG and MIK) who were blinded with regard 
to treatment group 
Immunohistochemical NIMP-R14 staining 
Sections were deparaffmized, rehydrated, and pre-mcubated with 20% normal rabbit 
serum for 15 minutes at room temperature Subsequently, sections were incubated 
for 1 hour with the primary antibody rat anti-NIMP-R14, a 25-30 kDa epitope that is 
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mainly present on neutrophils As a control, sections were incubated with normal 
rat IgG After a 30 minute incubation with the secondary antibody, rabbit anti-rat 
peroxidase, the peroxidase was developed with diammobenzidme (DAB), and 
sections were counterstamed with hematoxylin for 1 minute 
Immunohistochemical F4/80 staining 
Sections were deparaffmized, rehydrated, incubated for 12 minutes in warm 10 mM 
citrate buffer (pH 6 0), and subsequently treated with 3% H2O2 in methanol for 15 
minutes Thereafter, sections were incubated for 1 hour with the primary antibody, 
rat anti-F4/80 (Serotec, Oxford, UK) As a control, sections were incubated with 
normal rat IgG After a 30 minute incubation with the secondary antibody, 
biotmylated rabbit anti-rat, binding was detected using the ABC-HRP kit (Elite kit, 
Vector Laboratories, Burlmgame, CA) Peroxidase was developed with DAB, and 
sections were counterstamed with hematoxylin for 1 minute 
Immunohistochemical VDIPEN staining 
Sections were deparaffmized, rehydrated, and digested with chondroitmase ABC 
(0 25 units/ml in 0 I M Tris HCl [pH 8 0]) (Sigma-Aldrich, St Louis, MO) for 1 hour at 
37°C, to remove chondroitm sulfate from the PGs Subsequently, sections were 
treated with 1% H2O2 in methanol for 20 minutes and with 0 1% Triton X-100 in PBS 
for 5 minutes After incubation with 1 5% normal goat serum for 20 minutes, 
sections were incubated overnight at room temperature with the primary antibody, 
affinity-purified rabbit anti-VDIPEN IgG Affinity-purified rabbit IgG was used as a 
control In addition, sections were incubated with the secondary antibody, 
biotmylated goat anti-rabbit IgG, and binding was detected using biotm-streptavidm-
peroxidase staining (Elite kit) Induction of the peroxidase product was detected 
using nickel enhancement, and counterstammg was performed with 2% orange G for 
5 minutes The areas of immunostammg were expressed as a percentage of the total 
cartilage surface Scoring was performed by 2 independent observers (LCG and 
PLEMvL) who were blinded with regard to treatment group 
Culture and cytokine stimulation of cell lines 
The murine macrophage cell line RAW 264 7 (American Type Culture Collection 
[ATCC], Manassas, VA) was cultured m Dulbecco's modified Eagle's medium 
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum (PCS), pyruvate, 
and penicillin-streptomycin The IL-3-dependent murine myeloid progenitor cell line 
32Dcl3 26 was cultured in RPMI 1640 Dutch Modification (Invitrogen) supplemented 
with 10% WEHI-3B (ATCC) conditioned medium as a source of murine IL-3, 10% PCS, 
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pyruvate, L-glutamine, and penicillin-streptomycin. Cell cultures were maintained at 
37°C in a humidified incubator containing 5% COj, 95% air. For PMN differentiation, 
IxlO6 32Dcl3 cells were cultured for 12 days in 75 cm2 culture flasks in RPMI 1640 
supplemented with 100 ng/ml recombinant human granulocyte colony-stimulating 
factor (Rhône-Poulenc Rorer, Frankfurt, Germany), 10% FCS, pyruvate, L-glutamine, 
and penicillin-streptomycin. Medium was replaced every 3 days, and cells were 
adjusted to their initial cell concentration. Cytospin preparations were stained with 
H&E on day 12 for morphologic determination. For the study of regulation of FcyR 
expression on macrophages and PMNs, these cell lines were cultured for 24 hours 
with either 10 ng/ml of recombinant mouse IFNy (n = 3) or 100 ng/ml of 
recombinant mouse IL-17 (n = 3) (both from R&D Systems, Minneapolis, MN). 
Thereafter, FcyR expression was determined by quantitative real-time polymerase 
chain reaction (PCR) and fluorescence-activated cell sorting (FACS) analysis. 
RNA isolation from synovial tissue and cells. 
Six days after injection of the adenovirus, synovium samples were obtained in a 
standardized manner using biopsy punches. Synovial tissue was homogenized with a 
MagNALyser Instrument (Roche Applied Science, Almere, the Netherlands), and total 
RNA was extracted using an RNeasy Mini kit (Qiagen, Venlo, the Netherlands). For 
total RNA isolation of cultured cells, TRIzol reagent was used as described by 
Chomczynski and Sacchi . Total RNA was reverse transcribed into complementary 
DNA (cDNA) with Moloney murine leukemia virus reverse transcriptase, oligo(dT) 
primers, and dNTPs (Invitrogen). 
Quantitative real-time PCR 
Quantitative real-time PCR was performed using an ABI Prism 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA). The PCR amplification 
protocol was as follows: 2 minutes at 50oC, 10 minutes at 95°C, followed by 40 cycles 
of 15 seconds at 95°C and 1 minute at 60°C, with data collection during the last 30 
seconds. Primer sequences for the reference gene GAPDH and the genes of interest 
were as follows: for GAPDH, forward 5'-GGC-AAA-TTC-AAC-GGC-ACA-3' and reverse 
S'-GTT-AGT-GGG-GTC-TCG-CTC-CTG-S'; for FcyRI, forward S'-ACA-CAA-TGG-TTT-ATC-
AAC-GGA-ACA-3' and reverse 5'-TGG-CCT-CTG-GGA-TGC-TAT-AAC-T-3'; for FcyRIIB, 
forward 5'-GAC-AGC-CGT-GCT-AAA-TCT-TGC-T-3' and reverse 5'-GTG-TCA-CCG-TGT-
CTT-CCT-TGA-G-3'; for FcyRIII, forward 5'-GAC-AGG-CAG-AGT-GCA-GCT-CTT-3' and 
reverse 5'-TGT-CTT-CCT-TGA-GCA-CCT-GGA-T-3',· and for FcyRIV, forward S'-CCA-
GAG-TTA-AGG-ACA-GTG-GAA-TGT-AC-3' and reverse S'-GCA-ATA-GCC-AGC-CCA-TAT-
GG-3'. Quantitative real-time PCR was performed in a total volume of 25 μΙ, which 
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contained 5 μΙ of cDNA, 1 5 μΙ of forward primer (5 μΜ), 1 5 μΙ of reverse primer (5 
μΜ), 12 5 μΙ of SYBR Green Master Mix (Applied Biosystems), and 4 5 μΙ of distilled 
H2O For each sample, differences m threshold cycle (AACt) values were calculated 
by correcting the Ct of the gene of interest to the Ct of the reference gene GAPDH 
and comparing it with that of controls 
MCS analysis 
To determine FcyR expression on macrophages and PMNs, cells were analyzed using 
FACS Briefly, cells were labeled with the primary antibodies mouse anti-FcyRI 
(provided by Dr PS Tan, The Macfarlane Burnet Institute for Medical Research and 
Public Health, Austin Health Campus, Heidelberg, Victoria, Australia), rat anti-
FcyRII/lll (2 4G2, BD PharMingen, San Diego, CA), or Alexa Fluor 647-labeled 
Armenian hamster anti-FcyRIV (provided by FN) Cells were then washed and labeled 
with the secondary antibody fluorescein isothiocyanate (FITC)-conjugated sheep 
anti-mouse antibody (Cappel, West Chester, PA) for FcyRI or FITC-conjugated mouse 
anti-rat antibody (Zymed, South San Francisco, CA) for FcyRII/lll Fluorescence was 
analyzed using a FACSCahbur instrument (BD Biosciences, San Jose, CA) and 
CellQuest software 
Statistical analysis 
Differences between experimental groups were tested for significance using the 
Mann-Whitney U test Ρ values less than 0 05 were considered significant Results 
are expressed as the mean ± SEM unless stated otherwise 
Results 
Aggravation of cartilage destruction after local overexpression of IL-17 in IC-
mediated arthritis 
To determine whether local overexpression of IL-17 during ICA leads to aggravation 
of cartilage destruction, mice were injected mtra-articularly with AdlL-17 or with a 
control vector (AdDel70-3) 1 day prior to ICA induction As a control, knee joints of 
naive mice (without ICA) were injected with AdlL-17 or AdDel70-3 Six days after 
injection of AdlL-17 alone, mild PG depletion was observed, but severe cartilage 
destruction, as evidenced by chondrocyte death and MMP-mediated neoepitopes, 
was completely absent {Figures 1A-D) Five days after ICA induction, PG depletion 
was strongly increased (2-3-fold) in the group of AdlL-17-injected mice with ICA as 
compared with the control ICA mice (Figure 1A) Furthermore, we observed a 
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marked increase in chondrocyte death (2-4-fold), VDIPEN expression (3-fold), and 
cartilage erosion (4-11-fold) in the cartilage layers of the patella and femur in AdlL-
17-injected mice with ICA as compared with control ICA mice (Figures 1B-D). 
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Figure 1. Cartilage destruction, measured by proteoglycan (PG) depletion (A), chondrocyte death (Β), 
VDIPEN expression (C), and cartilage erosion (D), 6 days after injection of AdDel or AdlL-17 into the knee 
joints of naive mice and mice with ICA. Compared with control ICA mice (AdDel ICA), significant increases 
in PG depletion, chondrocyte death, VDIPEN expression, and cartilage erosion were observed in the 
cartilage layers of the patella and femur in AdlL-17-injected mice with ICA (AdlL-17 ICA). Bars show the 
mean ± SEM (n = 5 mice per group). * = Ρ < 0.04 versus control mice with ICA, by Mann-Whitney U test. 
Massive PMN influx characterizes the IL-17-mediated increase in joint inflammation 
We have previously shown that although local overexpression of IFNy during ICA 
does not alter inflammation severity, it does lead to a shift in the inflammatory cell 
mass infiltrating the knee joint, thereby increasing the influx of macrophages and 
decreasing the influx of PMNs (ICA group 1 in Table 1). The recombinant adenovirus 
encoding murine IFNy (AdlFNy) was used for overexpression of IFNy, and AdeGFP, 
encoding enhanced green fluorescent protein, was used as control vector. 
In the present study, we investigated the effect of IL-17 overexpression on joint 
inflammation. Compared with the control group, IL-17 overexpression in the knee 
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joints of naive mice resulted in mild inflammation only (Figure 2A). Strikingly, IL-17 
overexpression prior to ICA induction led to very severe inflammation of the knee 
joints (Figure 2A). The numbers of inflammatory cells present in the infiltrate and 
exudate were increased by 71% and 109%, respectively, as compared with the 
control group with ICA (Table 1). This IL-17-mediated increase in inflammation was 
characterized by massive infiltration of PMNs, as measured by immunolocalization of 
the PMN marker NIMP-R14. The percentage of PMNs that infiltrated into the 
synovium and joint cavity was significantly higher in the AdlL-17-injected mice with 
ICA (40% and 86%, respectively) than in the control ICA mice (13% and 48%, 
respectively) (Table 1). Notably, in the AdlL-17-injected mice with ICA, there was a 
strong adherence of PMNs to the cartilage surface, which was not observed in the 
control group with ICA (Figures 2B and C). Furthermore, we found that PMN 
adherence was correlated with the severity of cartilage destruction. 
No marked changes were found in the influx of macrophages, as determined by 
immunohistochemical staining for the macrophage marker F4/80 (Table 1). These 
results show that, unlike IFNy, IL-17 overexpression leads to a strong overall increase 
in inflammation severity and changes the composition of cells infiltrating into the 
knee joint. 
Table 1: Inflammation seventy, NIMP-R14, and F4/80 expression in mice 5 days after ICA induction 
ICA group 1 
AdeGFP 
AdIFNv 
ICA group 2 
wild type 
AdDel70-3 
AdlL-17 
FcRy-cham ' 
AdDel70-3 
AdIL 17 
Inflammation score. 
0-3 
Infiltrate 
1 40 ± 0 1 
1 60 ± 0 2 
1 3 5 1 0 1 
2 3 1 ± 0 2 t 
0 39 ± 0 1 
2 10 ± 0 2 
scale 
Exudate 
1 5 0 ± 0 1 
1 60 ± 0 2 
0 90 ± 0 1 
1 8 8 ± 0 3 t 
0 1910 1 
2 0 0 1 0 2 
NIMP-R14 expression, 
% of cells 
Infiltrate 
49 90 ± 2 9 
49 9 0 1 1 8 
13 00 1 2 5 
40 00 1 3 5t 
1 2 5 1 1 3 
40 00 1 3 5 
Exudate 
70 40 ± 5 6 
52 1014 4t 
48 0012 5 
86 25 12 4t 
2 50 1 1 4 
83 00 1 2 5 
F4/80 expression, 
%of 
Infiltrate 
4 1 1 0 1 3 5 
47 75 + 1 8 
32 00 y 2 5 
40 00 1 2 0 
36 25 + 3 1 
40 00 1 1 6 
cells 
Exudate 
50 70 + 2 7 
6108114+ 
27 0 0 1 2 5 
30 00 1 2 0 
5 00 1 3 5 
24 00 1 2 9 
Values are the mean ± SEM (η = 5 mice per group) For ICA group 1, mice were mtra-articularly injected 
with the recombinant adenovirus encoding murine IFNy (AdIFNy) or a control virus encoding enhanced 
green fluorescent protein (AdeGFP), 1 day prior to ICA induction. For ICA group 2, FcRy-cham" " mice and 
wild type controls were mtra-articularly injected with the recombinant adenovirus encoding murine IL-17 
(AdlL-17) or the replication-deficient adenovirus AdDel70-3, 1 day prior to ICA induction, 
t = Ρ < 0.04 versus control (AdeGFP- or AdDel70-3-injected) mice with ICA, by Mann-Whitney U test. 
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Figure 2. (A) Histological analysis of inflammation. The numbers of cells present in the synovium 
(infiltrate) and in the joint cavity (exudate) were scored on an arbitrary scale ranging from 0 (no 
inflammation) to 3 (severe inflammation). Five days after ICA induction, knee joints of AdlL-17-injected 
mice with ICA (AdlL-17 ICA) were severely inflamed. Bars show the mean ± SEM (η = 5 mice per group). * = 
Ρ < 0.04 versus control ICA mice (AdDel ICA), by Mann-Whitney U test. (B) and (C) Immunohistochemical 
staining of polymorphonuclear cells (PMNs) using NIMP-R14 in representative sections from a control ICA 
mouse (B) and an AdlL-17-injected mouse with ICA (C). Inflammation in AdlL-17-injected mice with ICA 
was characterized by a massive influx of PMNs adhering to the cartilage surface (arrows), which was not 
observed in control ICA mice. Original magnification χ200. 
Up-regulation of FcyRs and chemokines in synovium by overexpression of IL-17 
Because FcyRs are crucial mediators of cartilage destruction, FcyR mRNA levels were 
determined in the synovial biopsy samples that were obtained 6 days after 
adenovirus injection. Figure 3A shows that local overexpression of IL-17 in the knee 
joints of naive mice led to up-regulation of FcyRI (AACt = 3.67), FcyRIIB (AACt = 2.54), 
FcyRIII (AACt = 2.96), and FcyRIV (AACt = 4.95). Furthermore, IL-17 overexpression 
resulted in strong up-regulation of the PMN-attracting chemokines keratinocyte-
derived chemokine (KC) (AACt = 5.43) and macrophage inflammatory protein 2 (MIP-
2) (AACt = 4.32), whereas the control vector did not markedly alter either FcyR or 
chemokine mRNA levels. When IL-17 was injected prior to ICA induction, mRNA 
levels for all 4 FcyR classes were strongly increased (AACt = 6.61, 7.15, 6.63, and 8.38 
for FcyRI, FcyRIIB, FcyRIII, and FcyRIV, respectively), as were KC and MIP-2 mRNA 
levels (AACt = 8.07 and 7.78, respectively), as compared with the control group with 
ICA (AACt = 3.58, 1.79, 2.95, and 5.24 for FcyRI, FcyRIIB, FcyRIII, and FcyRIV, 
respectively, and AACt = 1.89 and 2.99 for KC and MIP-2, respectively) {Figure 38). 
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Figure 3. Expression of mRNA for Fey receptors (FcyRs) and chemokines in the synovium after IL-17 
overexpression in the knee joints of naive mice (A) and in the knee joints of mice 5 days after ICA 
induction (B). For each sample, differences in threshold cycle (ΔΔα) values were calculated by correcting 
the Ct of the gene of interest to the Ct of the reference gene GAPDH and comparing it with that of naive 
controls. Note the strong up-regulation of all FcyR classes and the PMN-attracting chemokines KC and 
MIP-2 in the AdlL-17-injected mice with ICA (AdlL-17 ICA) as compared with control ICA mice (AdDel ICA). 
Bars show the mean ± SD ΔΔΟ values from 3 independent experiments (n = 5 mice per group). 
In contrast to IFNy, IL-17 does not directly regulate FcyR expression in vitro 
Macrophages and PMNs are key mediators of joint inflammation and cartilage 
destruction in ICA, and both cell types are known to express FcyRs. To determine the 
effect of IL-17 on the expression of FcyRs by these cell types, and to compare its 
effect with that of IFNy, macrophage and PMN cell lines were stimulated for 24 
hours with either IFNy or IL-17. FcyR expression was then determined by 
quantitative PCR and FACS analysis. At the mRNA level, IFNy-stimulated 
macrophages showed up-regulation of the activating FcyRI, FcyRIII, and FcyRIV (AACt 
= 3.32, 1.66, and 3.88, respectively), and down-regulation of the inhibitory FcyRIIB 
(AACt = -3.42) (Figure 44). The IFNy-induced up-regulation of activating FcyRs was 
confirmed at the protein level by FACS analysis (Figure 4B). Stimulation of PMNs with 
IFNy resulted in strong up-regulation of mRNA levels for FcyRIV only (AACt = 6.01) 
(Figure 4C). At the protein level, however, we not only confirmed up-regulation of 
FcyRIV, but also found an increase in the expression of FcyRI and FcyRII/lll (Figure 
4D). In contrast to IFNy, stimulation of macrophages and PMNs with IL-17 did not 
have any effect on the expression of FcyRs at either the mRNA or the protein level 
(Figures 4A-D). These results suggest that the observed increase in FcyR mRNA levels 
in the synovium after IL-17 overexpression is only a reflection of the IL-17-mediated 
influx of FcyR-bearing inflammatory cells. 
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Figure 4. Expression of mRNA for FcyRs on RAW 264.7 macrophages (A), expression of FcyR protein on 
RAW 264.7 macrophages (B), expression of mRNA for FcyRs on 32Dcl3 polymorphonuclear cells (PMNs) 
(C), and expression of FcyR protein on 32Dcl3 PMNs (D) after stimulation with either 10 ng/ml of IFNy or 
100 ng/ml of IL-17 for 24 hours. IFNy up-regulated FcyRI, FcyRIII, and FcyRIV on macrophages (A and B) 
and FcyRIV on PMNs (C and D) at both the mRNA and protein levels, whereas IL-17 had no direct effect on 
the expression of FcyRs on macrophage or PMN cell lines. Bars show the mean + SD from 3 independent 
experiments performed in triplicate. See Figure 3 for other definitions. 
IL-17-mediated aggravation of cartilage destruction in IC-mediated arthritis is FcyR-
dependent 
Since we have found that activating FcyRs are of crucial importance for the induction 
of severe cartilage destruction during ICA, we investigated their role in IL-17-
mediated aggravation of cartilage destruction in this model. Briefly, FcRy-chain"'" 
mice, which lack functional activating FcyRs, and their wild type controls were 
injected intra-articularly with AdlL-17 or a control vector (AdDel70-3) 1 day prior to 
ICA induction. Histological analysis of samples obtained 5 days after ICA induction 
showed reduced inflammation in the control group of FcRy-chain-7' mice with ICA as 
compared with wild type controls, whereas inflammation severity was comparable in 
FcRy-chain and wild type mice when IL-17 was overexpressed prior to ICA 
induction (Figure 5A). 
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Figure 5. (A) Inflammation 5 days after ICA induction in FcRy-chain mice versus wild type (WT) mice. 
Note the similar inflammation severity in FcRy-chain '' mice and wild type mice when IL-17 was 
overexpressed prior to ICA induction. Cartilage destruction, as measured by proteoglycan (PG) depletion 
(B), chondrocyte death (C), VDIPEN expression (D), and cartilage erosion (E), 5 days after ICA induction in 
FcRy-chain mice versus wild type mice. Compared with the AdlL-17-injected wild type mice with ICA, PG 
depletion was significantly reduced and severe, irreversible cartilage destruction was completely absent in 
the AdlL-17-injected FcRy-chain ' mice with ICA. Bars show the mean ± SEM (η = 5 mice per group). * = Ρ 
< 0.003 versus AdlL-17-injected wild type mice with ICA, by Mann-Whitney U test. 
In addition, IL-17 overexpression during ICA in FcRy-chain mice resulted in a 
massive influx of PMNs without changing the macrophage influx, which was similar 
to the effects of IL-17-enhanced ICA in wild type mice (Table 1). Notably, despite the 
severe inflammation, neutrophil adherence to the cartilage surface, which was 
observed in wild type mice after IL-17 overexpression, was not present in FcRy-
chain mice. With respect to cartilage destruction, we observed a significant 
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reduction in PG depletion (50-60%) and a complete absence of chondrocyte death, 
VDIPEN expression, and cartilage erosion in the AdlL-17-injected FcRy-chain" " mice 
with ICA as compared with the wild type controls (Figures 5B-E). These data show an 
essential role of FcyRs in IL-17-mediated aggravation of cartilage destruction in ICA 
and additionally suggest the involvement of FcyRs in neutrophil adherence 
properties. 
Discussion 
The present study shows that local overexpression of IL-17 during ICA leads to 
aggravation of cartilage destruction, and that IL-17 mediates this effect by strongly 
enhancing the local amount of FcyR-bearing PMNs. In addition, we clearly 
demonstrated that activating FcyRs are indispensable for IL-17-mediated, severe, 
irreversible cartilage degradation. 
It has been shown that under naive conditions, local overexpression of the pro­
inflammatory cytokine IL-17 does not lead to severe cartilage destruction 28. These 
findings were confirmed by the results of the present study, showing that injection 
of AdlL-17 into the knee joints of naive mice results in mild PG depletion only, 
whereas severe cartilage destruction, such as chondrocyte death and MMP-
mediated VDIPEN expression, is completely absent. 
However, in several different arthritis models, it has been demonstrated that in the 
presence of an appropriate additional trigger, IL-17 overexpression can cause 
significant aggravation of cartilage destruction 20'28"30. in these arthritis models, 
multiple factors, such as Τ cells, Β cells, and ICs all contribute to cartilage 
degradation ' , making it difficult to discriminate which factors act in an additive or 
synergistic manner with IL-17. By injecting IL-17 before inducing ICA, a model 
wherein no Τ cells or Β cells are involved, but instead is mediated solely by ICs, we 
demonstrated that the presence of ICs alone is sufficient for IL-17 to cause 
aggravation of cartilage destruction. 
ICs mediate cartilage destruction via activation of FcyRs . Τ cell-derived cytokines, 
such as IFNy, regulate the expression of FcyRs 34'35, thereby aggravating the severity 
of cartilage degradation , which could also be a mechanism of IL-17-mediated 
cartilage destruction. In this study, a role of IL-17 in the regulation of FcyR expression 
was indeed suggested, since IL-17 overexpression in the knee joints of naive mice led 
to increased FcyR mRNA levels in the synovial infiltrate, which were even further 
enhanced when IL-17 was overexpressed prior to ICA induction. However, 
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stimulation of macrophage and PMN cell lines, the main cell types present in the 
synovial infiltrate, revealed that, in contrast to IFNy, IL-17 does not directly regulate 
FcyR expression on these cells. Injection of IL-17 into the knee joints of naive mice 
resulted in mild inflammation, and injection prior to ICA induction led to very severe 
inflammation, which explains the observed up-regulation of FcyRs in the synovium as 
merely a reflection of the IL-17-mediated increase in cell influx. 
A notable observation was the massive PMN influx that took place when IL-17 was 
injected before ICA induction, whereas no differences were found with respect to 
the influx of monocytes and macrophages. IL-17 has been shown to stimulate the 
production of neutrophil-attracting chemokines such as KC and MIP-2, but it does 
not affect the production of macrophage-attracting chemokines . In this study, 
KC and MIP-2 mRNA levels in the synovium were indeed strongly up-regulated after 
local overexpression of IL-17, explaining the observed shift in the composition of 
infiltrated cells towards a strongly enhanced PMN influx. 
Since neutrophils express FcyRs and IL-17 strongly stimulates infiltration of PMNs 
to the site of inflammation, we hypothesize that IL-17 aggravates cartilage 
degradation by strongly enhancing the influx of FcyR-bearing PMNs. It has been 
reported that neutrophils are crucial mediators for the development of streptococcal 
cell wall-induced arthritis in rats , the K/BxN serum-transfer model of arthritis , 
and anti-type II collagen antibody-induced arthritis in mice . Furthermore, it has 
been demonstrated that PMNs are able to degrade cartilage and to inhibit PG 
synthesis in vitro 
Moreover, an additional role of IL-17 in the activation of PMNs is suggested by our 
observation that PMNs strongly adhered to the cartilage surface in the IL-17-treated 
mice with ICA, but not in the control mice with ICA. In a previous study, we found 
that attachment of PMNs to the cartilage surface, and subsequent PMN activation, 
results in aggravation of MMP-mediated cartilage destruction during experimental 
arthritis45, whereas PMNs that do not adhere to the cartilage surface do not seem to 
be potent mediators of cartilage destruction ' . It is possible that IL-17 makes the 
cartilage surface more prone to PMN adherence. Previous studies have 
demonstrated that PMNs do not adhere to intact cartilage surfaces because the PGs 
that are normally present on the intact cartilage surface prevent PMN adhesion. 
However, after these PGs are broken down, PMN adhesion to the cartilage is 
observed . Since it is known that local overexpression of IL-17 induces PG depletion 
in the knee joints of naive mice, this could be one of the mechanisms by which IL-17 
mediates PMN adhesion to the cartilage. Other factors involved in PMN adherence 
that could be regulated by IL-17 are the expression of adhesion receptors on PMNs, 
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as well as the expression of adhesion molecules such as intercellular adhesion 
molecule-1, which is known to be present on chondrocytes Whether any of these 
mechanisms play a role m IL-17-enhanced PMN adherence is currently being 
investigated 
In the present study, we further examined the role of FcyRs by injecting IL-17 into 
FcRy-cham ' mice before ICA induction In earlier studies, we found that activating 
FcyRs are crucial for ICA induction 9 In this study, we demonstrated that, despite the 
absence of functional activating FcyRs, IL-17 overexpression still induced severe 
inflammation, again characterized by massive influx of PMNs This suggests that IL-
17 bypasses FcyR-regulated arthritis onset Since IL-17 does not directly regulate the 
expression of FcyRs, the most plausible explanation for this is that IL-17 induces the 
production of chemokmes, such as KC and MIP-2, leading to an increased cell influx 
Furthermore, infiltrated PMNs no longer adhered to the cartilage surface m FcRy-
cham mice, indicating that not only IL-17, but also FcyRs are important for PMN 
adherence to the cartilage surface 
Additionally, we demonstrated that PG depletion, a reversible form of cartilage 
degradation, is mediated partially by FcyRs and partially by IL-17 itself, since PG loss 
was still present m FcRy-cham mice, even though a significant reduction was 
observed as compared with the wild type controls This was not surprising, since it 
has already been shown that IL-17 alone can induce PG depletion when 
overexpressed locally m the knee joints of naive mice 28 It has been demonstrated 
that IL-17 acts via stimulation of nitric oxide production, resulting m inhibition of PG 
synthesis and stimulation of PG degradation 4850 With respect to the induction of 
severe, irreversible cartilage destruction, like chondrocyte death and MMP-mediated 
VDIPEN expression, we clearly demonstrated that IL-17 mediates its effect via 
activating FcyRs, since this was completely absent m FcRy-cham" mice This is the 
first study to show that FcyRs are of crucial importance m IL-17-mediated 
aggravation of cartilage destruction during ICA 
In conclusion, this study shows that ICs are an appropriate trigger for IL-17 to cause 
aggravation of cartilage destruction and that activating FcyRs are mdispensible 
mediators for the induction of severe, irreversible cartilage destruction In contrast 
to IFNy, which aggravates cartilage destruction via direct up-regulation of FcyR 
expression on both macrophages and neutrophils, IL-17 mediates its effect by 
strongly enhancing the influx of FcyR-bearmg PMNs and by stimulating PMN 
adherence to the cartilage surface 
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Abstract 
Objective The levels of both Fey receptors (FcyRs) and the alarmms S100A8 and 
S100A9 are correlated with the development and progression of cartilage 
destruction during antigen-induced arthritis (AIA). In this study we investigated the 
active involvement of S100A8, S100A9, and S100A8/A9 in FcyR regulation in 
macrophages, polymorphonuclear cells (PMNs), and synovium during AIA 
Methods Recombinant murine S100A8 was injected into the knee joints of naive 
mice and the synovium was isolated for analysis of FcyR expression by real-time 
polymerase chain reaction (PCR). Macrophages, including bone marrow-derived 
macrophages from Toll-like receptor 4 deficient mice (TIRA"'") and PMNs (32Dcl3 cell 
line) were stimulated with S100 proteins and FcyR expression was measured using 
real-time PCR and flow cytometry AIA was induced m the knee joints of S100A9" ~ 
mice and wild type controls The extent of cartilage destruction was determined by 
immunohistochemical analysis. 
Results- Intra-articular injection of S100A8 into the knee joints of naive mice strongly 
up-regulated messenger RNA (mRNA) levels of activating FcyRI (64-fold) and FcyRIV 
(256-fold) in the synovium. Stimulation of macrophages with S100A8 led to 
significant up-regulation of mRNA and protein levels of FcyRI and FcyRIV, but not 
FcyRIII, while the effects of S100A9 or S100A8/A9 complexes were less potent 
Stimulation of PMNs with S100 proteins had no effect on FcyR expression Up-
regulation of FcyRI and FcyRIV was abrogated in S100A8-stimulated macrophages 
from TLR4"/" mice, indicating that the induction of FcyR expression by S100A8 is 
mediated by TLR4 FcyR expression m the inflamed synovium of S100A9"/ mice was 
significantly lower on day 14 after AIA induction, and correlated with reduced 
severity of matrix metalloprotemase-mediated cartilage destruction 
Conclusion. S100A8 is a strong promoter of activating FcyRI and FcyRIV in 
macrophages through activation of TLR4, and acts as a regulator of FcyR expression 
in inflamed synovium m chronic experimental arthritis. 
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Joint inflammation and processes of tissue destruction such as cartilage erosion are 
characteristic features of rheumatoid arthritis (RA) In experimental models of 
chronic joint inflammation (murine antigen-induced arthritis [AIA]), severe cartilage 
destruction, resembling that in human disease, develops During AIA, large amounts 
of inflammatory cells, mainly macrophages, migrate into the synovial layer . These 
macrophages become activated, thereby releasing mediators that regulate the 
processes leading to severe cartilage and bone destruction Macrophages may 
regulate cartilage destruction directly by releasing cytokines, such as mterleukm-l 
(IL-1) and tumor necrosis factor alpha (TNFa), and matrix metalloprotemases 
(MMPs)2 
IgG-contammg immune complexes (ICs) are prominent triggers of macrophages, and 
these ICs are found in large amounts m both the synovium and cartilage, as well as m 
the joint fluid of many patients with RA . During IC-mediated joint inflammation, 
synovial macrophages are dominant players in the induction of severe cartilage 
destruction IgG-contammg ICs communicate with macrophages using Fey 
receptors (FcyRs) Binding of ICs to FcyRs causes activation of these cells In mice, the 
macrophage expresses 4 classes of FcyRs 89, and previous studies have shown that 
absence of the activating FcyRI, FcyRIII, and FcyRIV completely abrogated severe 
cartilage destruction in experimental joint inflammation . Thus, macrophage 
activation through FcyRs is an important event m the development of joint 
inflammation and cartilage destruction 
In a naive joint, FcyR expression on resident lining macrophages, but also on 
unstimulated monocytes, is low and only FcyRIII is ubiquitously expressed 13. During 
joint inflammation, FcyR expression becomes strongly up-regulated within the 
synovium, but the mechanisms involved in this up-regulation are still unknown. 
One group of candidates are components of the complement pathway. C5a is a 
split product of complement activation and has been shown to regulate FcyR 
expression via binding to the C5a receptor (C5aR) 1415. Another group of proteins 
known to become rapidly up-regulated and produced in large amounts during 
arthritis are the alarmms, which belong to the family of damage-associated 
molecular pattern proteins comprising endogenous ligands of so-called pattern 
recognition receptors Two important members are S100A8 (myeloid-related 
protein 8 [MRP8]) and S100A9 (MRP14), belonging to the S100 family of calcium-
bmdmg proteins. S100A8 and S100A9 can bind to each other, thereby forming 
complexes Levels of S100A8/A9 are very high in the synovial fluid of RA patients 
with active disease and are strongly correlated with the severity of joint 
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inflammation and joint destruction 18'19. Both proteins are released by activated 
phagocytes and are novel, endogenous ligands of Toll-like receptor 4 (TLR4). 
Recently, we investigated the role of S100A8/A9 in cartilage destruction during 
chronic joint inflammation in the knee joints of S100A9-deficient mice (SlOOAg-7-). In 
this model, we found that S100A8/A9 regulated severe cartilage destruction 
However, the molecular link between activation of TLR4 by these proteins and the 
pro-inflammatory and destructive effects in arthritis is not yet known. Since both 
FcyR expression and release of S100 proteins by hematopoietic cells are associated 
with cartilage destruction during arthritis, this prompted us to investigate the 
relationship between these 2 processes. 
In the present study, we investigated whether S100A8, S100A9, and the S100A8/A9 
complex are involved in the regulation of FcyRs on hematopoietic cells, and explored 
the role of these proteins in FcyR regulation in vivo during experimental arthritis. We 
observed that S100A8, and to a lesser extent, S100A9 and S100A8/A9, are regulators 
of activating FcyRI and FcyRIV on macrophages, but not on polymorphonuclear cells 
(PMNs), and that S100A8 signaling is regulated by TLR4. Mice lacking S100A8/A9 
showed a significantly reduced expression of activating FcyRs during chronic joint 
inflammation, indicating that S100A8/A9 might promote the chronicity of 
destructive arthritis by regulation of FcyR expression. 
Materials and methods 
Animals 
S100A9 mice were generated as previously described 21 and backcrossed to the 
C57BL/6 background for 10 generations. TLR4"/~ animals in C57BL/6 background 
were kindly provided by Prof. S. Akira (Osaka University, Osaka, Japan). Wild type 
C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) were used as controls. All 
mice were housed under specific pathogen-free conditions during breeding and 
experiments. Mice received autoclaved chow and acidified water ad libitum. Only 
mice that were healthy were used in the experiments, and they were age-matched 
(10-20 weeks) and sex-matched for each set of experiments. All experiments were 
approved by local authorities of the Animal Care and Use Committee. 
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S100A8, S100A9, and S100A8/A9 proteins 
Recombinant murine S100A8 and S100A9 were expressed and purified as described 
earlier2 2 2 3 Overexpression of 5100 proteins was obtained through a combination of 
a T7-based expression vector and the Escherichia coli BL21(DE3) cell line The 
identity of the protein was ascertained by mass spectrometry and Western blotting. 
In addition, all protein preparations were tested by Limulus amebocyte lysate assay 
(BioWhittaker, Walkersville, MD), and the endotoxin content in all preparations was 
lower than 5 pg hpopolysacchande (LPSJ^g protein, indicating that the maximal 
possible contamination of the S100 protein preparations would be <25 pg LPS/5 μg 
protein S100A8 could be heat-inactivated, whereas LPS cannot be rendered inactive 
at the temperature levels used to denature S100A8 . Moreover, LPS contamination 
was further ruled out on the basis of blocking experiments using polymyxin Β sulfate 
(Sigma-Aldrich, St. Louis, MO). For heterodimer formation, purified monomers were 
mixed m 8M urea, and renaturation was allowed to occur during extensive dialysis at 
decreasing concentrations of urea, according to the procedure also used for 
heterodimer formation in human cells 25 
Induction of experimental joint inflammation 
Recombinant murine S100A8 (5 μg) was injected directly into the knee joints of 
C57BL/6 mice The knee joints and synovium were isolated 1 and 3 days thereafter 
AIA was generated by immunizing the mice with 100 μg of methylated bovine 
serum albumin (mBSA; Sigma-Aldrich) emulsified in 100 μΙ of Freund's complete 
adjuvant (CFA; Difco Laboratories, Detroit, Ml). Injections were divided over both 
flanks and footpads of the front paws. Heat-killed Bordetella pertussis (RIVM, 
Bilthoven, the Netherlands) was administered mtrapentoneally as an additional 
adjuvant. One week thereafter, 2 subcutaneous booster injections with 50 μg of 
mBSA/CFA were administered m the neck region. Three weeks after these injections, 
arthritis was induced by mtra-articular injection of 60 μg of mBSA m 6 μΙ phosphate 
buffered saline (PBS) into the knee joint, resulting in chronic arthritis 
Isolation of inflamed synovium 
Well-defined synovial specimens were isolated from the inflamed knee joints as 
previously described 26. At 6 hours and days 1, 2, and 14 after AIA induction, tissue 
punches of synovial specimens were collected and either snap-frozen m liquid 
nitrogen for quantitative real-time polymerase chain reaction (PCR) analysis, or 
incubated for 1 hour in RPMI at room temperature (6 hours and day 1 after AIA 
induction), yielding washouts of synovium. These synovial washouts were used for 
measurements of S100A8/A9 
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Histological assessment of inflamed knee joints 
Total knee joints were isolated either on day 2, day 7, or day 14 after arthritis onset. 
The knee joints were decalcified, dehydrated, and embedded in paraffin. Tissue 
sections (7 μπι) were stained with hematoxylin and eosin (H&E). Seven sections 
spanning 120 μιτι, representing the whole knee joint, were analyzed to ensure a 
statistically meaningful assessment. Histopathologic changes were scored using the 
following parameters. Inflammation was graded on a scale from 0 (no inflammation) 
to 3 (severely inflamed joint) based on the influx of inflammatory cells into the 
synovium and joint cavity. MMP-mediated cartilage destruction was measured by 
immunodetection of MMP-induced neoepitopes (VDIPEN), with findings graded as 
the percentage of positive staining relative to the total cartilage surface. Four 
different areas of the cartilage surface of the knee joint (medial and lateral tibiae 
and femora) were measured, with results expressed as the mean ± SD. 
Immunohistochemical staining 
Knee joint sections were stained as previously described , using rat anti-F4/80 
(specific for murine macrophages; Serotec, Oxford, UK) or rat anti-NIMP-R14 
(specific for murine neutrophils; kindly provided by Dr. M. Strath, London, UK). 
Moreover, sections were stained with rabbit anti-VDIPEN antibodies (kindly provided 
by Dr. J. Mort, Montreal, Quebec, Canada), which recognize neoepitopes induced by 
MMPs. Biotinylated rabbit anti-rat, rabbit anti-rat peroxidase, or biotinylated goat 
anti-rabbit were used as a secondary antibody. Sections were counterstained with 
hematoxylin. 
Culture of macrophages and neutrophils 
Culture of macrophages and PMNs was performed as previously described 20'27. 
Briefly, tibiae from C57BL/6 mice were removed and bone marrow cells were flushed 
with culture medium (Dulbecco's modified Eagle's medium; Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal calf serum (FCS; HyClone, Logan, UT), pyruvate, 100 
units/ml penicillin, and 100 μg/ml streptomycin. The cell suspension was aspirated 
through a 21-gauge needle and filtered over a 100 μπι pore size Cell Strainer filter 
(Falcon, Franklin Lakes, NJ). Cells were washed twice, centrifuged (for 5 minutes at 
200g), and plated into 12-well flat-bottomed tissue-culture-treated plates (Costar, 
Cambridge, MA) at a density of 2xl0 6 cells per well. Cells were cultured in 1 ml 
culture medium containing 15 ng/ml recombinant murine macrophage colony-
stimulating factor (R&D Systems, Minneapolis, MN). The culture medium was 
replaced after 3 days. After 6 days of culture, wells were washed with PBS and 
dissolved in TRIzol reagent (Life Technologies, Breda, the Netherlands). The IL-3-
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dependent, murine myeloid progenitor cell line 32Dcl3 (kindly provided by Dr. J. 
Greenberger, Pittsburgh, PA) was cultured in RPMI 1640 (Invitrogen), supplemented 
with 10% WEHI-3B-conditioned medium (American Type Culture Collection) as a 
source of murine IL-3, 10% PCS, pyruvate, L-glutamme, and penicillin/streptomycin 
Cell cultures were maintained at 37°C in a humidified incubator containing 5% CO2, 
95% air. For differentiation of PMNs, IxlO6 32Dcl3 cells were cultured for 12 days m 
75 cm2 culture flasks in RPMI 1640, supplemented with 100 ng/ml recombinant 
human granulocyte colony-stimulating factor (Rhône-Poulenc Rorer, Frankfurt, 
Germany), 10% FCS, pyruvate, L-glutamme, and penicillin/streptomycin The medium 
was replaced every 3 days and cells were adjusted to their initial cell concentration. 
Cytospms were stained with H&E on day 12, for determination of morphologic 
features Macrophages or PMNs (1x10 cells) were stimulated for 24 hours with 
various concentrations of S100A8, S100A9, or S100A8/A9 complex (0 2, 1.0, and 5.0 
μg/ml), and analyzed for the expression of FcyRs using quantitative real-time PCR 
and fluorescence-activated cell sorting (FACS) analysis. 
Detection of FeyR messenger RNA levels using quantitative real-time PCR 
Total RNA was isolated in 1 ml TRIzol reagent and reverse transcribed into 
complementary DNA with Moloney murine leukemia virus reverse transcriptase, 
oligo(dT) primers, and dNTPs (Invitrogen). Quantitative real-time PCR was performed 
using the ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster 
City, CA) The PCR amplification protocol was as follows: 2 minutes at 50°C and 10 
minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C, 
with data collection during the last 30 seconds Messenger RNA (mRNA) for murine 
genes was amplified using specific primers (Biolegio, Maiden, the Netherlands) at a 
final concentration of 300 nmoles/hter m SYBR Green Master Mix (Applied 
Biosystems). For each sample, differences in threshold cycle (AÄCt) values were 
calculated by correcting the Ct of the gene of interest to the Ct of the reference gene 
GAPDH and comparing it with that of controls 
MCS analysis 
Cells were isolated by cold shock and incubated with mouse anti-FcyRI (kindly 
provided by Dr P. M Hogarth, Melbourne, Victoria, Australia), rat anti-FcyRII/lll 
(2 4G2, BD PharMmgen, San Diego, Ca), carboxyfluorescem-labeled rat anti-FcyRIII 
(R&D Systems), and Alexa Fluor 647-labeled Armenian hamster anti-FcyRIV (kindly 
provided by Dr F Nimmerjahn, Erlangen, Germany). FcyRI was detected using 
fluorescein isothiocyanate (FITC)-labeled sheep anti-mouse (Cappel, West Chester, 
PA) and FcyRII/lll was detected using FITC-labeled mouse anti-rat (Zymed, South San 
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Francisco, CA) FACS analysis was performed using a FACSCalibur instrument (Becton 
Dickinson, San Jose, CA) and CellQuest software 
Measurement of S100A8/A9 using enzyme-linked immunosorbent assay 
Murine S100A8/A9 complexes were measured using a modified sandwich enzyme-
linked immunosorbent assay (ELISA) protocol originally established for human 
S100A8/A9 23 Human antibodies were replaced by their murine counterparts (anti-
S100A8 as coating antibody and biotmylated anti-S100A9 as detection antibody), 
and a purified murine S100A8/A9 complex was used as standard 
Statistical analysis 
Differences between experimental groups were tested for significance using the 
Mann-Whitney U test Ρ values less than 0 05 were considered significant 
Results 
Preferential up-regulation of activating FcyRI and FcyRIV following mtra-articular 
injection ofS100A8 
In previous studies, we found that both FcyR expression and S100A8 expression are 
correlated with the severity of cartilage destruction Since FcyR expression on 
quiescent macrophages is low and S100A8 is one of the proteins initially secreted 
after macrophage activation, we investigated whether S100A8 is able to up-regulate 
FcyR expression in the synovium Five micrograms of S100A8 was injected directly 
into the knee joints of naive mice Although LPS was not detected by Limulus assay in 
the S100A8 preparation, the protein was injected either alone or in the presence of 
polymyxin Β As a further control, a non-relevant protein (5 μg of ovalbumin) was 
injected Histological assessment of the knee joints showed that a minor 
inflammation was induced on day 1 after a single injection of S100A8 Joint 
inflammation was -30% less than that seen m AIA on day 1 after induction 
Immunolocahzation using F4/80 showed that one part of the infiltrating cells 
consisted of monocyte/macrophages, whereas NIMP-R14 staining showed that the 
other part consisted of PMNs (Figures 1A and B, respectively, compared with isotype 
control m Figure 1C) Neutrophils were further analyzed microscopically m H&E-
stamed tissue sections The proportion of infiltrating neutrophils varied between 
32% and 48% of the total cell population, which corresponded to the number of 
NIMP-R14-positive cells No inflammation was induced after injection of polymyxin Β 
or ovalbumin alone (Figure ID) 
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FcyRI FcyRIIB FcyRIM FCYRIV 
Figure 1. Regulation of joint inflammation and Fey receptor (FcyR) expression by recombinant murine 
S100A8 in the knee joints of C57BL/5 mice. Five micrograms of S100A8 (alone or in combination with 
polymyxin B) was injected directly into the knee joints, which were isolated 1 and 3 days thereafter. Knee 
joint sections were stained for the macrophage marker F4/80 (A) and the neutrophil marker NIMP-R14 (B) 
(inset shows higher-magnification view), resulting in the detection of both cell types 1 day after injection 
of S100A8 alone, in comparison with a lack of staining in sections stained with isotype control IgG 
antibodies (C). (D) Absence of inflammatory cells in knee joints injected with 5.0 μg of ovalbumin or 
polymyxin Β alone. Original magnification χ200; χΙ,ΟΟΟ in inset in Β. (E) Analysis of FcyR mRNA levels 
(FcyRI, FcyRIIB, FcyRIII, and FcyRIV) by quantitative real-time PCR in synovial specimens isolated on day 1 
and day 3 after intra-articular injection with S100A8. Bars show the mean ± SD ΔΔα values, relative to the 
values in naive synovium, in samples from 5 mice in 1 of 2 independent experiments. 
On day 1 and day 3 after Injection of S100A8, the synovium was Isolated and FcyR 
expression was determined with real-time PCR. On day 1 after injection, mRNA levels 
of FcyRI, FcyRIIB, FcyRIII, and FcyRIV were Increased (Figure IE). Of particular note 
are the strongly enhanced mRNA levels of FcyRI and FcyRIV (64-fold and 256-fold, 
respectively). No effect of polymyxin Β alone or ovalbumin was found. 
Stimulation of FcyR expression on macrophages in vitro by S100A8 
Since intra-articular injection of S100A8 alters the amount of FcyR-bearlng 
Inflammatory cells present in the joint, we additionally investigated whether S100A8 
was able to directly up-regulate FcyR expression on macrophages and neutrophils in 
vitro. Bone marrow-derived macrophages were stimulated with various 
concentrations of S100A8 (0.2, 1.0, and 5.0 μg/ml). In macrophages, a significant. 
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concentration-dependent up-regulation of activating FcyRI and FcyRIV, but not 
FcyRIII, was observed, indicated by AACt values for FcyRI and FcyRIV of 2.0 and 1.5, 
respectively, in cultures with 1.0 μg/nnl of S100A8, and AACt values of 3.1 and 2.6, 
respectively, in cultures with 5.0 μg/ml S100A8 {Figures 2A-D). Levels of the 
inhibitory FcyRIIB were only moderately up-regulated (AACt = 1.2 and 2.2 with 1.0 
μg/ml and 5.0 μg/ml S100A8, respectively). Although C5aR, which is involved in FcyR 
regulation, showed up-regulated expression levels after intra-articular injection of 
S100A8, no up-regulation was found after direct stimulation of macrophages with 
S100A8 {results not shown). 
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Figure 2. Regulation of Fey receptor (FcyR) mRNA levels in bone marrow-derived macrophages stimulated 
with recombinant murine S100A8 at concentrations of 0.2, 1.0, or 5.0 μg/ml. A concentration-dependent 
increase in FcyRI (A), FcyRIIB (B), and FcyRIV (D), but not in FcyRIII (C), was observed, with maximal mRNA 
levels in macrophages stimulated with 5.0 μg/ml of S100A8. Bars show the mean ± SD AACt values, 
relative to the values in unstimulated cells, from 3 independent experiments. * = Ρ < 0.05 versus 
unstimulated cells, by Mann-Whitney U test. 
In addition, the possibility that FcyR expression was also elevated at the protein level 
was investigated with FACS analysis. Analysis of protein levels revealed that 90% of 
the macrophages expressed FcyRI, 50-65% expressed FcyRII/lll, and 35-50% 
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expressed FcyRIV. Interestingly, when results were expressed as the mean 
fluorescence intensity (MFI) of staining, it was found that FcyRI and FcyRIV, in 
particular, were up-regulated in a concentration-dependent manner after 
stimulation of macrophages with S100A8. For FcyRI, an increase in the MFI of 31%, 
54%, and 85%, relative to that in unstimulated cells, was observed, while for FcyRIV, 
an increase of 10%, 40%, and 150% was observed, after stimulation with 0.2, 1.0, 
and 5.0 μg/ml S100A8, respectively. FcyRIII was not up-regulated, which suggests 
that the slight increase in FcyRII/lll staining was completely due to up-regulation of 
the inhibitory FcyRIIB (Figure 3). 
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Figure 3. Expression of Fcv receptor (FcyR) proteins on the cell surface of macrophages 24 hours after 
stimulation with various concentrations of S100A8 (0.2, 1.0, and 5.0 μ§/ΓηΙ). Expression of FcyRI, FcvRII/lll, 
FcyRIII, and FcyRIV was determined by flow cytometry, with results expressed as the mean ± SD mean 
fluorescence intensity (MFI) of FcyR expression from 3 independent experiments. Note that there is a 
concentration-dependent increase in the MFI for activating FcyRI and FcyRIV, and only a slight increase in 
the MFI for FcyRII/lll. · = Ρ < 0.05 versus unstimulated macrophages, by Mann-Whitney U test. 
We additionally explored the efficacy of S100A8 in comparison with that of S100A9 
and the S100A8/A9 complex, using the most effective doses (1.0 μg/ml each). Bone 
marrow-derived macrophages were stimulated with S100A8, S100A9, or S100A8/A9, 
and FcyR expression levels were measured using FACS analysis. As an additional 
control in the FACS analyses, interferon-y (IFNy) (10 ng/ml) was used. As expected, 
IFNy stimulation clearly up-regulated the expression of FcyRI and FcyRIV. S100A8 
was more potent than S100A9 or the S100A8/A9 complex in up-regulating activating 
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FcyRI and FcyRIV. Differences in efficacy were not found regarding the expression of 
FcyRII/lll (F;sfure44). 
In addition to macrophages, PMNs also express FcyRs and these cells are 
abundantly present during acute arthritis. To further investigate whether S100A8 
and S100A9 proteins are able to regulate FcyR expression on neutrophils, a PMN cell 
line {32Dcl3) was used. Unstimulated PMNs displayed much lower FcyR expression 
levels when compared with bone marrow-derived macrophages. With FACS analysis, 
only low expression of both FcyRI and FcyRIV was detected, whereas FcyRII/lll levels 
were somewhat higher. Stimulating these cells with IFNy for 24 hours significantly 
up-regulated the expression of FcyRI, FcyRII/lll, and FcyRIV (Figure 48). In contrast, 
stimulation of PMNs with 1.0 μg/ml of S100A8, S100A9, or S100A8/A9 for 24 hours 
did not increase FcyR expression on the PMN cell surface [Figure 48). 
macrophages β PMN 
SIOOA8 S100A9 S100A8/A9 ΙΡΝγ - S100A8 S100A9 S100A8/A9 IFNy 
Figure 4. Regulation of Fey receptor (FcyR) expression in bone marrow-derived macrophages and 
polymorphonuclear cells (PMNs) (32Dcl3 cell line) by recombinant murine S100 proteins. Macrophages (A) 
and PMNs (B) were stimulated with 1.0 μg/ml S100A8, S100A9, or S100A8/A9, or with 10 ng/ml 
interferon-y (IFNy) as a control. FcyR expression was determined using flow cytometry. Bars show the 
mean ± SD mean fluorescence intensity (MFI) from 3 independent experiments. Note that in 
macrophages, S100A8 was the most potent stimulator of activating FcyRI and FcyRIV, whereas FcyRII/lll 
(but not FcyRIII) was marginally elevated by all 3 S100 species (A). Note that, in contrast to the effects of 
IFNy, none of the S100 species was able to up-regulate FcyRI, FcyRII/lll, or FcyRIV on the surface of PMNs 
(B). * = Ρ < 0.05 versus unstimulated cells, by Mann-Whitney U test. 
TLR4 is the dominant receptor mediating SlOOAS-stimulated FcyR expression 
In a previous study, it was observed that TLR4 is the dominant receptor mediating 
S100A8 signaling in macrophages, as determined according to the production of 
TNFa 24. To further investigate whether TLR4 is the dominant receptor for regulation 
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of FcyR expression, bone marrow-derived macrophages from TLR4' ' mice and their 
wild type controls were stimulated with 1.0 pg/ml S100A8 for 24 hours. Of note, 
mRNA levels of FcyRI and FcyRIV, but not those of FcyRIII, were significantly up-
regulated in wild type mice, as indicated by ΔΔΟ: values of 2.2 and 1.2 for FcyRI and 
FcyRIV, respectively. Messenger RNA expression of FcyRIIB was only slightly 
increased. Interestingly, when macrophages from TLR4 mice were stimulated for 
24 hours, no raise in the mRNA expression of activating FcyRI and FcyRIV was found 
{Figure 5A). 
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Figure 5. Effects of S100A8 (1.0 μ§/ηιΙ) on Fey receptor (FcyR) expression on macrophages from Toll-like 
receptor 4 deficient (TLRA"'") mice compared with wild type controls (WT). (A) Levels of mRNA for FcyRI, 
FcyRII, FcyRIII, and FcyRIV were determined by real-time PCR, with results expressed as the mean ± SD 
AACt values relative to unstimulated macrophages. Note that in wild type macrophages, FcyRI and FcyRIV 
were strongly up-regulated, whereas complete abolition of FcyR regulation was found in TLR4 ^ 
macrophages. (B and C) Protein levels of FcyRI, FcyRII, FcyRIII, and FcyRIV were determined by flow 
cytometry, with results expressed as the mean ± SD percentage of FcyR-bearing cells (B), or as the mean ± 
SD mean fluorescence intensity (MFI) (C) from 3 independent experiments. Most cells expressed FcyRI, 
whereas only a subpopulation (40-50%) expressed FcyRIV, and expression of FcyRII/lll was even lower (B). 
Note that stimulation of wild type macrophages with S100A8 significantly up-regulated the MFI for FcyRI 
and FcyRIV, whereas no up-regulation of these receptors was found on TLR4"/" macrophages (C). * = Ρ < 
0.05 versus unstimulated cells, by Mann-Whitney U test. 
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Moreover, measurement of the protein levels by FACS analysis again showed that 
only a subpopulation of cells (40-50%) expressed FcyRIV, whereas 85-95% of the cells 
expressed FcyRI (Figure SB). The MFI for FcyRI and FcyRIV on wild type macrophages 
was up-regulated after S100A8 stimulation by 62% and 31%, respectively, while the 
MFI for FcyRII/lll was up-regulated by 33%. However, on the cell surface of S100A8-
stimulated TLR4"/" macrophages an increase in the MFI for FcyRI, FcyRIV, and 
FcyRII/lll, was completely absent (Figure 5C). 
Regulation of FcyR expression and cartilage destruction in vivo by S100A8/A9 in 
chronic experimental joint inflammation 
We next investigated the in vivo role of S100A8/A9 in the regulation of FcyRs during 
experimental joint inflammation in S100A9~ " mice. AIA was elicited by injecting 
mBSA into the knee joints of S100A9"/" mice and their wild type controls, both of 
which had been previously immunized with the antigen. At 6 and 24 hours after AIA 
induction, high levels of S100A8/A9 proteins were observed in the synovial washouts 
from wild type mice. No S100A8/A9 complexes were detected in the synovial 
washouts from the inflamed arthritic joints of S100A9" ~ mice (Figure 6A). Washouts 
derived from naive synovium did not contain S100A8/A9 proteins. 
Histological assessments performed on day 2 and day 14 after AIA induction 
showed no differences in joint inflammation, whereas on day 7 synovial 
inflammation was somewhat lower in S100A9~ ~ mice when compared with wild type 
mice (Figure 6B). Furthermore, recruitment of neutrophils and macrophages was 
characterized by immunolocalization studies. No significant difference in the 
neutrophil-to-macrophage ratio was observed between S100A9 mice and their 
wild type controls. On days 2, 7, and 14 after AIA induction the PMN content, 
expressed as the percentage of total inflammatory cell mass, was 38% (n = 5), 13% (n 
= 4), and 0% (n = 5), respectively, in wild type mice and 37% (n = 5), 10% (n = 5), and 
0% (n = 5), respectively, in SlOOAg"7" mice. 
Expression of FcyR mRNA levels in the synovial tissue of arthritic SlOOAg"7" mice 
was high on day 2 up to day 14 when compared with naive synovium (results not 
shown). On day 14, but not on day 2, FcyR expression was significantly lower in 
arthritic ΒΙΟΟΑΘ-'- mice when compared with wild type controls (Figures 6C and D). 
The latter finding suggests that there is an overexpression of pro-inflammatory 
factors in the acute phase of arthritis, whereas S100A8/A9 becomes particularly 
important in the regulation of FcyRs during the chronic phase of inflammatory 
reactions. Of note, cartilage destruction on day 14, as measured with VDIPEN 
staining, was significantly lower in S100A9"/~ mice when compared with wild type 
controls (Figure 6E). 
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Figure 6. Analysis of synovial specimens from S100A9" " mice and wild type controls after AIA induction. 
(A) Levels of S100A8/A9 complexes were measured in synovial washouts 6 and 24 hours after AIA 
induction. Note the high amounts of S100A8/A9 in the washouts of wild type mice, whereas the complex 
was barely detectable in the inflamed synovia of S100A9'/' mice. (B) Inflammatory cell mass in knee joints 
of S100A9 and wild type mice up to 14 days after AIA induction, graded using an arbitrary scale from 0 
to 3. (C and D) Levels of mRNA for FcyRI, FcyRII, FcyRIII, and FcyRIV were determined in the inflamed 
synovia of S100A9'/" mice and wild type controls on day 2 (C) and day 14 (D) after AIA induction. Results 
are expressed as ΔΔΟ values relative to the values in wild type mice. Note that on day 2, mRNA levels for 
all FcyRs were comparable between the groups, whereas on day 14 FcyR expression was much lower in 
the inflamed synovia of S100A9"'' mice. (E) The effect of S100A8/A9 on cartilage destruction was 
determined by VDIPEN staining in the knee joints of S100A9'/' mice and wild type controls 14 days after 
AIA induction. The areas of immunostaining were expressed as a percentage of the total cartilage surface, 
determined on 4 different cartilage surfaces (lateral and medial tibiae and femora). Bars in A-Ε show the 
mean ± SD (n = 8 mice per group). * = Ρ < 0.05 versus wild type, by Mann-Whitney U test. 
116 
Chapter 5 
Discussion 
S100A8 and S100A9 are among the proteins whose expression is most strongly up-
regulated m numerous inflammatory diseases, such as RA, inflammatory bowel 
disease, vasculitis, and cancer 1728. Both molecules are secreted by activated 
phagocytes and have pro-inflammatory effects 29. S100A8 and S100A9 are novel, 
endogenous ligands of TLR4 and promote experimental arthritis, as was shown by 
previous observations of reduced cartilage destruction m S100A9" " mice (also 
lacking S100A8 at the protein level) m AIA 20 However, the molecular link between 
TLR4 activation by these proteins and the devastating effects observed in arthritis is 
not yet clear In this study, we have shown that S100A8, and to a lesser extent, 
S100A9 and the S100A8/A9 complex, can cause a shift m the FcyR expression 
balance towards activating FcyRs, thereby making the cell more sensitive to IC 
stimulation 
FcyRs are important receptors m mediating inflammation and cartilage destruction 
during IC-mediated arthritis In previous studies, we have demonstrated that the 
severity of joint inflammation and destruction is regulated by the balance between 
activating and inhibitory FcyRs on immune cells, such as macrophages and PMNs 
FcyR expression on quiescent macrophages and neutrophils is low, and only FcyRIII is 
constitutively expressed on the cell surface When macrophages are activated, 
FcyR expression is rapidly up-regulated, making the cells more prone to bind and 
phagocytose ICs 31. In our study, mtra-articular injection of S100A8 into the knee 
joints of naive mice caused a shift towards activating FcyRI and FcyRIV m the 
synovium within 24 hours S100A8 was described in earlier studies as the active 
component of the S100A8/A9 complex, whereas S100A9 protects S100A8 against 
degradation Ample influx of both FcyR-bearmg monocytes and PMNs was found 
m SlOOAS-injected knee joints, which may be due to the pro-inflammatory effects of 
S100A8 on endothelial cells , as well as stimulation of IL-1 and TNFa production 
by synovial cells These cytokines subsequently induce monocyte-attractmg 
chemokmes, such as macrophage inflammatory protein l a 
Up-regulation of FcyRs in the inflamed synovium was related not only to the influx of 
inflammatory cells into the joint, but also to direct up-regulation of FcyRs on the 
cells. In vitro stimulation of macrophages with S100A8 showed a strong, 
concentration-dependent up-regulation of the activating FcyRI, FcyRIV, and, to a 
lesser extent, the inhibitory FcyRIIB This shift towards activating FcyRs makes the 
macrophages more sensitive to IC activation. The selective expression of 
predominantly FcyRI and FcyRIV is consistent with observations of FcyR expression m 
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the inflamed synovium during the course of AIA Activation of macrophages by 
FcyR ligation with ICs leads to up-regulation of S100A8, S100A9, and S100A8/A9, 
thereby generating a positive feedback loop 
Although S100A9 and the S100A8/A9 complex were also able to slightly up-
regulate FcyRII/lll and FcyRIV, they were clearly less effective than S100A8 In 
contrast, just like S100A8, S100A9 and the complex are capable of stimulating 
macrophages to produce other molecules, such as the cytokines IL-lß and TNFa , 
which, however, fail to regulate FcyR expression 
Murine neutrophils express FcyRIII and FcyRIV and low levels of FcyRI 
Neutrophil activation by immobilized ICs requires the activity of FcyRIII and FcyRIV, 
but not FcyRI39 Hereby, FcyRIII and FcyRIV play overlapping, redundant roles In the 
present study, the PMN cell line expressed only low levels of FcyRs when compared 
with expression levels m macrophages In general, mature PMNs do not generate 
high amounts of new proteins In the PMN cell line studied, FcyR expression was not 
elevated m response to S100A8, S100A9, or the complex, m contrast to the 
stimulatory effects of IFNy This suggests that, although activated PMNs secrete 
large amounts of S100 proteins, no positive feedback loop is initiated by S100 
proteins, and that the regulatory effect of S100A8 on FcyR expression is mainly 
found on macrophages 
Various receptors, such as N-glycans and the receptor for advanced glycation end 
products , have been suggested as receptors for S100A8 and S100A9, but so far, 
only TLR4 has been confirmed to have functional relevance in vivo However, both 
homodimers and heterodimers of S100A8 and S100A9 have been described, each of 
which may bind and activate receptors in different ways Moreover, the 
importance of each receptor may be associated with the specific cell type studied N-
glycans, which are present on various receptors, have been shown to be particularly 
important on chondrocytes ^ 
In the present study, we found that TLR4 is the dominant receptor for S100A8-
stimulated FcyR expression on macrophages, since no regulation was observed after 
stimulation of macrophages derived from TLR4 ' mice In a previous study, wherein 
TLR4-mutant C3H/HeJ mice were used, it was shown that S100A8 interacts with the 
LPS-bmdmg receptor complex, as demonstrated by a lack of TNFa production in 
macrophages of these mice 24 S100A8 initiates activation of the canonical TLR4 
signaling pathway mediated by myeloid differentiation factor 88 and IL-1 receptor-
associated kinase 1, which results in the expression of pro-inflammatory TNFa 
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through activation of NF-κΒ ^ TLR4 has been shown to be a crucial receptor in 
mediating joint inflammation and destruction 4 3''4 Inhibition of TLR4 breaks the 
inflammatory loop in autoimmune destructive arthritis , and a shift from TLR2 
towards TLR4 dependency was observed in the erosive stage of chronic arthritis, 
coincident with TLR4-mediated IL-17 production 
Interestingly, when experimental joint inflammation was induced in the knee joints 
of SIOOAS"7" mice, the severity of synovial inflammation was comparable with that in 
wild type mice throughout the course of AIA up to day 14 after arthritis induction 
This is consistent with the findings m an earlier study m the K/BxN mouse model 
FcyR expression m the inflamed synovium was significantly down-regulated in the 
chronic phase of joint inflammation, which suggests that S100A8 is important in FcyR 
regulation during chronic arthritis Shortly after AIA induction, FcyR expression in the 
inflamed synovium was comparable between S100A9 mice and wild type controls 
An explanation for this may be that other inflammatory mediators, released during 
the acute phase of inflammation, are involved m the regulation of FcyR expression 
These include cytokines, such as IFNy or IL-13 , and complement components, C5a 
m particular Elegant studies by Konrad et al have shown that C5a suppresses 
the transcription of FcyRIIB and induces the transcription of FcyRIII in macrophages 
in a phosphatidylmositol 3-kinase-dependent manner iS Although S100A8 is 
secreted m large amounts at the start of acute joint inflammation, its effect on FcyR 
expression during the acute phase may be taken over by C5a, whose binding to C5aR 
may be the dominant mechanism of FcyR regulation At later phases of arthritis, 
when ICs are phagocytosed and complement is consumed, factors like S100A8, 
which are released over a prolonged period of time, may become more important in 
regulating activating FcyRs and could promote the chromcity of destructive disease 
The present study shows that S100A8 and, to a lesser extent, S100A9 and the 
S100A8/A9 complex, regulate the expression of activating FcyRs on macrophages 
and in inflamed synovia during joint inflammation, which may contribute to the 
induction of joint destruction S100 proteins, S100A8 in particular, might be an 
important marker for predicting the development of severe cartilage destruction and 
may also form a new target for therapeutic approach 
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Abstract 
Objective To study the active involvement of the myeloid-related proteins S100A8 
and S100A9 in joint inflammation and cartilage destruction during antigen-induced 
arthritis (AIA). 
Methods. Joint inflammation and cartilage destruction were measured with mTc 
uptake and histology. The role of S100A8/A9 was investigated by inducing AIA in 
SlOOAg"7- mice that also lack S100A8 at protein level, or by mtra-articular injection 
of S100A8 m murine knee joints. Cartilage destruction was measured using 
immunolocalization of the neoepitopes VDIPEN or NITEGE Messenger RNA (mRNA) 
levels of matrix metalloprotemases (MMPs) and cytokines were measured using real-
time polymerase chain reaction 
Results: Immunization of S100A9" " mice with the antigen mBSA induced normal 
cellular and humoral responses, not different from wild type controls However, joint 
swelling on day 3 and day 7 after AIA induction was significantly lower (36 and 70%, 
respectively) Histologically, on day 7 of AIA, cellular mass was much lower (63-80%) 
and proteoglycan (PG) depletion from cartilage layers was significantly reduced 
(between 50-95%) Cartilage destruction mediated by MMPs was absent m S100A9 
mice, but clearly present in controls MMP-3, 9, and 13 mRNA levels were 
significantly lower in arthritic synovia of S100A9 " mice. In vitro stimulation of 
macrophages by the S100A8/A9 heterodimer or by S100A8 elevated mRNA levels of 
MMP-3, 9, and in particular MMP-13 Intra-articular injection of S100A8 caused 
prominent joint inflammation and PG depletion 1 day thereafter Significant up-
regulation of mRNA levels for S100A8, S100A9, mterleukm-l (IL-1), MMP-3, 13 and a 
dismtegrm and metalloprotemase with thrombospondm motifs 4 (ADAMTS4) was 
found m the synovium, and correlated with strong up-regulation of NITEGE 
neoepitopes within the cartilage layers 
Conclusions S100A8/A9 regulate joint inflammation and cartilage destruction during 
antigen-induced arthritis. 
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During rheumatoid arthritis (RA), large amounts of inflammatory cells, mainly 
macrophages, migrate into the synovial layer . A significant correlation was found 
between the number of activated macrophages and the occurrence of cartilage 
destruction 2'3. In previous studies we found that activated macrophages are crucial 
in regulating joint inflammation and cartilage destruction during experimental 
arthritis *"6. Selective elimination of synovial lining macrophages prior to or during 
experimental arthritis inhibited synovial inflammation almost completely and 
diminished cartilage destruction . 
Cells of the innate immune system, especially macrophages, are activated by 
recognition of invading microorganisms through pathogen-associated molecular 
patterns (PAMPs) and by recognition of tissue damage through damage-associated 
molecular patterns (DAMPs). There is a growing body of evidence that DAMPs 
promote inflammatory responses after being released by activated cells . Most 
DAMPs exhibit a kind of double life: within the cell they play a role in cellular 
homeostasis, e.g., as calcium-binding proteins, chaperones, or chromatin-stabilizing 
molecules 8. After secretion into the extracellular compartment upon cell damage or 
cell activation they become danger signals, which activate leukocytes and 
endothelial cells 9. Due to their inflammatory activities the terms "endokines" or 
"alarmins" have been introduced for these molecules 
The most prominent proteins released by activated macrophages are the 
calgranulins myeloid-related protein 8 (MRP8; S100A8) and MRP14 (S100A9). Both 
proteins belong to the S100 family of calcium-binding proteins that is comprised of 
22 members . S100A8 and S100A9 form non-covalently associated complexes that 
exhibit typical properties of DAMPs 12. The heterodimeric S100A8/A9 complex 
modulates polymerization of microtubules during migration of phagocytes, thereby 
integrating p38 mitogen-activated protein kinase (MAPK) and calcium dependent 
signaling . S100A8 has been shown to be the active component of this complex, 
whereas S100A9 exhibits rather regulatory functions and protects S100A8 from 
degradation . Inflammatory mediators such as interleukin-1 (IL-1), tumor necrosis 
factor α (TNFa), and interferon-y (IFNy) stimulate macrophages to up-regulate and 
secrete S100A8/A9, and it is now clear that S100A8/A9 induces pro-inflammatory 
responses in leukocytes and endothelial cells13'14. 
The nature of surface receptors for S100A8/S100A9 and their signaling pathways is a 
matter of debate 15'16. Recently it was found that Toll-like receptor 4 (TLR4) is the 
dominant receptor for S100A8 signaling 17. S100A9, and the S100A8/A9 heterodimer, 
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in absence of a secondary stimulus like lipopolysacchande (LPS), fail to activate 
macrophages 17. Stimulation of macrophages with S100A8 leads to nuclear factor-κΒ 
(NF-KB) and MARK signaling 1 5 1 6 . 
S100A8, S100A9, and the S100A8/A9 heterodimer accumulate in inflammatory fluids 
and are postulated to be involved in the pathogenesis of RA . Expression levels of 
S100A8/A9 correlated well with the severity of arthritis and levels were higher m 
synovial fluid than in blood 18 Moreover, S100A8 and S100A9 are both expressed in 
macrophages present in the synovial lining and sublmmg layers, but also in the 
inflamed synovial pannus tissue that invades cartilage and bone Recently it was 
found that S100A8/A9 levels strongly correlated with radiological damage 
suggesting an active role of these proteins in RA pathogenesis. 
In the present study we investigated the functional role of S100A8/A9 in joint 
inflammation and cartilage destruction during antigen-induced arthritis (AIA) using 
mice that were made deficient for S100A9. Targeted deletion of the S100A9 gene in 
mice results m a loss of both S100A8 and S100A9 proteins, probably due to a high 
turnover of isolated S100A8 in absence of its binding partner S100A9 22 Our results 
show that S100A8/A9 regulate joint inflammation and may also directly regulate 
induction of cartilage destruction. 
Materials and methods 
Animals 
S100A9 '' mice were generated as described previously 22 23 S100A9"7" mice and wild 
type control httermates were used in our experiments All mice were housed under 
specified pathogen-free conditions during breeding and experiments. For each set of 
experiments mice were age-matched (10-20 weeks) and sex-matched. All 
experiments were approved by the local authority Animal Care and Use Committee 
and were performed by personnel certified by the Dutch Ministry of WVC. 
S100A8 and S100A8/A9 proteins 
Recombinant murine S100A8 and S100A8/A9 were expressed and purified as 
described previously . The identity of the proteins was ascertained by ammo acid 
sequencing and electrospray ionization mass spectrometry Endotoxin 
contaminations were excluded by blocking experiments using polymyxin Β sulfate 
(Sigma-Aldnch, St Louis, MO). In addition, all protein preparations were tested by 
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Limulus amebocyte lysate assay (BioWhittaker, Walkersville, MD) and LPS content 
was not detectable (sensitivity ~0 7±0 5 pg LPS^g protein), indicating that the 
maximal possible contamination of S100 protein preparations was <1 2 pg LPS^g 
protein As a control, a non-relevant protein (5 μg of ovalbumin) was injected 
Induction of Antigen-Induced Arthritis 
Mice were immunized with 100 μg of methylated bovine serum albumin (mBSA, 
Sigma-Aldnch) emulsified in 100 μΙ of Freund's complete adjuvant (CFA, Difco 
Laboratories, Detroit, Ml) Injections were divided over both flanks and footpads of 
the front paws Heat-killed Bordetella pertussis (RIVM, Bilthoven, the Netherlands) 
was administered mtrapentoneally as an additional adjuvant One week thereafter, 2 
subcutaneous booster injections with 50 μg of mBSA/CFA were administered in the 
neck region Three weeks after these injections, arthritis was induced by intra­
articular injection of 60 μg of mBSA in 6 μΙ of phosphate buffered saline (PBS) into 
the right knee joint, resulting in chronic arthritis 
Humoral immunity against mBSA 
Antibodies of various isotypes (IgG, IgGl, lgG2a, lgG2b, lgG3) directed against mBSA 
were measured m the sera of individual mice with an enzyme-linked immunosorbent 
assay (ELISA) Antigen was coated on microliter plates (Gremer, Alphen a/d Rijn, the 
Netherlands) at a concentration of 100 μg/ml Antibody titers were assessed by two­
fold serial dilution of the sera followed by detection of bound mouse Ig with 1 500 
diluted peroxidase-conjugated rabbit anti-mouse Ig (Miles Laboratories, Elkhart, IN) 
O-Phenylenediamme (1 mg/ml, Sigma-Aldnch) was used as substrate for peroxidase, 
and the antibody titer was determined by using 50% of the maximal extinction as an 
endpomt 
Cellular immunity against mBSA 
Mouse spleen cells were isolated and washed m RPMI (Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal calf serum (FCS), glutamm (2 mM), and pyruvate (1 
mM) Erythrocytes were lysed by treatment of the cells with an 0 16 M NH4CI 
solution in 0 17 M Tris (pH 7 2) for 5 mm After two washes m RPMI, the cells were 
plated in plastic Τ flasks (75 mm2) (Falcon Plastics, Oxnard, CA) After 60 minutes of 
incubation at 370C, non-adherent cells were harvested by aspiration and two 4-5 ml 
RPMI washes of the adherent cells One hundred μΙ of RPMI containing 1x10 Τ cell-
enriched spleen cells were placed m each well of a sterile, U-bottomed polystyrene 
microculture plate (Costar, Cambridge, MA) Antigens or mitogens were added m 
another 100 μΙ to give a total volume of 200 μΙ, and final concentrations of antigen of 
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50, 25, 12, 6, and 3 μg/ml. Cultures were maintained at 37°C in a humidified 
atmosphere of 2% CO2 and 98% air for 4 days. Sixteen hours before harvesting, 1 μ ϋ 
of [3H]-thymidine (6.7 μϋ/πΊΓηοΙ; New England Nuclear, Boston, MA) was added in 
25 μΙ of RPMI. Cultures were harvested with a cell harvester (Tomtec, Hamden, CT) 
and [3H]-thymidine incorporation was determined. 
Intra-articular injection of recombinant S100A8 
A total of 6 μΙ of PBS containing 5 μg of recombinant S100A8 (together with 
polymyxin Β [10 μg/ml]) was injected into the knee joint cavity of normal C57BL/6 
mice. As controls, 6 μΙ of ovalbumin (5 μg), polymyxin Β (10 μg/ml), or PBS were 
injected. One and 3 days thereafter, knee joints were processed for histology. 
99mTc uptake measurements 
Joint inflammation was measured by mTc pertechnetate uptake in the knee joint. 
Mice were injected intra-peritoneally with 12 μο 99mTc. Gamma radiation was 
assessed by use of a collimated Nal scintillation crystal with the knee in a fixed 
position. Arthritis was scored as the ratio of 99mTc uptake in the right and the left 
knee joint. Right:left ratios >1.1 were taken to indicate inflammation of the right 
knee joint. 
Histology of arthritic knee joints 
Total knee joints of mice were isolated 7 days after arthritis onset. Knee joints were 
decalcified, dehydrated, and embedded in paraffin. Tissue sections (7 μπι) were 
stained with hematoxylin and eosin (H&E) or Safranin 0. Histopathologic changes 
were scored using the following parameters. Inflammation was graded on a scale 
from 0 (no inflammation) to 3 (severe inflamed joint) based on the influx of 
inflammatory cells into the synovium and joint cavity. Cartilage destruction was 
measured as chondrocyte death and surface erosion, and was determined in various 
cartilage layers (medial and lateral femur and tibia) in total knee joint sections that 
were stained with H&E. Chondrocyte death was determined as the percentage of 
cartilage area containing empty lacunae in relation to the total area. Cartilage 
surface erosion was determined as the amount of cartilage lost in relation to the 
total cartilage area. All experiments were scored separately and independently of 
each other in a blinded way by two independent observers. Data were expressed as 
the mean of all cartilage layers measured. 
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Immunohistochemical analysis of VDIPEN, NITEGE, and myeloid-related proteins 
5100A8 and S100A9 
Formalin-fixed sections were digested with protemase-free chondroitmase ABC (0 25 
units/ml m 0 1 M Tris-HCI [pH 8 0]) (Sigma-Aldrich) to remove the glycosammoglycan 
side chains, followed by incubation with affinity-purified rabbit anti-VDIPEN or rabbit 
anti-NITEGE IgG The primary antibody was detected using biotmylated goat anti-
rabbit IgG and avidm-streptavidm-peroxidase (Elite kit. Vector Laboratories, 
Burlingame, CA) Counterstaming was performed with orange G (2%) The areas of 
immunostammg were expressed as percentage of the total cartilage surface Rabbit 
anti-sera against recombinant murine S100A8 and S100A9 were produced as 
described previously Specificity of the antibodies was analyzed by 
immunoreactivity against recombinant S100A8 and S100A9 and Western blot 
analysis of granulocyte lysates Sections were stained using a final antibody 
concentration of 1 μg/ml Primary antibodies were detected using peroxidase-
conjugated antibodies against rabbit IgG (Dako, Carpintena, CA) Finally, sections 
were counterstamed with Mayer's hematoxylin (Merck, Darmstadt, Germany) 
Stimulation of macrophages by recombinant S100A8 and S100A8/A9 
Bone marrow cells were differentiated into macrophages by culturmg in Dulbecco's 
modified Eagle's medium (Invitrogen) containing 10% PCS, pyruvate, and 10 ng/ml 
macrophage colony-stimulating factor (M-CSF) for 7 days Thereafter, macrophages 
(IxlO 6 per ml) were stimulated with various concentrations of S100A8 or the 
S100A8/A9 heterodimer for 24 hours 
Detection of MMP messenger RNA levels using quantitative real-time polymerase 
chain reaction 
RNA was isolated from well-defined synovial specimens or bone marrow-derived 
macrophages (C57BL/6) Synovial biopsies were taken with a biopsy punch (diameter 
3 mm) from tissue adjacent to the suprapatellar ligament Total RNA was isolated 
with 1 ml of TRIzol reagent (Life technologies, Breda, the Netherlands) and reverse 
transcribed into complementary DNA (cDNA) with Moloney murine leukemia virus 
reverse transcriptase, oligo(dT) primers, and dNTPs (Invitrogen) Messenger RNA 
(mRNA) levels for S100A8, S100A9, cytokines (IL-1, TNFa, and IL-6), MMPs (MMP-3, 
9, 13 and 14), and a dismtegrm and metalloprotemase with thrombospondm motifs 
4 (ADAMTS4) and ADAMTS5 were detected using the ABI Prism 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA) The polymerase chain 
reaction (PCR) amplification protocol was as follows 2 minutes at 50°C and 10 
minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C, 
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with data collection during the last 30 seconds. Messenger RNA for murine genes 
was amplified using specific primers (Biolegio, Maiden, the Netherlands) at a final 
concentration of 300 nmoles/liter in SYBR Green Master Mix (Applied Biosystems). 
Relative quantification of the PCR signals was performed by comparing the threshold 
cycle (Ct) value of the gene of interest in each sample with the Ct value of the 
reference gene GAPDH (ACt). Then, mRNA levels were compared with that of 
controls (AACt). 
Statistical analysis 
Differences between experimental groups were assessed using the Wilcoxon rank 
test. 
Results 
Myeloid-related proteins S100A8 and S100A9 are abundantly expressed in inflamed 
synovium during experimental arthritis 
We first investigated the expression levels of S100A8 and S100A9 in inflamed 
synovium during AIA. RNA was isolated from synovia obtained from inflamed knee 
joints at several time points after AIA induction (days 0.16,1, 2, 4, and 7). Messenger 
RNA expression levels of S100A8 and S100A9 were both strongly up-regulated (1000-
2000 times) when compared with expression levels found in naive synovium. The 
expression of S100A8 and S100A9 was already maximal on day 1 and remained high 
up to 7 days after arthritis induction {Figures 1A and ß). 
Additionally, we investigated the expression levels of S100A8 and S100A9 protein 
on day 7 after AIA induction by immunolocalization in formalin-fixed total knee joint 
sections. Abundant protein expression of S100A8 and S100A9 was predominantly 
found within the inflammatory cell mass and especially macrophages and 
polymorphonuclear cells (PMNs) were stained (Figures ICand D). 
S100A8/A9 regulates joint inflammation during antigen-induced arthritis 
Since S100A8 and S100A9 were abundantly expressed in the inflamed synovium 
during AIA, we next investigated the role of these proteins in joint inflammation 
using mice that were made deficient for S100A9. Previous studies have shown that in 
addition to S100A9, S100A8 protein is also absent in the myeloid cells of these mice. 
Thus, targeted deletion of S100A9 leads to a complete lack of functional S100A8/A9 
complexes in these mice . As the absence of S100A8/A9 may alter the 
immunological response against the mBSA antigen, thereby impairing the onset and 
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course of arthritis, we first determined the humoral and cellular immune responses 
to mBSA 4 weeks after Immunization. Humoral immunity was tested by ELISA. Total 
IgG, IgGl, lgG2a, lgG2b, and lgG3 anti-mBSA levels in sera (titers between 11-14) 
were not significantly different between immunized wild type and S100A9" " mice. 
Cellular immunity, as measured by spleen lymphocyte stimulation against various 
concentrations of mBSA (stimulation index between 2-4), was also not different 
between knockout and control animals. 
A S100A8 Β S100A9 
l l l l l HUI 
0.16 1 2 4 7 0.16 1 2 4 7 
Days after AIA induction Days after AIA induction 
C S100A8 D S100A9 
Figure 1 mRNA and protein expression levels of S100A8 and S100A9 were determined in inflamed 
synovium after induction of antigen-induced arthritis (AIA). (Α-B) mRNA levels were measured in inflamed 
synovia isolated on days 0.16,1, 2, 4, and 7 after AIA induction using quantitative real-time PCR. Note that 
mRNA levels of S100A8 (A) and S100A9 (B) are significantly increased. (C-D) Protein levels of S100A8 (C) 
and S100A9 (D) were determined by immunolocalization in total knee joint sections on day 7 after AIA 
induction. S100 proteins are highly expressed by polymorphonuclear cells and macrophages within the 
synovium up to 7 days after AIA induction. In non-inflamed synovium, no expression of S100A8 and 
S100A9 was found (data not shown). Original magnification χ400. 
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Figure 2: Swelling of the knee joint, reflecting cellular activation, was determined as rightleft ratios of 
59mTc uptake on days 3 and 7 after induction of antigen-induced arthritis (AIA) in the right knee joint of 
S100A9"'' mice and wild type controls. (A). On day 7 after AIA induction swelling was almost absent in the 
knee joints of arthritic S100A9 mice. (B) The number of cells present in the synovium (infiltrate) and in 
the knee joint cavity (exudate) was determined using an arbitrary scale from 0-3 (0 = no cells, 1 = minor, 2 
= moderate, 3 = maximal). Data are the mean ± SD from 2 independent experiments. In each experiment 7 
mice per group were used. * = Ρ <0.05, by Wilcoxon rank test. (C and D) Frontal knee joint sections on day 
7 after AIA induction of S100A9"/_ mice (D) and wild type controls (C). Note the significantly lower cell 
mass in S100A9' ' knee joints when compared to wild type controls. Original magnification x250. F, femur; 
JS, joint space; P, patella; S, synovium. 
Subsequently, AIA was induced and knee joint swelling was determined at various 
time points thereafter. On day 7, but not on day 3, after AIA induction joint 
inflammation, as measured by mTc uptake, was significantly lower in arthritic knee 
joints of SlOOAiT7- mice {Figure 2A). To further support these findings, histology of 
arthritic knee joints was investigated. On day 7 after AIA induction, the cell mass in 
the joint cavity (exudate) and in the synovial layer (infiltrate) were significantly 
reduced (53 and 80%, respectively), suggesting that S100A8/A9 promotes the influx 
of cells (Figures 2B and D versus wild type control [Figure 2D]). 
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S100A8/A9 regulates proteoglycan depletion, MMP-mediated cartilage destruction, 
and chondrocyte death during antigen-induced arthritis 
Whether S100A8/A9 is involved in cartilage destruction was investigated m various 
cartilage layers of inflamed knee joints on day 7 after AIA induction Proteoglycan 
(PG) depletion, a marker of early cartilage destruction, was significantly reduced in 
the inflamed knee joints of S100A9 animals (Figures 3A and E) when compared 
with wild type controls (Figure 3D) The occurrence of chondrocyte death, measured 
as the percentage of empty lacunae within the cartilage area, varied from 15 to 35% 
in arthritic wild type mice and was almost completely prevented m S100A9 mice 
(Figure 3C) MMPs are essential in the induction of severe cartilage degradation 
starting on day 5 of AIA MMP-mediated neoepitopes were measured m various 
cartilage layers using VDIPEN immunolocahzation On day 7 after AIA induction, 
VDIPEN staining was moderately elevated in wild type mice and 15 to 25% of the 
cartilage surfaces expressed the neoepitope In the inflamed knee joints of S100A9" 
mice, VDIPEN staining was almost completely absent at that time point (Figures 3B 
and 6 versus wild type control [Figure 3F\) 
S100A8/A9 regulates MMP and ADAMTS expression in inflamed synovium and bone 
marrow-derived macrophages 
To investigate whether S100A8/A9 regulates the expression of proteolytic enzymes 
in the synovium, we isolated well-defined synovial specimens from the inflamed 
knee joints of S100A9 / mice and wild type controls on day 7 after AIA induction 
Messenger RNA levels of S100A8 and various MMPs (MMP-3, 9, and 13, and 14) and 
ADAMTS enzymes were determined by quantitative real-time PCR Messenger RNA 
levels of S100A8 were 64 times lower in the inflamed synovia of S100A9 ' mice 
when compared to wild type controls Furthermore, S100A8 protein could not be 
detected by immunolocahzation m the inflamed synovia of S100A9/ mice, 
indicating that these mice also lack S100A8 (data not shown) The mRNA levels of 
MMP-3, 9, and 13, and also of ADAMTS4 and 5 were significantly lower (4, 8, 12, 4, 
and 3 times, respectively) in the inflamed synovia of S100A9 mice when compared 
to their wild type controls (Figure 3H) 
As synovial macrophages are crucial cells m mediating cartilage destruction, we 
next investigated the direct effect of S100A8 and the S100A8/A9 heterodimer on 
MMP expression by macrophages Bone marrow-derived macrophages were 
stimulated with various concentrations (0 2, 1 0, and 5 0 μg/ml) of S100A8 or 
S100A8/A9 To exclude effects due to LPS contaminations, all preparations of 
S100A8 and S100A9 were tested by Limulus assay and LPS was not detectable 
(sensitivity ~0 7 ± 0 5 pg ΙΡ$/μζ protein) Interestingly, 5 μg/ml of S100A8 or 
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S100A8/A9 complex up-regulated mRNA expression levels of MMP-2, 3, 9, and, in 
particular, MMP-13 (MMP-13: 16-fold and 10-fold by S100A8 and S100A8/A9, 
respectively) (Figure 31). This confirms that S100A8 is the active component of the 
S100A8/A9 complex. Furthermore, blockade with polymyxin Β (10 μg/ml) did not 
alter the pro-inflammatory effects of S100A8 and S100A8/A9 {data not shown). 
Figure 3: Cartilage destruction on day 7 after induction of antigen-induced arthritis (AIA) in knee joints of 
SIOOAÎT' ' mice and wild type controls. (A, D, and E) Proteoglycan depletion was measured as loss of 
Safranin Ο staining from various cartilage layers in the knee joint using an arbitrary score from 0-3 (0 = no 
loss, 1 = minor, 2 = moderate, 3 = maximal) (A). Loss of staining was significantly lower in the lateral tibia 
of S100A9 mice (E) when compared with wild type controls (D). (B, F, and G) VDIPEN staining, 
expressing matrix metalloproteinase (MMP)-mediated cartilage degradation, was determined in various 
cartilage layers and expressed as percentage positive staining of the total cartilage area (B). VDIPEN 
staining was almost absent in arthritic knee joints of S100A9"'' mice (G) when compared to wild type 
controls (F). (C) Chondrocyte death, expressed as the percentage of cartilage area containing empty 
lacunae in relation to the total area. Note that chondrocyte death was almost absent in arthritic SlOOAg''' 
mice. Data express the mean ± SD of 7 mice per group. Two independent experiments were performed. * 
= P<0.05, by Wilcoxon ranktest. LF, lateral femur; LT, lateral tibia; MF, medial femur; MT, medial tibia. (H) 
mRNA levels of various MMPs and ADAMTS enzymes in inflamed synovia of S100A9 ^ mice on day 7 after 
AIA induction, corrected for mRNA levels in wild type controls. Messenger RNA levels were measured by 
quantitative real-time PCR and synovia of 7 mice were determined separately. Note that MMP-3, 9, and 
particularly MMP-13, were significantly lower in S100A9 animals. (Ι) MMP mRNA levels in macrophages, 
24 hours after stimulation with 5 pg/ml of S100A8 or S100A8/A9. S100A8 significantly upregulated MMP-
3, 9, and particularly MMP-13. 
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Intra-articular injection of S100A8 causes joint inflammation, PG depletion, and up-
regulation ofSlOOAS, S100A9, cytokine, and MMP mRNA levels 
To further investigate whether S100 proteins are able to directly induce joint 
inflammation and/or cartilage destruction, 5 μg of S100A8 (in the presence of 
polymyxin B) was injected into the knee joints of normal C57BL/6 mice. On day 1 and 
day 3 thereafter, knee joints were isolated for histological examination. A moderate 
amount of inflammatory cells was found within the synovium (infiltrate) and joint 
cavity (exudate) (Figure 4A) and the synovial lining layer was significantly thickened 
{Figure 4C versus control. Figure 4D). Maximal inflammation was observed on day 1 
and was lower on day 3 (Figures 4A and β). Intra-articular injection of polymyxin Β 
alone had no effect. 
Figure 4: Joint inflammation, 1 (A) and 3 (B) days after intra-articular injection of 5 μ§ of S100A8 into the 
knee joints of C57BL/6 mice. Total knee joint sections were stained with hematoxylin and eosin and joint 
inflammation (infiltrate and exudate) was scored using an arbitrary scale from 0-3 (0 = no cells, 1 = minor, 
2 = moderate, 3 = maximal). Note that moderate inflammation was observed on day 1 after injection of 
S100A8 (C) when compared with control (D). F, femur; P, patella. Data represent the mean ± SD of 6 mice 
for each time point. * = Ρ < 0.05, by Wilcoxon rank test. Original magnification x400. 
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Additionally, the effect of intra-articular injection of S100A8 on synovial activation 
was investigated using quantitative real-time PCR. On day 1 after injection, a 
significant auto-induction of S100A8, but also up-regulation of S100A9 was observed 
(Figure 5A). Cytokine levels, IL-1 in particular, were significantly upregulated on day 1 
(IL-lß, IL-6, and TNFa by 96, 3, and 6 times, respectively) (Figure 5B). MMPs and 
ADAMTS enzymes, crucial in mediating PG depletion, were also significantly up-
regulated on day 1 (MMP-3, 9,13, and 14 by 24, 4,12, and 4 times, respectively, and 
ADAMTS4 and 5 by 6 and 3 times, respectively) (Figure 5C). Interestingly, MMP-14 
expression remained high up to day 3 (Figure 5C). 
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Figure 5: mRNA levels of S100 proteins (A), cytokines (interleukin-lß (IL-lß), IL-6, tumor necrosis factor α 
(TNFa) (B), and matrix metalloproteinases (MMPs; MMP-3, 9, 13, 14) and a disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTS) enzymes (ADAMTS4 and 5) (C) in inflamed 
synovia, on day l a n d day 3 after intra-articular injection of 5 μg of S100A8. Data represent the mean + SD 
of 6 mice. Note that strong elevations of all genes are found 1 day after injection of S100A8. 
PG depletion (measured as loss of Safranin Ο staining) was determined in various 
cartilage layers of the knee joint. Intra-articular injection of S100A8 caused PG loss 
varying from 20% in the medial femur and tibia up to 70% in the lateral tibia. The 
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highest PG depletion was observed on day 1 after injection (Figures 6A and S). 
Injection of 5 μ§ of ovalbumin or PBS alone had no effect on synovial inflammation 
or PG depletion (Figure 6C). To further analyze whether MMPs or aggrecanases were 
responsible for the observed PG depletion, total knee joint sections were stained 
with anti-VDIPEN or anti-NITEGE antibodies. A single injection of S100A8 failed to 
induce MMP-mediated neoepitopes within the cartilage (data not shown). In 
contrast, NITEGE neoepitopes were markedly present on day 1 after injection of 
S100A8 (Figures 6D and F) when compared with ovalbumin injected controls (Figure 
6E). 
100 
g 75-
1 control protein 
IS100A8 
•- * I I 
I 5°- Τ 
MT LF 
cartilage layers 
••••^wmam 
MT LF LT 
cartilage layers 
._ 
F 
Figure 6: (Α-C) Proteoglycan depletion in various cartilage surfaces of the knee joint (A), 1 day after a 
single injection of 5 μg of S100A8 or ovalbumin. Proteoglycan depletion was measured as loss of red 
staining from Safranin 0 stained knee joint sections and expressed as percentage depletion of the total 
cartilage surface. Note that moderate depletion was measured on day 1 after injection of S100A8 (B) 
when compared with ovalbumin injected knee joints (C). (D-F) Induction of ADAMTS neoepitopes 
(NITEGE) in various cartilage surfaces of the knee joint (D), 1 day after a single injection of 5 pg of S100A8 
or ovalbumin. NITEGE expression was determined by immunolocalization using specific antibodies. Note 
that S100A8 induces large scale NITEGE expression (F) when compared with ovalbumin injected knee 
joints (E). Data represent the mean ± SD of 6 mice. * = Ρ < 0.05, by Wilcoxon rank test. LF, lateral femur; 
LT, lateral tibia; MF, medial femur; MT, medial tibia. 
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Discussion 
In the present study we found that S100A8/A9 regulates joint inflammation and 
cartilage destruction during AIA S100A8/A9 may regulate joint inflammation in 
various ways Potentially, S100A8/A9 proteins might be involved in the generation of 
antibodies and Τ cells obligatory for AIA development However, neither antibody 
titers nor antigen-specific Τ cell activation against mBSA were different between 
immunized S100A9 / mice and wild type controls This suggests that the observed 
differences in inflammation are not related to the development of immunological 
responses, but rather to pro-inflammatory effects on innate immune mechanisms 
upon local production of S100 proteins within the inflamed joint 
S100A8 and S100A9 were initially identified in the context of RA 26 Early infiltrating 
monocytes and granulocytes that express S100A8 and S100A9 have been found in 
the lining and sublming layers of inflamed synovial tissue, and both proteins are also 
expressed m macrophage-hke cells within the lining layer The expression of S100A8 
and S100A9 was found to be strongest at the cartilage-pannus junction, which is the 
primary site of cartilage destruction and bone erosion m arthritis The 
concentration of S100A8/A9 in synovial fluid is more than 10-fold higher compared 
with concentrations m serum, indicating that these proteins are released by 
activated phagocytes within the synovium Expression levels and serum 
concentrations of S100A8/A9 are well correlated with disease activity in RA, juvenile 
RA, and psoriatic arthritis 2 8 2 9 , and even more important, they are well correlated 
with radiological damage A novel inflammatory syndrome, characterized by an 
extraordinarily high expression of these two calcium-binding molecules, confirms a 
direct role of S100A8 and S100A9 in inflammatory processes m the joint, since 
arthritis is a common symptom in most affected patients In addition, previous 
data from experimental arthritis models have already provided indirect evidence for 
a local role of S100A8/A9 m arthritis Mice lacking Fey receptors show a clear 
correlation between disease activity, cartilage destruction, activation of synovial 
macrophages, and expression of S100A8 and S100A9 m experimental arthritis 
Secretion of S100A8/A9 is associated with activation of phagocytes 3Λ The 
S100A8/A9 complex binds to endothelial cells by specific interactions with heparan 
sulfate proteoglycans and novel carboxylated N-glycans 35 S100A8/A9 induces a 
thrombogemc and inflammatory response m endothelial cells, which is caused by the 
induction of pro-inflammatory chemokmes and adhesion molecules, as well as by a 
loss of cell-cell contact, thereby increasing the endothelial permeability The 
S100A8/A9 complex increases the binding activity of the mtegrm receptor 
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CDllb/CD18 on neutrophils, which enhances adhesion of these cells to endothelial 
cells 37 Furthermore, S100A8/A9 proteins have recently been shown to stimulate 
macrophages to produce cytokines such as IL-1 and TNF 17. These cytokines are 
crucial m activating synovial lining cells, thereby inducing chemokmes such as 
macrophage inflammatory protein 1 alpha (MlP-lct) and IL-8, involved in the influx of 
monocytes and PMNs 
Besides joint inflammation, levels of cartilage destruction were also significantly 
decreased in SlOOAiT7- mice. Early cartilage destruction in antigen-induced arthritis 
is characterized by loss of aggrecan ADAMTS family members are thought to be 
involved in mediating this early aggrecan loss during AIA 383 ADAMTS proteins are 
glutamyl endopeptidases that cleave the aggrecan core protein at a series of specific 
sites. ADAMTS4 and 5 m particular have been implicated m tissue destruction during 
RA. Recently, Stanton et al clearly demonstrated that ablation of the ADAMTS5 gene 
protected against aggrecan loss and cartilage erosion in AIA 40. In the present study 
we found that a single mtra-articular injection of S100A8 leads to strong up-
regulation of ADAMTS4 and 5 within the synovium and marked expression of 
ADAMTS generated neoepitopes (NITEGE) was found within the cartilage layers of 
the knee joint. After mtra-articular injection, S100A8 may bind to as yet unknown 
macrophage receptors resulting in activation and subsequent release of ADAMTS 
enzymes ADAMTS4 and 5 are synthesized as latent precursor proteins that require 
activation through removal of their pro-domain before they can exert catalytic 
activity. Proprotem convertases can efficiently remove the pro-domain through 
cleavage, in the case of ADAMTS4, at Arg212/Phe213, thereby generating the active 
41 
enzyme 
MMPs are crucial in mediating late cartilage destruction in AIA 35 MMP-mediated 
neoepitopes (VDIPEN) did not occur earlier than on day 5 after AIA induction MMP-
3 appeared to be the dominant MMP within this model since VDIPEN staining was 
completely inhibited in MMP-3 knockout mice VDIPEN neoepitopes co-localize 
with collagenase-mduced neoepitopes, suggesting that activation of MMPs 
eventually leads to cartilage erosion 38. MMP-3 may thereby act by activating MMP-
13. 
In the present study we found that synovial expression of MMPs, MMP-13 m 
particular, was significantly down-regulated in SlOOAif^ mice A plausible 
explanation might be that the low expression of MMPs is a result of the lower 
amount of inflammatory cells present within the synovia of these mice Lower 
activity and recruitment of inflammatory cells in arthritic S100A9"/" mice can either 
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be due to an intracellular function of S100A8/A9 in signal transduction, or to 
extracellular effects initiated upon release of S100A8/A9 by activated phagocytes. 
We therefore investigated whether S100A8/A9 can directly stimulate macrophages 
to produce MMPs. Stimulation of macrophages with the S100A8/A9 complex, but 
also with the S100A8 homodimer, strongly up-regulated mRNA expression levels of 
MMP-3, 9, and 13. This stimulatory effect was not caused by LPS since addition of 
polymyxin Β did not alter the results. S100A8 has previously been described as the 
active component of the S100A8/A9 complex, whereas S100A9 seems to function 
predominantly as the regulatory unit1 3 '1 7. We confirmed the active role of S100A8 in 
our model by showing the induction of different MMPs in macrophages by S100A8 
and the S100A8/A9 complex. It may therefore seem surprising to find protective 
effects during experimental arthritis in SIOOAS''' mice. However, by keeping in mind 
the fact that S100A8 protein levels are highly dependent on the presence of S100A9, 
probably due to degradation of isolated S100A8 in the absence of its binding partner 
S100A9, this finding can be easily explained 17. S100A8 protein expression is almost 
undetectable in mature granulocytes and monocytes of S100A9~/" mice. Thus, 
targeted deletion of S100A9 results in SIOOAS/Ag"7" phagocytes 22'23. 
In addition to stimulation of macrophages in vitro, intra-articular injection of S100A8 
into the knee joint resulted in strong up-regulation of MMP-3, 13, and 14 in the 
synovium. We also found that S100A8 was able to stimulate its own expression, as 
well as that of S100A9 in murine macrophages, which may reflect another positive 
feedback mechanism promoting inflammatory reactions. A single injection of S100A8 
into murine knee joints failed to induce MMP-mediated VDIPEN expression in the 
cartilage. S100A8 is a 10 kDa protein with an electric point around 7. Due to these 
physicochemical characteristics, the protein will be cleared from the joint very 
rapidly. This may explain why larger concentrations are needed to induce significant 
amounts of S100A8/A9 that can mediate an effect. 
MMPs are released in a latent form and need an activation step in order to become 
active. Production of oxygen radicals may be involved in this activation step. Recent 
findings have shown that arthritic mice with impaired oxygen radical production 
(p47phox~/~), display high MMP mRNA levels in the synovium but low VDIPEN 
neoepitope expression in the cartilage, suggesting that oxygen radicals are crucial in 
mediating MMP activation 42. S100A8 and S100A9 have been described to modulate 
the turnover of oxygen radicals in the extracellular space, which could be the 
molecular mechanism by which these calcium-binding proteins modulate MMP 
.. .. 43 
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Our present findings suggest that S100A8/S100A9 proteins, which have been shown 
to be a reliable marker of disease activity and joint inflammation in rheumatic 
diseases, are key effectors/amplifiers of inflammation and cartilage destruction, and 
may form new interesting targets to combat this crippling disease. 
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Abstract 
Objective· To investigate whether S100A8 is actively involved in matrix 
metalloprotemase (MMP)-mediated chondrocyte activation 
Methods: S100A8 and S100A9 proteins were detected by immunolocahzation in 
inflamed knee joints of mice with various forms of murine arthritis The murine 
chondrocyte cell line H4 was stimulated with pro-inflammatory cytokines or S100A8. 
Messenger RNA (mRNA) and protein levels were measured by real-time polymerase 
chain reaction and intracellular fluorescence-activated cell sorting (FACS) analysis 
Breakdown of aggrecan on the pericellular surface of the chondrocytes was 
measured using VDIPEN and NITEGE antibodies and FACS, and breakdown m patellar 
cartilage was measured by immunolocahzation. 
Results S100A8 and S100A9 proteins were abundantly expressed m and around 
chondrocytes in inflamed knee joints after induction of antigen-mduced arthritis or 
onset of spontaneous arthritis in mterleukm-l (IL-1) receptor antagonist knockout 
mice. Stimulation of chondrocytes with the pro-inflammatory cytokines tumor 
necrosis factor α, IL-lß, IL-17, and mterferon-y caused strong up-regulation of 
S100A8 mRNA and protein levels and, to a lesser extent, up-regulation of S100A9 
Stimulation of chondrocytes with S100A8 induced significant up-regulation of MMP-
2, 3, 9, 13, ADAMTS4, and ADAMTS5 mRNA levels (up-regulated 4, 4, 3, 16, 8, and 4 
times, respectively). VDIPEN and NITEGE neoepitopes were significantly elevated m a 
concentration-dependent manner on chondrocytes treated with 0.2, 1 0, or 5.0 
μg/ml of S100A8 (VDIPEN levels were elevated 17%, 67%, and 108%, respectively, 
and NITEGE levels were elevated 8%, 33%, and 67%, respectively) S100A8 
significantly increased the effect of IL-lß on MMP-3, 13, and ADAMTS5 expression 
Mouse patellae incubated with both IL-lß and S100A8 showed elevated NITEGE 
levels within the cartilage matrix when compared with patellae incubated with IL-lß 
or S100A8 alone. 
Conclusion These findings indicate that S100A8 and S100A9 are found in and around 
chondrocytes in experimental arthritis S100A8 up-regulates and activates MMPs 
and aggrecanase-mediated pericellular matrix degradation 
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Breakdown of the cartilage matrix is one of the hallmarks of rheumatoid arthritis 
(RA). Cartilage destruction is predominantly mediated by cytokines, enzymes, and 
oxygen radicals 1'2. These mediators are released by synovial cells and chondrocytes. 
In experimental arthritis, clear pericellular activation of chondrocytes is observed 
based on the expression of large amounts of neoepitopes induced by 
metalloproteinases, representing breakdown of the pericellular matrix , which 
eventually leads to erosion. 
In arthritis, a group of proteins called damage-associated molecular patterns or 
alarmins are expressed in response to stress . Two important members of this group 
are S100A8 (myeloid-related protein 8 [MRP8]) and S100A9 (MRP14), which belong 
to the S100 family of calcium-binding proteins 5. These proteins are characterized by 
the presence of 2 Ca +-binding sites of the EF-hand type. S100A8 and S100A9 exist in 
the form of heterodimers that are secreted by phagocytes during inflammatory 
activation. The S100A8/A9 heterodimer accumulates in inflammatory fluids and is 
postulated to be involved in the pathogenesis of RA ' . A previous study showed that 
levels of S100A8/A9 correlated well with the severity of arthritis and correlated 
strongly and independently with joint damage . S100A8 and S100A9 are primarily 
expressed by macrophages and neutrophils present in the synovial lining and 
sublining layers, but they are also expressed in the inflamed synovial pannus tissue, 
which invades cartilage and bone ' . Recently, it was found that both proteins are 
expressed by hypertrophic chondrocytes present in the growth plates of normal 
cartilage . 
Murine S100A8 is an endogenous ligand of Toll-like receptor 4 (TLR4) and exhibits 
cytokine-like functions, thereby stimulating the expression of pro-inflammatory 
molecules such as cytokines and adhesion receptors . Complex formation with 
S100A9 antagonizes these effects, indicating a regulatory role of conformational 
changes of these 2 proteins on biological functions 10'11. In addition, S100A8/A9 has 
been described to interact with endothelial cells, resulting in an inflammatory, 
thrombotic, and apoptotic phenotype 1215. S100A8 is released in high amounts by 
macrophages and neutrophils during inflammatory arthritis and, due to its small size, 
can easily penetrate into the cartilage matrix and bind to chondrocytes 
Furthermore, S100A8/A9 may also be formed by activated chondrocytes, which may 
have effects on both intracellular functions and degradation of the pericellular 
matrix of chondrocytes. 
Although TLR4 is the dominant receptor mediating S100A8 signaling in 
macrophages , other putative binding sites for S100A8/A9 have been suggested, 
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including heparan sulfate proteoglycans, carboxylated N-glycans, and the receptor 
for advanced glycation end products (RAGE)12'13. 
Recently, we investigated the role of S100A8/A9 in cartilage destruction in 
experimental arthritis using S100A9-deficient mice 17. Targeted deletion of the 
S100A9 gene results in a loss of both S100A9 and S100A8 protein in myeloid cells, 
probably due to a high turnover of free S100A8 in the absence of its binding partner 
S100A9 18'19. We found that S100A8/A9 regulated both joint inflammation and 
cartilage destruction. Furthermore, when S100A8 was injected into the knee joints of 
naive mice, moderate proteoglycan (PG) depletion was observed, suggesting that 
this protein may be involved in mediating cartilage destruction. 
In the present study, we investigated first whether S100A8 and S100A9 are 
expressed by activated chondrocytes, and second whether S100A8 is able to directly 
activate chondrocytes, leading to matrix metalloproteinase (MMP)-mediated 
cartilage matrix breakdown. Our results indicate that S100A8 and S100A9 are 
expressed intracellularly in chondrocytes in experimental arthritis and that 
extracellular S100A8 is a stimulator and activator of MMPs on the pericellular 
surface of the chondrocyte. 
Materials and methods 
Animals 
C57BL/6 and wild type BALB/c mice were purchased from Charles River (Sulzfeld, 
Germany). Interleukin-l receptor antagonist knockout (IL-IRa ) mice on a BALB/c 
background were generated as described previously . Control mice were 10-12 
weeks old. Mice were housed in filter-top cages, and water and food were provided 
ad libitum. Animal studies were approved by the Institutional Review Board of the 
Radboud University Nijmegen Medical Centre and were performed according to the 
appropriate codes of practice. S100A9~ ~ mice were generated as previously 
described 18 and backcrossed to the C57BL/6 background for 6 generations. C57BL/6 
mice (obtained from The Jackson Laboratory, Bar Harbor, ME) were used as controls. 
S100A8 protein 
Recombinant murine S100A8 was expressed and purified as described earlier 21'22. 
Overexpression of S100A8 was obtained through a combination of a T7-based 
expression vector and the Escherichia coli BL21(DE3) cell line. The identity of the 
153 
Chapter 7 
protein was ascertained by mass spectrometry and Western blotting. In addition, all 
protein preparations were tested by Limulus amebocyte lysate assay (BioWhittaker, 
Walkersville, MD), and hpopolysacchande (LPS) content was not detectable 
(sensitivity ~0.7 ± 0 5 pg LPS^g protein), indicating that the maximal possible 
contamination of the S100 protein preparations was <1.2 pg LPS^g protein. S100A8 
could be heat-mactivated, whereas LPS cannot be rendered inactive at the 
temperature levels used to denature S100A8 10 Moreover, LPS contamination was 
further excluded by blocking experiments using polymyxin Β sulfate (Sigma-Aldnch, 
St. Louis, MO) 
Induction of experimental arthritis 
Antigen-induced arthritis (AIA) was induced by immunizing C57BL/6 mice with 100 
μ§ of methylated bovine serum albumin (mBSA; Sigma-Aldnch) emulsified m 100 μΙ 
of Freund's complete adjuvant (CFA). Injections were divided over both flanks and 
footpads of the front paws. One week later, 2 subcutaneous booster injections with 
50 μg of mBSA/CFA were administered in the neck region Two weeks after these 
injections, arthritis was induced by mtra-articular injection of 60 μg of mBSA m 6 μΙ 
of phosphate buffered saline (PBS) into the knee joint, resulting in chronic arthritis 
23
. IL-IRa mice were killed at week 15, when the incidence of arthritis was high 2i 
Histological analysis of arthritic murine knee joints 
Total knee joints of mice were isolated on days 7 and 14 after the induction of AIA, 
whereas IL-IRa" ~ mice were killed at week 15 For standard histological analysis, 
knee joints were decalcified, dehydrated, and embedded in paraffin. Sections 
measuring 7 μιτι thick were cut and stained with hematoxylin and eosm 
Immunohistochemical detection of VDIPEN, NITEGE, and myeloid-related proteins 
S100A8 and S100A9 
Formalin-fixed sections were digested with protemase-free chondroitmase ABC (0.25 
units/ml m 0.1M Tris HCl [pH 8 0]) (Sigma-Aldnch) to remove the glycosammoglycan 
side chains, followed by incubation with affinity-purified rabbit anti-VDIPEN IgG (a 
kind gift from Dr J S Mort, Montreal, Quebec, Canada) or rabbit anti-NITEGE IgG 
(Acris Antibodies, Hiddenhausen, Germany) The primary antibody was detected 
using biotmylated goat anti-rabbit IgG and avidm-streptavidm-peroxidase (Elite kit, 
Vector Laboratories, Burlmgame, CA). Orange G (2%) was used for counterstammg 
The areas of immunostammg were expressed as percentage of the total cartilage 
surface. Goat polyclonal antibodies against a peptide near the C-termmus of 
recombinant murine S100A8 and S100A9 (Santa Cruz Biotechnology, Santa Cruz, CA) 
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were also used for immunolocalization Sections were stained using a final antibody 
concentration of 1 μg/ml. Primary antibodies were detected using peroxidase-
conjugated second-stage antibodies against rabbit IgG (Dmova, Hamburg, Germany) 
Finally, sections were counterstamed with Mayer's hematoxylin (Merck, Darmstadt, 
Germany) 
Measurement ofNITEGE neoepitopes in patellar cartilage 
Patellae were derived from normal C57BL/6 mice and the synovium was carefully 
removed. Patellae were incubated with 5 μg/ml of S100A8, 10 ng/ml of IL-lß, or a 
combination of S100A8 and IL-lß for 24 hours. Patellae were decalcified in EDTA, 
and 5 μιη sections were stained with anti-NITEGE antibodies or Safranm Ο 
Stimulation of chondrocyte cell line H4 with recombinant S100A8 
Chondrocyte cell line H4 25 was cultured in Dulbecco's modified Eagle's medium F12 
containing 10% fetal calf serum (PCS). Chondrocytes (IxlO 6 per ml) were stimulated 
with various concentrations of S100A8 (0.2, 1 0, or 5.0 μg/ml) for 24 hours. TLR4, 
RAGE, or carboxylated N-glycan receptors were inhibited with the potent TLR4 
antagonist E5564 (Entoran, Eisai, Woodchff Lake, NJ), rabbit anti-mouse polyclonal 
RAGE (Sigma-Aldnch), or GB31 monoclonal antibody (mAb), which detects 
carboxylated N-glycans IL-6 was blocked using rat anti-mouse IL-6 (clone MP5-20F3, 
BD PharMmgen, San Diego, CA). 
Measurement of cytokines using Lummex 
Levels of IL-lß, IL-6, and tumor necrosis factor α (TNFa) were determined using 
Lummex multi-analyte technology The BioPlex system in combination with multiplex 
cytokine kits (Bio-Rad, Hercules, CA) was used. Cytokines were measured m 50 μΙ of 
chondrocyte culture medium. The sensitivity of the multiplex kit was 5 pg/ml for IL-
lß, IL-6, and TNFa. 
Detection of MMP messenger RNA levels using quantitative real-time polymerase 
chain reaction 
RNA was isolated from the H4 chondrocyte cell line with 1 ml of TRIzol reagent (Life 
Technologies, Breda, the Netherlands) and reverse transcribed into complementary 
DNA (cDNA) with Moloney murine leukemia virus reverse transcriptase, oligo(dT) 
primers, and dNTPs (Invitrogen) Messenger RNA (mRNA) levels for S100A8, S100A9, 
cytokines (IL-1, TNFa, and IL-6), MMPs (MMP-3, 9, 13, and 14), ADAMTS4, and 
ADAMTS5 were detected using the ABI Prism 7000 Sequence Detection System 
(Applied Biosystems, Foster City, CA) The polymerase chain reaction (PCR) 
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amplification protocol was as follows 2 minutes at 50°C and 10 minutes at 95°C, 
followed by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C, with data 
collection during the last 30 seconds Messenger RNA for murine genes was 
amplified using specific primers (Biolegio, Maiden, the Netherlands) at a final 
concentration of 300 nmoles/hter m SYBR Green Master Mix (Applied Biosystems) 
Relative quantification of the PCR signals was performed by comparing the threshold 
cycle (Ct) value of the gene of interest m each sample with the Ct value of the 
reference gene GAPDH (ACt) Then, mRNA levels were compared with that of 
controls (AACt) 
Intracellular staining ofSlOOAS and S100A9 
Chondrocytes (IxlO5 cells/100 μΙ) were fixed in 2% PBS-buffered paraformaldehyde 
for 20 minutes at 4°C Cells were washed and additionally incubated with 100 μΙ of 
fluorescence-activated cell sorting (FACS) buffer (containing 0 1% saponin) for 30 
minutes at 4°C Thereafter, 5 μg/ml (in FACS buffer containing 0 1% saponin) of the 
primary antibodies goat anti-mouse S100A8, goat anti-mouse S100A9, or normal 
goat IgG (Santa Cruz Biotechnology) was added and incubated for 30 minutes at 4°C 
Cells were then washed and additionally incubated with fluorescein isothiocyanate 
(FITC)-labeled mouse anti-goat antibody (Santa Cruz Biotechnology) for 30 minutes 
at 40C Fluorescence was measured using FACS analysis 
Construction of H4 reporter cell lines for measurement of in vitro activity ofNF-κΒ 
The NF-KB reporter plasmid was constructed in the laboratory of Prof Dr W Falk 
(Regensburg, Germany) Briefly, the NF-κΒ binding sites were derived from the 
human immunodeficiency virus long terminal repeat enhancer (5'-GGGACTTTCC-3') 
and cloned into the pCAT promoter vector The NF-κΒ binding repeats, followed by 
the minimal promoter and luciferase gene from pCAT, were excised from the vector 
using Bgl II and Hind III and inserted into the pGL3 basic vector (pGL3-5XNF-KB) In 
addition, the insert was hgated into the eukaryotic expression plasmid pcDNA3 1 
exchanging the CMV promoter H4 chondrocytes were transfected with pcDNA3 1 
NF-κΒ luciferase, using Lipofectamme 2000, according to the recommendations of 
the manufacturer (Invitrogen, San Diego, CA) Positive cells were selected based on 
stable incorporation of the transgene using Zeocm (InvivoGen, San Diego, CA) at a 
concentration of 800 μg/ml The transfected cells were submitted to clonal selection 
by limiting dilution S100A8 responsiveness of the reporter cell was quantified by 
measurement of NF-KB-mduced production of luciferase Luciferase activity was 
quantified using the Bright-Glo luciferase assay system (Promega, Madison, Wl), 
followed by luminometric detection using a Fluostar Galaxy lummometer, according 
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to the recommendations of the manufacturer (Polarstar Galaxy BMG, Offenburg, 
Germany) 
Measurement of MMP- and aggrecanase-mediated cartilage destruction in 
chondrocytes using FACS analysis 
Chondrocytes that were stimulated with S100A8 or left unstimulated were tested for 
the expression of MMP- and aggrecanase-mduced neoepitopes using FACS analysis 
Chondrocyte cell lines were cultured in F12 medium containing 10% FCS 
Chondrocytes (IxlO 6 cells) were stimulated with 0 2, 1 0, or 5 0 μg/ml of S100A8 for 
24 hours Cells were subsequently isolated by cold shock and incubated with affmity-
punfied rabbit anti-VDIPEN or anti-NITEGE IgG The primary antibody was detected 
using biotmylated goat anti-rabbit IgG and FITC-conjugated mouse anti-goat IgG 
(Jackson ImmunoResearch, West Grove, PA) 
Results 
Expression of SI00A8 and S100A9 by chondrocytes in experimental murine arthritis 
and human RA 
Whether S100A8 and S100A9 are expressed by activated chondrocytes was 
investigated in inflamed knee joints of mice with various forms of murine arthritis 
Previous studies have shown that immune complexes mediate severe cartilage 
matrix destruction and that strong staining of MMP-mduced aggrecan cleavage sites 
m cartilage layers occurs particularly m the pericellular area of the chondrocyte 
When serial sections of inflamed knee joints of mice with AIA were stained with anti-
S100A8 and anti-S100A9 antibodies, both proteins were clearly detected m 
chondrocytes lying m femoral and tibial cartilage surfaces, and also m the matrix 
surrounding the chondrocytes S100 proteins were expressed m both the early stage 
(day 7) {Figures 1A and D) and late stage (day 14) (Figures IB and E) of the disease 
Inflamed ankle joints of IL-IRa / mice, which spontaneously develop arthritis, also 
showed moderate expression of both S100A8 and S100A9 proteins in and around 
chondrocytes (Figures 1C and F) No staining of S100A8 and S100A9 proteins was 
detected m cartilage layers of naive murine knee joints (Figure IH) or m inflamed 
knee joints (day 14 of AIA) of S100A9 '" mice (Figure IG) To further investigate 
whether S100A8 is also produced by human chondrocytes, cartilage specimens 
derived from patients with late-stage RA were stained with an antibody directed 
against human S100A8 Interestingly, S100A8 was also clearly detected m human 
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chondrocytes, particularly in the proteoglycan-depleted areas of the cartilage (Figure 
II). 
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Figure 1. Expression of S100A8 and S100A9 by chondrocytes in sections of mice with antigen-induced 
arthritis (AIA), IL-lRa' " mice, S100A9 mice, naive mice, and human patients with late-stage rheumatoid 
arthritis (RA). (Α-F) Significant expression of S100A8 and S100A9 in and around chondrocytes in murine 
knee joint sections on day 7 (A and D) and on day 14 (B and E) after AIA induction, and in knee joint 
sections of IL-lRa"'" mice, in which arthritis develops spontaneously (C and F). (G and H) Lack of S100A8 
expression in murine knee joint section on day 14 after AIA induction in S100A9~/" mice (G) and in naive 
mice (H). (I) Clear S100A8 staining in chondrocytes lying in proteoglycan-depleted areas of cartilage 
derived from human patients with late-stage RA. 
Induction of S100A8 and S100A9 in murine chondrocyte cell lines by pro­
inflammatory cytokines 
We next investigated whether pro-inflammatory cytokines involved in cartilage 
destruction were able to up-regulate the expression of S100A8 and S100A9 in 
chondrocytes. The murine chondrocyte cell line H4 was stimulated for 24 hours with 
various pro-inflammatory cytokines (IL-lß, TNFa, IL-17, and interferon-y [IFNy]), and 
S100A8 and S100A9 mRNA and protein levels were measured by real-time PCR and 
intracellular FACS analysis. Levels of mRNA for S100A8 were significantly up-
regulated by all cytokines when compared with unstimulated cells (ΔΔΟ: 2.9, 3.2,4.2, 
and 4.3 with IL-lß, TNFa, IL-17, and IFNy, respectively), and the relative expression 
of S100A8 was higher than that of S100A9 (Figure 2A). Moderate levels of both 
S100A8 and S100A9 proteins were found in unstimulated chondrocytes (Figure 28). 
In chondrocytes stimulated with cytokines the expression of S100A8 was up-
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regulated more strongly than was the expression of S100A9. Stimulation with IL-lß, 
TNFa, IL-17, and IFNy up-regulated the expression of S100A8 by 61%, 100%, 50%, 
and 78%, respectively, and up-regulated the expression of S100A9 by 27%, 24%, 
27%, and 33%, respectively (Figure 2B). 
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Figure 2. Levels of S100A8 and S100A9 mRNA and protein, 24 hours after stimulation of murine 
chondrocytes with 10 ng/ml interleukin-lß (IL-lß), tumor necrosis factor α (TNFa), IL-17, or interferon-y 
(IFNy). Messenger RNA and protein levels were measured using real-time PCR and intracellular FACS 
analysis (A) Levels of S100A8 and S100A9 mRNA, normalized to levels in unstimulated chondrocytes. 
S100A8 mRNA was more strongly up-regulated than S100A9 mRNA when compared with levels in 
unstimulated chondrocytes. (B) Intracellular expression of S100A8 and S100A9 protein. Protein levels of 
both S100A8 and S100A9 were high in unstimulated control chondrocytes. All cytokines up-regulated 
intracellular protein levels of S100A8 more strongly than they did levels of S100A9. Bars show the mean ± 
SD from 3 independent experiments. * = Ρ < 0.05 versus unstimulated chondrocytes, by Mann-Whitney U 
test. 
Production of IL-6 by chondrocytes stimulated with S100A8 
We subsequently investigated whether S100A8 itself could stimulate chondrocytes 
to release the pro-inflammatory cytokines TNFa, IL-la, IL-lß, and IL-6. H4 
chondrocytes were stimulated with 0.2, 1.0, or 5.0 μg/ml of S100A8. Using real-time 
PCR, we found that mRNA for IL-6 was significantly up-regulated in S100A8-
stimulated chondrocytes. Maximal IL-6 levels were observed in chondrocytes 
stimulated with 1.0 μg/ml of S100A8 (Figure 3A)Jhe mRNA levels of TNFa, IL-la, 
and IL-lß, however, were not elevated when compared with unstimulated cells. 
Consistent with these findings, S100A8 stimulation induced a concentration-
dependent up-regulation of protein levels of IL-6, but not of IL-la, IL-lß, or TNFa, as 
detected in the culture medium with Luminex (Figure 3B). Maximal IL-6 protein 
production occurred when chondrocytes were stimulated with 5.0 ug/ml of S100A8. 
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However, neutralization of IL-6 with IL-6-blocking antibodies (10 μg/ml) did not alter 
the surface expression of MMP-mediated neoepitopes, indicating that IL-6 is not 
important in mediating chondrocyte activation (data not shown). 
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Figure 3. Induction of IL-6 mRNA and protein levels after stimulation of chondrocytes with 0.2, 1.0, or 5.0 
μ§/ηιΙ of S100A8. (A) Levels of IL-6 mRNA, determined by real-time PCR. Maximal up-regulation of IL-6 
mRNA occurred in chondrocytes stimulated with 1.0 pg/ml of S100A8. (B) Levels of IL-6 protein in the 
culture medium, determined with Luminex. Maximal up-regulation of IL-6 protein levels occurred in 
chondrocytes stimulated with 5.0 pg/ml of S100A8. In addition to IL-6, mRNA and protein levels of TNFot, 
IL-lot, and IL-lß were measured. Stimulation with S100A8 elevated mRNA and protein levels of IL-6 only. 
Bars show the mean ± SD of 3 independent experiments. * = Ρ < 0.05 versus unstimulated chondrocytes, 
by Mann-Whitney U test. 
Up-regulation and activation ofMMPs in chondrocytes stimulated with S100A8 
A previous study performed in S100A9"^ mice showed that S100A8 may be involved 
in MMP-mediated cartilage destruction . Furthermore, we have previously found 
that a single injection of 5 μg of recombinant S100A8 into the knee joints of mice 
induced ADAMTS-mediated neoepitopes in the cartilage layers 17. Since chondrocyte 
activation may be a result of direct activation by S100A8, we first investigated 
whether S100A8 directly up-regulates MMP mRNA levels in chondrocytes. H4 cell 
lines were stimulated with various concentrations of S100A8 for 24 hours, and 
mRNA levels of various MMPs (MMP-2, 3, 9, and 13) and aggrecanases (ADAMTS4 
and 5) were determined using real-time PCR. A significant concentration-related up-
regulation of all MMPs was found {Figure 4A). Maximal response was observed in 
chondrocytes stimulated with 1.0 μg/ml of S100A8. MMP-2, 3, 9, and 13 and 
ADAMTS4 and 5 were up-regulated 4-, 4-, 3-, 16-, 8-, and 4-fold, respectively, in 
chondrocytes stimulated with 1.0 μg/ml of S100A8. 
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Figure 4. Up-regulation and activation of matrix metalloproteinases (MMPs) and aggrecanases (ADAMTS) 
in H4 chondrocytes stimulated with S100A8. (A) Levels of mRNA for MMP-2, 3, 9, and 13 and ADAMTS4 
and 5 in chondrocytes stimulated with 0.2, 1.0, or 5.0 μg/ml of S100A8. Maximal levels were found in 
chondrocytes stimulated with 1.0 μg/ml of S100A8. (B and C) Expression of VDIPEN and NITEGE 
neoepitopes on the cell surface of chondrocytes 24 hours after stimulation with S100A8, determined with 
flow cytometry, and expressed as the percentage of positive cells (B) and the mean fluorescence intensity 
(MPI) (C). Note that there was a concentration-dependent increase in the expression of both VDIPEN and 
NITEGE neoepitopes, with the highest expression observed in chondrocytes stimulated with 5.0 μg/ml of 
S100A8. Bars show the mean ± SD of 3 independent experiments. * = Ρ < 0.05 versus unstimulated 
chondrocytes, by Mann-Whitney U test. (D-F) Chondrocytes stained with irrelevant IgG (D), unstimulated 
chondrocytes stained with anti-VDIPEN antibodies (E), and SlOOAS-stimulated chondrocytes stained with 
anti-VDIPEN antibodies (F), showing significantly higher staining of SlOOAS-stimulated chondrocytes. 
To further investigate whether, besides up-regulating mRNA of MMPS, S100A8 also 
directly activates MMPs and ADAMTS enzymes, aggrecan cleavage sites expressed 
on the surface of the chondrocytes were measured using anti-VDIPEN and anti-
NITEGE antibodies and FACS analysis. In chondrocytes stimulated with 0.2,1.0, or 5.0 
μ§/ηιΙ of S100A8, a concentration-related up-regulation of MMP-induced 
neoepitopes was detected, as measured by the percentage of positive cells (Figure 
4B) and by the mean fluorescence intensity (MFI) of the cells (Figure 4C). In 
chondrocytes stimulated with 0.2, 1.0, and 5.0 μg/ml of S100A8, the MFI of VDIPEN-
positive cells was increased 17%, 67%, and 108%, respectively, and the MFI of 
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NITEGE-positive cells was increased 8%, 33%, and 67%, respectively (Figure 4C). 
Compared with control IgG (Figure 4D), unstimulated chondrocytes displayed some 
pericellular staining (Figure 4E), suggesting that activation occurred before 
stimulation with S100A8, which was significantly elevated after 24 hours of 
stimulation with S100A8 (Figure 4F). 
Stimulation of cartilage destruction bySlOOAS and IL-Ιβ 
Since IL-lß is a dominant cytokine involved in the stimulation of MMP production in 
chondrocytes, we compared the effects of S100A8, IL-lß, and the combination of 
S100A8 and IL-lß on chondrocytes. H4 chondrocytes were stimulated for 24 hours 
with either 1.0 μg/ml of S100A8, 10 ng/ml of IL-lß, or a combination of both. Using 
real-time PCR, we found that both S100A8 and IL-lß stimulated mRNA expression of 
MMPs, whereas the combination of the 2 showed an additive effect (Figure 5A). We 
additionally investigated the effect of these mediators on ADAMTS activation in 
anatomically intact cartilage. Murine patellae were isolated and fully depleted of 
synovial tissue. When patellae were stimulated with 5.0 μg/ml of S100A8 for 24 
hours, a significant increase in NITEGE neoepitopes was detected as compared with 
cartilage incubated with a control protein (ovalbumin) (Figure SB). S100A8-induced 
NITEGE expression was comparable with NITEGE expression found after incubation 
with 10 ng/ml of IL-lß, while the combination of S100A8 and IL-lß further elevated 
NITEGE expression (Figure SB). Serial sections were additionally stained with 
Safranin 0. The amount of NITEGE expression correlated well with loss of red 
staining, representing loss of proteoglycans from the cartilage surface (Figures SB 
and C). 
Activation of chondrocytes by S100A8 via NF-κΒ activation, which is partly mediated 
by carboxylated N-glycans 
NF-KB-mediated gene expression has been shown to play a crucial role in cartilage 
destruction 26. To investigate whether S100A8 signals via NF-κΒ, a stably transfected 
chondrocyte reporter cell line that can directly measure NF-κΒ activity was used. 
Stimulation of chondrocytes with recombinant S100A8 induced a concentration-
dependent up-regulation of NF-κΒ activity. In chondrocytes stimulated with 0.2, 1.0, 
and 5.0 μg/ml of S100A8, NF-κΒ activity was up-regulated 5%, 10%, and 19%, 
respectively. These findings suggest that this signaling pathway is activated by 
S100A8 (Figure 6A). 
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Figure 5. (A) Levels of matrix metalloproteinase (MMP) and ADAMTS mRNA, measured by real-time PCR, 
in H4 chondrocytes stimulated with 1.0 μg/ml of S100A8, 10 ng/ml of IL-lß, or a combination of the 2 for 
24 hours. Note that S100A8 enhanced IL-lß-stimulated MMP expression. Bars show the mean ± SD of 2 
independent experiments. * = Ρ < 0.05 versus chondrocytes stimulated with IL-lß, by Mann-Whitney U 
test. (B) NITEGE neoepitope expression, determined by staining with NITEGE antibodies and (C) loss of 
proteoglycans, determined by staining with Safranin O, in unstimulated mouse patellae (control) and 
patellae stimulated with 5.0 μg/ml of S100A8, 10 ng/ml of IL-lß, or a combination of the 2 for 24 hours. 
S100A8 elevated the IL-lß-induced NITEGE neoepitope expression and loss of proteoglycans. 
We further investigated which receptor(s) might be involved in S100A8-mediated 
NF-KB signaling. Putative receptors are TLR4 and/or carboxylated N-glycans. 
Recently, it was found that TLR4 is the dominant receptor for S100A8 signaling in 
macrophages . For that reason, we first determined the expression of TLR4 on the 
surface of the chondrocyte cell line, using FACS analysis. TLR4 expression on the cell 
membrane appeared to be very low (-10% of the cells stained positive and MFI 
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levels were low). In contrast, intracellular staining of TLR4 was very high, suggesting 
that TLR4 receptors had been internalized (results not shown). Stimulation of 
chondrocytes with S100A8 in the presence of 100 μΜ of E5564, a potent TLR4 
antagonist, did not alter VDIPEN or NITEGE expression on the chondrocyte surface 
(Figure 66). 
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Figure 6. (A) Stimulation of NF-κΒ activity in chondrocytes by S100A8. Luminescence in unstimulated NF-
KB reporter cell lines and cell lines stimulated with 0.2, 1.0, or 5.0 μg/ml of S100A8 for 24 hours. (B-D) 
Receptor involvement in S100A8 signaling was determined by flow cytometry using the TLR4 antagonist 
E5564 (100 μΜ), and antibodies against carboxylated N-glycans (mAb GB3.1) and RAGE. (B) Expression of 
the MMP-mediated neoepitopes VDIPEN and NITEGE, and expression of TLR4 in unstimulated 
chondrocytes, SlOOAS-stimulated chondrocytes, and chondrocytes stimulated with S100A8 and E5564. 
Low expression of TLR4 was observed, and blockade of TLR4 had no effect on S100A8-enhanced VDIPEN 
or NITEGE expression. (C) Expression of VDIPEN, NITEGE, and carboxylated N-glycans in unstimulated 
chondrocytes, S100A8-stimulated chondrocytes, and chondrocytes stimulated with S100A8 and GB3.1. 
Chondrocytes expressed carboxylated N-glycans and blockade of N-glycans partially inhibited S100A8-
enhanced VDIPEN and NITEGE expression. (D) Expression of VDIPEN, NITEGE, and RAGE in unstimulated 
chondrocytes, S100A8-stimulated chondrocytes, and chondrocytes stimulated with S100A8 and anti-
RAGE. RAGE was expressed by -50% of the cells, but blockade of RAGE did not alter S100A8-enhanced 
VDIPEN or NITEGE expression. Bars show the mean ± SD of 3 independent experiments. * = Ρ < 0.05 
versus unstimulated chondrocytes, by Mann-Whitney U test. 
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We also investigated the role of carboxylated N-glycans, which have been described 
as receptors for S100A8, S100A9, and S100A12 27 S100A12 is absent in mice, and it 
is assumed that, in mice, S100A8 exhibits some of the pro-inflammatory effects 
attributed to the function of S100A12 in humans28 FACS analysis showed that -30% 
of the chondrocytes were stained positive for the anti-N-glycan mAb GB3 1, which 
also binds to carboxylated N-glycans present on receptors such as RAGE 
Interestingly, the antibody partially inhibited both VDIPEN and NITEGE expression in 
S100A8-stimulated chondrocytes VDIPEN expression was inhibited by 44%, and 
NITEGE expression was inhibited by 57% (Figure 6C) Since carboxylated N-glycans 
are also expressed on RAGE, and it has been suggested that RAGE is involved in S100 
signaling, we investigated whether RAGE is involved m the activation of 
chondrocytes by S100A8 Using a neutralizing antibody, we found that -50% of the 
chondrocytes expressed RAGE, but blockade of this receptor did not alter S100A8-
stimulated VDIPEN and NITEGE expression (Figure 6D), suggesting that other, not yet 
identified, carboxylated N-glycan receptors are important 
Discussion 
In the present study, we showed that both S100A8 and S100A9 proteins were 
expressed in and around chondrocytes present m the cartilage layers of knee joints 
from mice with experimental arthritis, whereas S100A8 was also detected m 
chondrocytes m cartilage of human patients with RA 
Recently, S100A8 and S100A9 were found in cartilage and bone of naive mice 9 
S100A8 in particular was found in alkaline phosphatase-positive chondrocytes within 
the growth plate, where the cartilaginous matrix was calcifying, suggesting that 
these proteins are involved in chondrocyte maturation and matrix calcification 9 In 
the present study, S100A8 and S100A9 protein expression in cartilage layers of knee 
joints from naive mice was low, suggesting that mediators of inflammation are 
responsible for elevated S100A8/A9 expression observed within chondrocytes m 
inflamed joints 
In RA, various macrophage- (IL-lß, TNFa) and Τ cell-derived cytokines (IFNy, IL-17) 
are strongly involved in mediating cartilage destruction 2 9 3 0 All of these cytokines 
have also been shown to regulate S100A8 production m macrophages 3 1 3 3 In the 
present study, we found that these cytokines also stimulate S100A8 and S100A9 
protein production inside chondrocytes Unstimulated chondrocyte cell lines 
expressed moderate concentrations of S100A8 and S100A9 mtracellularly The 
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chondrocyte cell line used in this study was isolated from murine femoral heads and 
immortalized by transfection with the SV40 large Τ antigen gene 25. Although these 
cells preserve the chondrocyte phenotype, it has been shown that immortalization 
leads to activation of NF-κΒ, which may explain the high content of S100A8 and 
S100A9 proteins present within unstimulated cells. 
Accumulation of intracellular S100A8/A9 complexes may lead to alteration in Ca + 
homeostasis 34, protein phosphorylation (via interaction with kinase substrates) , 
and polymerization of microtubules, leading to impaired exocytosis . In 
macrophages, S100A8 and S100A9 are secreted after activation of protein kinase C 
via a novel pathway requiring an intact microtubule network . Whether 
accumulation of S100A8/A9 proteins inside the chondrocyte is involved in forming a 
hypertrophic state is currently under investigation. 
Apart from intracellular S100A8/A9, chondrocytes may also be stimulated externally 
by S100 proteins produced by activated synovial cells. Activated macrophages and 
neutrophils present within the inflamed synovium are predominant sources of these 
proteins. S100A8, S100A9, and the heterodimer complex are secreted and found in 
large concentrations (up to 75 μg/ml) in RA synovial fluid 6. These proteins are 
strongly expressed in pannus invading the cartilage 8, and a significant correlation 
has been found between the presence of these proteins in the synovial fluid of RA 
patients and the occurrence of joint inflammation and tissue damage . 
In mice, S100A8 mediates activation of macrophages, whereas complex formation 
with S100A9 antagonizes this pro-inflammatory effect . S100A8 stimulation of 
chondrocytes induced strong up-regulation of MMP mRNA, MMP-13 in particular, 
which has been shown to degrade type II collagen matrix 37. Of the various pro­
inflammatory cytokines studied, only IL-6 was released 24 hours after stimulation 
with S100A8. However, although IL-6 has been described to contribute to MMP-
mediated cartilage destruction, especially in the presence of IL-lß , neutralization 
of IL-6 did not impair S100A8-induced MMP activation on the chondrocyte surface. 
IL-lß is a dominant cytokine involved in mediating cartilage destruction by 
stimulating MMP production in chondrocytes . In the present study, we found that 
S100A8 enhanced the effect of IL-lß on MMP-3, 13, and ADAMTS5 expression, 
which resulted in enhanced NITEGE expression and loss of proteoglycans from 
patellar cartilage. ADAMTS5 has been shown to be the key enzyme involved in 
proteoglycan depletion in AIA 40. IL-lß stimulates the production of latent MMPs, 
which need a further activation step in order to degrade cartilage. 
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Since S100A8 up-regulates and activates MMPs, tight regulation is needed. One 
mechanism is binding to the regulatory unit S100A9. It has been shown that 
S100A8/A9 complexes are unable to activate macrophages 10. A further mechanism 
is that free S100A8 is highly sensitive for oxidation. Hypochlorite, the major oxidant 
of activated neutrophils, oxidizes the single Cys residue of S100A8, which makes the 
molecule dysfunctional . Since S100A8 is able to induce reactive oxygen species , 
it may inactivate itself. A third mechanism may be regulation on the receptor level. 
Putative receptors for S100A8 signaling are TLR4, heparan sulfate proteoglycans, 
carboxylated N-glycans, and RAGE. TLR4 has been shown to be responsible for 
S100A8 signaling in macrophages 10. Although TLR4 has been clearly detected on 
murine chondrocytes , its expression was very low on the surface of the 
chondrocyte cell line examined in the present study. In contrast, large amounts of 
TLR4 were detected inside the chondrocyte (data not shown), suggesting that this 
receptor is internalized. Earlier studies showed that TLR4 was localized in the 
cytoplasm and nuclei of lung cells, after strong stimulation with LPS . Since TLR4 
expression on the membrane was low, and blockade of TLR4 using E5564, an LPS 
antagonist inhibiting cellular activation by competitively preventing the binding of 
LPS to MD-2 , was not effective, we conclude that TLR4 is not the dominant 
receptor in S100A8 signaling in the chondrocyte cell line used in this study. However, 
in inflammatory arthritis other pro-inflammatory cytokines may induce surface 
expression of TLR4 and thus amplify this mechanism of activation. Further studies 
are now in progress to elucidate the role of TLR4 in S100A8-mediated signaling in 
chondrocytes. 
A second group of receptors which has been described in S100A8 signaling are 
carboxylated N-glycans . By staining with mAb GB3.1, we showed for the first time 
carboxylated N-glycan expression on chondrocytes. Carboxylated N-glycans are 
expressed on RAGE and possibly on other cell surface receptors 29'',6. RAGE uses 
signaling mechanisms parallel to TLR4. RAGE-ligand interaction also activates MAP 
kinase family members, such as JNK, p38, and ERK. Members of the S100 family, 
such as S100A4, S100A11, and S100A12, have been shown to stimulate chondrocytes 
through RAGE ligation and downstream activation of the MAP kinase pathway A7AS. 
In the present study, however, inhibition of RAGE itself using a neutralizing antibody 
did not impair S100A8-stimulated MMP activation. In contrast, blockade of 
carboxylated N-glycans partially inhibited MMP activation, suggesting that other as 
yet unknown carboxylated N-glycan expressing receptors are important in S100A8 
signaling. 
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S100A8 and S100A9 lead a double life. Inside the chondrocyte they may have a 
chaperone function, which is currently under investigation, whereas S100A8 may act 
as a stimulator and activator of MMPs after it is secreted. In the present study, we 
demonstrated that S100A8 and S100A9 are found in and around chondrocytes in 
experimental arthritis and in cytokine-activated chondrocytes. Furthermore, 
extracellular S100A8 is a potent regulator of MMP expression and significantly 
enhances the effect of IL-lß on ADAMTS activation. S100A8 has already been 
described as a marker of inflammation. The present study shows that S100A8 might 
also contribute to cartilage destruction and may lead to new therapeutic approaches 
to combat this crippling disease. 
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Abstract 
Objective Rheumatoid arthritis, associated with elevated S100A8 and S100A9 levels, 
is characterized by severe bone erosions caused by enhanced osteoclast formation 
and activity In this study we investigated the role of S100A8 and S100A9 m 
osteoclastic bone destruction in murine antigen-induced arthritis (AIA) 
Methods Bone destruction was analyzed in arthritic knee joints of S100A9" mice, 
also lacking S100A8 protein expression, and wild type controls Osteoclast precursors 
from S100A9 ' and wild type mice were differentiated into osteoclasts in vitro 
Additionally, precursors were stimulated with S100A8, S100A9, or S100A8/A9 during 
osteoclastogenesis Receptor involvement was investigated using an anti-RAGE 
blocking antibody, soluble RAGE, or TLR4 / osteoclast precursors Experiments were 
analyzed for the formation of osteoclasts, actm rings, regulation of osteoclast 
markers, and bone resorption 
Results Bone erosions and cathepsm Κ staining were significantly suppressed m 
SlOOAg^" mice after AIA induction However, osteoclast precursors from S100A9"7" 
mice developed normally into functional osteoclasts, excluding a role for intrinsic 
S100A8/A9 In contrast to S100A9 and S100A8/A9, addition of S100A8 during 
osteoclastogenesis resulted m stimulation of osteoclast formation in conjunction 
with enhanced actm ring formation and increased bone resorption Analysis of the 
putative receptor for S100A8 in osteoclastogenesis revealed that osteoclast 
differentiation and function could not be inhibited by blocking RAGE, whereas the 
increase m osteoclast number and enhanced bone resorption were completely 
abrogated using TLR4" " osteoclast precursors 
Conclusion This study demonstrates that S100A8 stimulates osteoclast formation 
and activity and suggests that both S100A8 and TLR4 are important factors in 
mediating osteoclastic bone destruction in experimental arthritis 
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Bone erosions are an important hallmark of rheumatoid arthritis (RA) and typically 
result from enhanced formation and activity of osteoclasts in affected joints. 
Osteoclasts originate from hematopoietic precursors of the monocyte/macrophage 
lineage that differentiate into multinucleated osteoclasts under the influence of 
macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-KB 
ligand (RANKL) \ 
The interdisciplinary research field of osteoimmunology, combining osteoclast 
biology and immunology, has contributed significantly to the understanding of bone 
loss in RA, where the inflamed synovium is an active site of interplay between 
immune and bone cells. Arthritic synovium is enriched with activated macrophages, 
which are strong producers of inflammatory mediators that also drive 
osteoclastogenesis, such as interleukin 1 (IL-1) and tumor necrosis factor alpha 
(TNFa)2. The alarmins S100A8 and S100A9, key players in initiation and amplification 
of inflammatory responses , are the most up-regulated proteins present in RA 
synovial fluid and they are significantly correlated with arthritis severity and joint 
degradation 46. S100 proteins are low molecular weight calcium-binding proteins 
mainly produced by monocytes, macrophages, and neutrophils, and secreted upon 
activation. 
In general, S100A8 and S100A9 are co-expressed and form a heterodimer complex 
(S100A8/A9), in which S100A8 is the active component and S100A9 stabilizes S100A8 
to prevent its degradation. Besides heterodimers, homodimers can be formed as 
well, which may exert other functions than the heterodimer complex. Targeted 
deletion of the S100A9 gene results in loss of both S100A8 and S100A9 protein 
expression, probably due to rapid degradation of S100A8 as its binding partner 
S100A9 is absent ' . S100 proteins are implicated in various intra- and extracellular 
functions. Intracellularly they maintain cell homeostasis by binding calcium and 
regulating cell migration and tubulin polymerization. Once these proteins are 
secreted they can mediate inflammatory responses by exerting cytokine-like 
functions, resulting in attraction and activation of leukocytes9'10. 
The receptor through which S100A8 and S100A9 exert their effect is still an area of 
debate. Promotion of tumor cell growth by S100A8/A9 was shown to be mediated 
by the receptor for advanced glycation end products (RAGE) . Recently, S100A8 and 
the S100A8/A9 complex were identified as endogenous ligands of Toll-like receptor 4 
(TLR4) . Toll-like receptors belong to the family of pattern recognition receptors, 
recognizing both exogenous pathogen-associated molecular patterns (PAMPs), as 
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well as endogenous damage-associated molecular patterns (DAMPs), to which the 
alarmms S100A8 and S100A9 belong 13 
Both TLR4 and RAGE are important for osteoclast differentiation and function 
RAGE"7 mice display increased bone mineral density and decreased bone resorptive 
activity in vivo Bone marrow-derived precursors exhibit impaired osteoclast 
formation and reduced bone resorptive activity in vitro Local injections of the 
bacterial endotoxin lipopolysacchande (LPS) strongly increase osteoclast numbers 
and bone resorption, which is blocked in C3H/HeJ mice carrying a single point 
mutation of an ammo acid in the cytoplasmic domain of TLR4, resulting m impaired 
intracellular signal transduction 15 
Using S100A9~/~ mice, also lacking S100A8 protein expression, we have previously 
shown that S100A8 and S100A9 are important mediators of matrix 
metalloprotemase (MMP)-mediated cartilage destruction in experimental antigen-
induced arthritis (AIA)16 Prominent expression of S100A8 and S100A9 m osteoclasts 
was previously reported 17, but their function in osteoclasts and arthritic bone loss 
has not been investigated The aim of the present study was to investigate the role 
of S100A8 and S100A9 in osteoclast-mediated bone destruction during antigen-
induced arthritis, as well as their role m osteoclastogenesis and the activity of 
osteoclasts 
Materials and Methods 
Mice 
S100A9 " mice were generated as previously described 7 and backcrossed to 
C57BL/6 background for 10 generations TLR4 '" animals m C57BL/6 background 
were provided by Prof S Akira (Research Institute for Microbial Diseases, Osaka 
University, Osaka, Japan) Control C57BL/6 mice were purchased from Elevage-
Janvier (Le Genest Samt Isle, France) Mice were housed m filter-top cages and a 
standard diet and water were provided ad libitum All animal studies were approved 
by the institutional research ethics committee 
Induction of Antigen-Induced Arthritis 
Mice were immunized with 100 μg of methylated bovine serum albumin (mBSA, 
Sigma-Aldnch, St Louis, MO), emulsified in 100 μΙ Freund's complete adjuvant (CFA, 
Difco Laboratories, Detroit, Ml) Injections were divided over both flanks and 
footpads of the front paws Heat-killed Bordetella pertussis (RIVM, Bilthoven, the 
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Netherlands) was administered mtrapentoneally as an additional adjuvant Two 
subcutaneous booster injections with m total 50 μg mBSA/CFA were given m the 
neck region 1 week after the initial immunization Three weeks after these 
injections, AIA was induced by injecting 60 μg of mBSA m 6 μΙ phosphate buffered 
saline (PBS) directly into the knee joint, resulting in chronic arthritis 
Histological analysis 
Total knee joints were isolated, fixed in 4% formalin for 4 days, decalcified m formic 
acid, dehydrated, and embedded m paraffin Frontal sections of 7 μηη were prepared 
and stained with hematoxylin and eosm (H&E) to study bone erosion, which was 
graded on a scale ranging from 0 (no erosion) to 3 (complete bone loss). Osteoclast 
activity was visualized by immunohistochemistry for the osteoclast activity marker 
cathepsm Κ Sections were deparaffmized, rehydrated, and treated with 3% H2O2 m 
methanol for 15 minutes Subsequently, sections were pre-mcubated with 10% 
casein m PBS for 30 minutes and thereafter incubated for 1 hour with the primary 
antibody rabbit anti-cathepsm Κ (Abeam, Cambridge, UK) As a control, sections were 
incubated with normal rabbit IgG Additionally, sections were incubated with the 
secondary antibody, biotinylated goat anti-rabbit IgG and binding was detected using 
the ABC-HRP kit (Elite kit, Vector Laboratories, Burlmgame, CA). Peroxidase was 
developed with diammobenzidme (DAB) and sections were counterstamed with 
hematoxylin for 1 minute 
Bone marrow isolation and osteoclastogenesis 
Bone marrow was isolated from femurs and tibiae by flushing the marrow cavity 
with culture medium (α-Minimum Essential Medium; Invitrogen, Carlsbad, CA) 
supplemented with 5% PCS, 100 U/ml penicillin, and 100 μg/ml streptomycin) using a 
sterile syringe with a 21G needle. Single-cell suspensions were obtained by gently 
aspirating the cell clumps through the syringe Bone marrow cells were washed and 
plated into 96-well plates at a density of IxlO5 cells per well m 150 μΙ culture 
medium containing 30 ng/ml recombinant murine M-CSF (R&D Systems, 
Minneapolis, MN) with or without 40 ng/ml recombinant murine RANKL (RANKL-TEC, 
R&D Systems) Additionally, cells were seeded on 650 μιη thick bovine cortical bone 
slices. Culture media were replaced every 3 days 
S100A8 protein levels were measured m supernatants of S100A9 cultures by 
enzyme-linked immunosorbent assay (ELISA) as described previously 
Recombinant murine S100A8, S100A9, or the S100A8/A9 heterodimer, purified as 
previously described 18, was added to cell cultures from day 4 onwards LPS 
contamination was tested by Limulus amebocyte lysate (LAL) assay LPS was not 
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detectable (sensitivity ~0 7 ± 0 5 pg LPS/Vg protein), indicating that the maximal 
possible contamination of S100 protein preparations was <1 2 pg LPS^g protein 
Purified E Coli LPS (1 0 μg/ml, Sigma-Aldrich) was used as a control where indicated 
RAGE ligation was blocked by incubation with a specific RAGE-blockmg antibody (a-
RAGE) 1 hour prior to addition of S100A8, according to the manufacturer's protocol 
(166 μg/ml, R&D systems) Additionally, 40 μg/ml recombinant human soluble RAGE 
(sRAGE), generated as previously reported , was pre-mcubated with S100A8, 1 
hour prior to addition to osteoclast cultures 
F-Actm staining and confocal microscopy 
Actm ring formation in osteoclasts cultured on bone was analyzed with confocal 
microscopy Osteoclast membranes were visualized with CD44 staining as previously 
described 2° Bone slices were washed m PBS and fixed m 4% PBS-buffered 
paraformaldehyde for 10 minutes Non-specific binding was blocked for 30 minutes 
with 10% normal goat serum, followed by 1 hour incubation with rat anti-CD44 
(IM7 8 1 , Cedarlane Laboratories, Burlington, Canada) Bound antibody was 
visualized with goat anti-rat-Alexa Fluor 647 (Invitrogen) F-actm was stained using 
Alexa Fluor 488-conjugated phalloidm (Invitrogen) Nuclei were stained with 
Propidium Iodide (PI, Sigma-Aldrich) Image stacks were generated with a Leica TCS-
SP2 confocal laser scanning microscope (Leica Imaging Systems Ltd, Wetzlar, 
Germany) using an argon laser (Alexa Fluor 488 and PI) and a helium laser (Alexa 
Fluor 647) 
MCS analysis 
Six different bone marrow subsets were analyzed by two-color flow cytometric 
analysis as previously described Briefly, freshly isolated bone marrow cells were 
washed m lxPBS/1% BSA and labeled with biotmylated ER-MP12, recognizing CD31 
After washing, cells were labeled with FITC-conjugated ER-MP20, recognizing Ly-6C, 
and streptavidm-PE conjugate (Biolegend, San Diego, CA) Fluorescence was 
analyzed using a fluorescence-activated cell sorter (FACSCahbur, BD biosciences, San 
Jose, CA) and FlowJo software (Tree Star, Ine , Ashland, OR) 
Tartrate-resistant acid phosphatase staining and cell count 
After 6 or 9 days of culture the number of tartrate-resistant acid phosphatase-
positive multinucleated cells (TRACP+ MNCs) was determined Cells were washed in 
PBS, fixed m 4% PBS-buffered formaldehyde for 10 minutes, and stained for TRACP 
activity using the leukocyte acid phosphatase kit according to the manufacturer's 
protocol (Sigma-Aldrich) Only cells with three or more nuclei were considered 
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osteoclast. Based on the number of nuclei per cell, each osteoclast was assigned to 
one of three groups: 3-5 nuclei, 6-10 nuclei, or >10 nuclei, since the number of nuclei 
may reflect the maturity of the osteoclast 
Osteoclast resorption assay 
To determine resorption pit formation by osteoclasts differentiated on bone slices, 
cells were lysed in water and cell remnants were mechanically removed by 
sonicating the bone slices in 10% ammonia for 30 minutes. The bone slices were 
thoroughly washed and incubated in a 10% saturated alum (KAI(S04)2-12H20) 
solution for 10 minutes. Finally, bone slices were washed again and resorption pits 
were stained with Coomassie brilliant blue (PhastGel Blue R-350; GE Healthcare Bio-
Sciences, Uppsala, Sweden). Five micrographs per slice from pre-determined 
positions were taken with a digital camera mounted on an inverted light microscope. 
The percentage of resorbed bone area was quantified using the Qwin image analysis 
system (Leica). 
RNA isolation and quantitative polymerase chain reaction 
Total RNA of cultured cells was isolated using TRIzol reagent and reverse transcribed 
into complementary DNA (cDNA) with Moloney murine leukemia virus reverse 
transcriptase, oligo(dT) primers, and dNTPs (Invitrogen). Quantitative real-time 
polymerase chain reaction (PCR) was performed using the ABI Prism 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA). QPCR amplification protocol 
was as follows: 2 minutes at 50°C, 10 minutes at 95°C, followed by 40 cycles of 15 
seconds at 95°C and 1 minute at 60Τ, with data collection during the last 30 
seconds. Product specificity was confirmed by post-amplification dissociation curve 
analysis. QPCR was performed in a total volume of 20 μΙ, containing 4 μΙ cDNA, 1.2 μΙ 
forward primer (5 μΜ), 1.2 μΙ reverse primer (5 μΜ), 10 μΙ SYBR Green Master Mix 
(Applied Biosystems), and 3.6 μΙ dh^O. Samples were normalized for GAPDH 
expression by calculating the delta Ct (ACt = QGAPDH - Ct tareet gene)· Relative gene 
expression was calculated as 2~,Δα). 
Statistical analysis 
Statistics were performed using GraphPad Prism version 4.0 (GraphPad Software 
Inc., San Diego, CA). Student's t-test (two tailed) was performed for comparisons 
between wild type and knockout mice regarding the number of TRACP* MNCs and 
for analysis of actin ring formation. Bone resorption levels were analyzed by Mann-
Whitney U test. Ρ values less than 0.05 were considered significant. Results are 
expressed as mean ± SEM. 
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Results 
Reduced bone erosions in S100A8/A9-deficient mice with antigen-induced arthritis 
To study the involvement of S100A8 and S100A9 in osteoclast-mediated bone 
destruction during experimental arthritis, total knee joints of S100A9~ ~ and wild 
type mice were isolated on day 7 and day 21 after AIA induction and processed for 
histological analysis. Seven and 21 days after AIA induction bone erosions were 
significantly suppressed in S100A9 mice, as compared to wild type controls (58% 
and 56% reduction, respectively) (Figure 1A). Additionally, immunohistochemical 
staining for the osteoclast activity marker cathepsin Κ displayed significantly 
decreased numbers of osteoclasts in the knee joints of S100A9-deficient animals 7 
days after AIA induction (Figure IB). On day 21 after AIA induction the number of 
osteoclasts within the knee joints was strongly decreased in both wild type and 
knockout mice and differences were no longer significant (Figure IB). 
Β 
day 7 day 21 
Timepoint after AIA induction 
wild type 
S100A9-/-
day 7 day 21 
Timepoint after AIA induction 
— 
wild type 
! 
s 
' -
S100A9-/-
Figure 1. Reduced bone destruction in knee joints of S100A9 mice 7 and 21 days after AIA induction. (A) 
Histopathologic bone erosion score graded on a scale from 0 (no erosion) to 3 (complete bone loss). (B) 
Detection of osteoclasts by immunohistochemical staining for the osteoclast activity marker cathepsin K. 
Bars show the mean + SEM for at least 6 mice per group. * = P< 0.01 versus wild type, by Mann-Whitney 
U test. (Right) Images showing that 7 days after AIA induction the number of osteoclasts (arrows) in the 
knee joints of SIOOAS"'" mice was significantly reduced compared with wild type controls. Β = bone; S = 
synovium. Original magnification x250. 
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Normal development of S100A8/A9-deficient osteoclast precursors into functional 
osteoclasts 
To determine whether the intrinsic lack of S100A8 and S100A9 affects the 
differentiation and function of osteoclasts, bone marrow was isolated from 
SlOOAiT^ and wild type mice, and differentiated towards osteoclasts under the 
influence of M-CSF and RANKL. First, we measured S100A8 protein production by 
SIOOAD-'- osteoclasts with ELISA. In line with studies demonstrating the absence of 
S100A8 protein expression in myeloid cells of SlOOAiT^ mice 7;8, S100A8 was not 
detected in the supernatants of S100A9' ~ osteoclast cultures (data not shown). 
10 20 
% positive cells Total 3-5 6-10 >10 
# nuclei/ cell 
r'-O'-y^»^ % * wild type 
- ν M 
day 6 day 9 resorption 
Figure 2. Differentiation and function of bone marrow-derived osteoclasts from S100A9"7" and wild type 
mice. (A) Composition of 6 bone marrow subsets in SIOOAS-'" and wild type mice discriminated by ER-
MP12/ ER-MP20 staining and analyzed by flow cytometry. (B and C) Formation of TRACP* multinucleated 
cells (MNCs) (B) and bone resorption lacunae (C) by SIOOAS"7' and wild type osteoclasts 6 and 9 days after 
differentiation in vitro. Values are the mean ± SEM (η = 6 mice per group). * = Ρ < 0.01 versus wild type, by 
Student's t-test. (D) Representative images of TRACP staining and Coomassie brilliant blue staining of 
resorption pits. Original magnification x200. 
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Next, we determined the composition of osteoclast precursors in the bone marrow 
by flow cytometry. Using monoclonal antibodies recognizing CD31 (ER-MP12) and 
Ly-6C (ER-MP20) 21, 6 subpopulations were discriminated, of which early blast cells 
(CD31h'/Ly-6C_), myeloid blasts (CD3l7Ly-6C+), and monocytes (CD3l7Ly-6Ch') are 
the populations that give rise to osteoclasts . Compared with wild type mice 
increased percentages of myeloid blasts, monocytes, and granulocytes were found in 
SIOOAS''' mice (6.5 ± 0.3% versus 8.1 ± 0.2%, 6.7 ± 0.3% versus 8.3 ± 0.4%, and 23.5 
± 0.9% versus 27.4 ± 0.7% for wild type versus SlOOAg"'" bone marrow cells, 
respectively), whereas no differences were detected in the composition of the 
remaining subpopulations (Figure 2A). 
Despite subtle differences in bone marrow composition, in vitro osteoclastogenesis 
led to the formation of comparable osteoclast numbers in the cultures of S100A9" " 
and wild type mice, and no differences were found in the average number of nuclei 
per cell (Figures 2B and D). Furthermore, mRNA expression levels of the osteoclast 
markers nuclear factor of activated Τ cells, cytoplasmic 1 (NFATcl), dendritic cell-
specific transmembrane protein (DC-STAMP), TRACP, calcitonin receptor (CTR), and 
cathepsin Κ (CTSK) were similar in control and SIOOAS''' osteoclasts (data not 
shown). Finally, osteoclast function was investigated by analysis of resorption pit 
formation 6 and 9 days after osteoclast differentiation on bone slices. As shown in 
Figures 2C and O, no differences were observed in the formation of resorption pits 
generated by bone marrow-derived osteoclasts from S100A9~ " mice and wild type 
controls. 
S100A8 stimulates osteoclast formation and bone resorption 
The previous results indicate that intrinsic S100A8 and S100A9 production by 
precursors is not required for normal osteoclast differentiation and function. In RA, 
however, S100 proteins are produced in excessive amounts by activated 
macrophages and polymorphonuclear cells, which may affect the differentiation of 
precursors attracted to the site of inflammation. Therefore, we investigated the 
effect of S100A8, S100A9, and the S100A8/A9 complex on osteoclast differentiation 
and function. Addition of S100A8 at day 4 of differentiation resulted in a significantly 
enhanced, dose-dependent formation of TRACP* MNCs (Figure 3A). Next, mRNA 
expression levels of osteoclast markers were determined by quantitative PCR, which 
showed that the expression of osteoclast markers was not changed after stimulation 
with S100A8 (Figure 3B). To determine whether the changes in osteoclast 
differentiation also affected their function, osteoclasts were differentiated on bone 
in the presence of S100A8. After 6 days of culture the percentage of bone resorbed 
by S100A8-stimulated osteoclasts was dose-dependently increased as compared 
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with unstimulated controls and reached significance with doses of 1.0 and 5.0 μ§/η-ιΙ 
S100A8 {Figures 3C and D). 
In contrast, addition of S100A9 or the S100A8/A9 heterodimer to 
osteoclastogenesis cultures resulted only in a minor increase in the formation of 
TRACP+ MNCs containing 3-5 nuclei per cell, whereas expression levels of osteoclasts 
markers and resorption pit formation on bone were not affected by these stimuli 
{data not shown). Since these results suggest that stimulation of osteoclast 
formation and bone resorption is specific for S100A8, further research was focused 
on investigating the effects of S100A8 at a dose of 1.0 pg/ml. 
S100A8 concentration 
^M control 
CD 0 2 Mg/ml 
• 1 0 MQ/ml 
• • 5 0 ny/m 
Β 
S100A8 concentration 
control 
control 0.2 1.0 5.0 
S100A8 concentration (ng/ml) resorption 
Figure 3. Dose-dependent stimulation of osteoclast differentiation and function by S100A8. Bone marrow-
derived osteoclast precursors were differentiated in vitro for 6 days. At day 4 of differentiation 0.2, 1.0, or 
5.0 pg/ml recombinant S100A8 was added. Formation of TRACP* multinucleated cells (MNCs) (A), relative 
mRNA expression levels of the osteoclast markers TRACP, cathepsin Κ (CTSK), NFATcl, DC-STAMP, and 
calcitonin receptor (CTR) (B), and bone resorption levels (C) of SlOOAS-stimulated osteoclasts and 
unstimulated controls. Values are the mean ± SEM of η = 6 mice per group. * = Ρ < 0.05; ** = Ρ < 0.01 
versus control, by Student's t-test (A) or by Mann-Whitney U test (C). (D) representative images of TRACP 
staining and resorption pit formation after stimulation with 1.0 μg/ml S100A8. Note that SlOOAS-
stimulated osteoclasts are more stretched out than unstimulated controls. Original magnification x200. 
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Enhanced actin ring formation in SlOOAS-stimulated osteoclasts 
In the presence of S100A8 a marked change in osteoclast morphology was observed. 
Stimulated cells proved to be more stretched out than unstimulated controls (Figure 
3D), suggesting a role for S100A8 in the organization of the osteoclast cytoskeleton. 
Actin ring formation is highly characteristic for osteoclasts and is a prerequisite for 
bone resorption . To study the effect of S100A8 stimulation on actin ring 
formation, F-actin in osteoclasts cultured on bone was stained using Alexa Fluor 488-
phalloidin and analyzed with confocal microscopy. The changes in osteoclast shape 
when cultured on plastic were not present when osteoclasts were cultured on bone. 
Osteoclast size was found to be comparable for control and S100A8-stimulated 
osteoclasts (Figures 4A and ß). However, the number of actin rings per cell in 
S100A8-stimulated osteoclasts were significantly increased as compared to 
unstimulated controls (Figures 4A and C). 
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Figure 4. Effect of S100A8 stimulation (1.0 μg/m\) on actin ring formation by osteoclasts. (A) 
Representative images of osteoclasts cultured on bone and analyzed using confocal microscopy. F-Actin 
was stained with Alexa Fluor 488-phalloidin (green), membranes were stained with Alexa Fluor 647-CD44 
(blue), and nuclei were stained with propidium iodide (red). Osteoclast size (B) and number of actin rings 
per osteoclast (C). Bars show the mean. ** = Ρ < 0.001 versus control, by Student's t-test. On average, 38 
± 9 osteoclasts/bone slice were analyzed (n = 6 bone slices per group). 
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SlOOAS-stimulated osteoclast differentiation and function is mediated by TLR4 
The receptor through which S100A8 mediates its effect is still a matter of debate. 
Involvement of RAGE has been demonstrated, whereas recently it was shown that 
S100A8 mediates its effects in macrophages via TLR4. To study the role of RAGE, 
osteoclast precursors from wild type C57BL/6 mice were stimulated with S100A8 in 
the presence of a specific RAGE blocking antibody or soluble RAGE. Blockade of 
RAGE however, did not suppress the S100A8-enhanced formation of TRACP+ MNCs 
and bone resorption [Figures 5A-C), indicating that, on osteoclasts, RAGE is not the 
receptor via which S100A8 mediates its effects. 
control S100A8 a-RAGE u-RAGE + S100A8 
Figure 5. RAGE blockade does not Inhibit SlOOAS-stimulated osteoclast differentiation and function. 
Osteoclast precursors were differentiated in vitro for 6 days. On day 4 of differentiation RAGE ligation was 
blocked by addition of anti-RAGE (166 μg/ml) 1 hour prior to stimulation with recombinant S100A8 (1.0 
μg/ml). Additionally, 1.0 μg/ml S100A8 was pre-incubated together with 40 μg/ml of soluble RAGE 
(sRAGE) 1 hour prior to addition to the osteoclast culture. Formation of TRACP* multinucleated cells 
(MNCs) (A) and resorption pits on bone (B). Values are the mean ± SEM of η = 6 mice per group. * = Ρ < 
0.05; ** = Ρ < 0.01; ns = not significant by Student's t-test (A) or by Mann-Whitney U test (B). (C) 
Representative images of Coomassie brilliant blue staining of resorption lacunae for osteoclast cultures 
incubated with anti-RAGE. Original magnification x200. 
Next, we investigated the role of TLR4 in SlOOAS-stimulated osteoclast formation. 
Bone marrow from TLRA'7' mice and wild type littermates (TRL4+/+) was isolated and 
differentiated into osteoclasts in the presence or absence of S100A8. Stimulation 
with 1.0 pg/ml purified E. Coli LPS was used as a positive control for TLR4 activation. 
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The composition of bone marrow subpopulations, as identified by ER-MP12/ER-
MP20 staining, was similar for both wild type and TLRA"'" animals {data not shown). 
On day 6 of culture the formation of TRACP+ MNCs was analyzed, RNA was isolated, 
and resorption pit formation on bone was quantified. Stimulation of TLR4+ + 
osteoclasts with S100A8 increased the formation of TRACP* MNCs, predominantly of 
cells containing 3-5 and 6-10 nuclei [Figure 6A), and again did S100A8-stimulated 
osteoclasts have an increased tendency to be more stretched out. In contrast, 
stimulation of TLR4 osteoclasts with S100A8 did neither alter the number nor 
shape of osteoclasts [Figures 6A and ß). Finally, analysis of bone resorption capacity 
showed that bone resorption levels were significantly increased in S100A8-
stimulated TLR4 osteoclasts, whereas this effect was completely blocked in 
S100A8-stimulated TLR4'/' osteoclasts [Figure 6C). 
A 
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Figure 6. Suppression of S100A8-stimulated osteoclast differentiation and function in TLR4 '" osteoclasts. 
(A) Formation of TRACP* multinucleated cells (MNCs) and (C) bone resorption levels. Values are the mean 
± SEM of η = 6 mice per group. · = Ρ < 0.05; ** = Ρ < 0.01 versus TLRa"'", by Student's t-test (A) or by 
Mann-Whitney U test (C). (B) Representative images of TRACP-stained osteoclasts. Note the change in 
morphology of S100A8-stimulated TRL4*'* osteoclasts towards a more stretched out phenotype, which is 
absent in S100A8-stimulated TLR4 '" osteoclasts. Original magnification χ200. 
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Discussion 
In the present study we have demonstrated for the first time that the alarmin 
S100A8 stimulates both osteoclast formation and function. Since S100A8 levels are 
significantly increased in arthritic joints and strongly correlated to the severity of 
joint destruction, these results suggest that S100A8 is an important factor in 
mediating osteoclastic bone destruction in RA. 
The observation that both S100A8 and S100A9 are strongly expressed in osteoclasts 
suggested that these proteins might play an important role in the maturation and 
function of osteoclasts and skeletal development . This idea was further supported 
by the finding of significantly reduced bone erosion levels after AIA induction in 
SIOOAS"7" mice as compared with wild type controls. Immunolocalization of the 
osteoclast marker cathepsin Κ showed significantly reduced osteoclast numbers in 
SIOOAQ^- mice on day 7 after AIA induction. On day 21 after AIA induction osteoclast 
numbers were strongly reduced and the difference between wild type and knockout 
animals was no longer significant, indicating that in this arthritis model mediation of 
osteoclastic bone destruction is transient and seems to occur primarily in the early 
phase of disease. 
To further investigate the role of S100A8 and S100A9 in osteoclasts, we first studied 
the role of these S100 proteins in normal osteoclast differentiation and function. 
Analysis of bone marrow subpopulations revealed increased percentages of two 
fractions that contain osteoclast precursors (myeloid blasts and monocytes) in 
S100A9 mice. Despite these differences, and the lack of protein expression of both 
S100A8 and S100A9, osteoclast precursors from S100A9"/_ animals developed 
normally into TRACP+ multinucleated osteoclasts and the bone resorption capacity of 
these osteoclasts was also not affected. The possibility of differences in maturation 
kinetics was excluded, because different time points after the start of differentiation 
were analyzed and none of these time points displayed differences between 
S100A9"/" and wild type osteoclasts. These findings are in accordance with those 
from previous studies, demonstrating subtle differences in bone marrow 
composition that do not result in abnormal development of S100A9 mice. 
Furthermore, no abnormalities in bone phenotype have been described ' . From 
these findings it can be concluded that S100A8 and S100A9 are not required for 
normal physiological development of osteoclasts and the increased number of 
osteoclast precursors present within the bone marrow compartment appears 
irrelevant for bone mass levels in vivo. 
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In RA, proliferation of inflamed synovial lining cells and infiltration of activated 
macrophages results in the formation of pannus that covers the surface of cartilage 
and bone, establishing close interactions between immune and bone cells. Activated 
macrophages in the pannus tissue produce multiple factors that control both 
immunity and bone homeostasis, creating an imbalance between bone formation 
and bone resorption in favor of the latter, resulting in severe bone destruction ' 
Of the various factors produced in the inflamed synovium, S100A8 and S100A9 are 
the most up-regulated, and they are produced in excessive amounts " . In the 
S100A8/A9 heterodimer complex, S100A8 is the active component and S100A9 
stabilizes S100A8 to prevent its degradation 7. Recently, we demonstrated that in 
murine macrophages, S100A8, independent of complex formation with S100A9, up-
regulated activating Fey receptors and MMPs, which are important mediators of 
cartilage destruction in arthritis 26'27. Additionally, we demonstrated that S100A9 and 
the heterodimer complex were much less potent ' . Since bone erosion levels were 
strongly reduced in arthritic S100A9~ " mice, which also lack S100A8 protein 
expression, we hypothesize that external S100A8, produced by activated 
macrophages, stimulates osteoclast differentiation and the function of precursors 
that are attracted to the site of inflammation. 
Our hypothesis is supported by the finding that stimulation of osteoclastogenesis 
with S100A8 resulted in dose-dependently increased osteoclast numbers and bone 
resorption, whereas stimulation with S100A9 or the S100A8/A9 complex affected 
neither osteoclast formation nor function, which is similar to our previous findings in 
macrophages where S100A8 was also more potent than S100A9 and the 
heterodimer complex . The stimulatory effects of S100A8 cannot be explained by 
the induction of genes known to be important for the differentiation and function of 
osteoclasts such as NFATcl29'30, DC-STAMP 31, TRACP 32, and cathepsin Κ 33, because 
their expression was not regulated by S100A8 stimulation. However, we did notice a 
marked change in the shape of the osteoclasts. Osteoclast differentiation in the 
presence of S100A8 resulted in osteoclasts that appeared to be more stretched out 
than unstimulated control osteoclasts. 
Regulation of cell morphology is a complex process involving components of the 
cytoskeleton including actin microfilaments, microtubules, and intermediate 
filaments . Attachment of osteoclasts to the bone matrix induces their activation 
and leads to reorganization of the actin cytoskeleton, formation of sealing zones, 
and a polarized ruffled membrane juxtaposed to bone. The formation of actin rings is 
highly characteristic for osteoclasts and is related to their capacity to resorb bone 
189 
Chapter 8 
Previously it has been demonstrated that S100A9, in complex with S100A8, 
promotes polymerization of microtubules and that SlOOAEf7 granulocytes contain 
significantly less polymerized tubulin Although binding of S100 proteins to other 
components of the cytoskeleton such as keratin, vimentm, and F-actm has been 
reported 3 7 3 9 , functional consequences of these interactions have not been 
thoroughly investigated Because the differentiation and bone resorptive capacity of 
S100A8/A9 ' osteoclasts were normal, it is not likely that osteoclast morphology is 
regulated by direct interactions of S100A8 with cytoskeletal components However, 
the clear changes m the shape of S100A8-stimulated osteoclasts did motivate us to 
further investigate whether external osteoclast activation with S100A8 could 
stimulate actm ring formation in osteoclasts 
Culturmg osteoclasts on bone was different from cultunng osteoclasts on plastic 
since the differences in morphology were less prominent and osteoclast size was 
comparable when cells were cultured on bone These findings stress earlier studies 
on the impact of mineral substrates on osteoclastogenesis, showing increased 
osteoclast formation of osteopontm (OPN) ' cells when cultured on plastic, which 
was no longer present when cultured on bone However, F-actm staining 
demonstrated that S100A8-stimulated osteoclasts contained significantly more actm 
rings per cell Since bone resorption only occurs when a sealing zone is formed and 
the actm ring is present, creating the acidic environment crucial for cathepsm Κ 
activity 4 1 4 3 , this suggests that S100A8 enhances the bone resorptive capacity per 
osteoclast 
Finally, we investigated which receptor regulated the S100A8-mediated effects on 
osteoclasts Putative receptors described for S100A8 are N-glycans , RAGE 1, and 
TLR4 Although binding of S100A8 to each of these receptors has been 
demonstrated, functional relevance has only been found for its ligation to RAGE and 
TLR4 To investigate the role of RAGE m S100A8 stimulation of osteoclasts RAGE 
ligation was blocked either using a specific blocking antibody or by pre-mcubation of 
S100A8 with soluble RAGE However, neither method suppressed the increased 
formation of osteoclasts and enhanced bone resorption, suggesting that another 
receptor mediates the stimulatory effects of S100A8 on osteoclasts 
Another potential candidate is TLR4, a crucial receptor involved in mediating joint 
destruction in experimental arthritis 4 5 4 6 S100A8 was shown to be an endogenous 
ligand for TLR4, inducing intracellular translocation of MyD88 and activating IRAK-1 
and NF-KB 1 , the latter being crucial for osteoclast differentiation and function ' l 7 4 8 
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Using TLR4" " osteoclasts we clearly demonstrated complete blockade of the 
S100A8-mediated increase in osteoclast formation and bone resorption 
In conclusion, this study demonstrates that S100A8, but not S100A9 or the 
S100A8/A9 heterodimer, stimulates osteoclast differentiation, thus increasing the 
number of osteoclasts S100A8 also appears to stimulate osteoclast activity by 
enhancing the formation of actin rings, likely resulting in an increased bone 
resorptive capacity per cell Altogether, these effects ultimately lead to enhanced 
resorption induced by S100A8, which was found to be mediated by TLR4 The 
reduced bone erosion levels m arthritic S100A9 mice, together with our in vitro 
findings, indicate that both TLR4 and S100A8 are important factors m mediating 
osteoclastic bone destruction m experimental arthritis 
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Chapter 9 
Chronic inflammation, cartilage destruction, and bone erosions are key features of 
RA It is considered an autoimmune disease wherein inflammatory and destructive 
processes are driven by a complex interplay between invading immune cells and 
resident joint cells 1 Uncontrolled production of autoantibodies results m the 
formation of immune complexes, which provoke cellular activation via FcyRs, key 
regulators of immunogenic and tolerogenic responses Immune complexes are 
abundantly present m the sera and joints of RA patients and play an important role 
in the onset and progression of inflammatory and destructive processes within the 
joints Aberrant activation and expression of activating and inhibitory FcyRs is 
therefore detrimental to joint integrity In animal models of arthritis it has been 
shown that FcyRs are crucial mediators of inflammation and cartilage destruction 3 
Furthermore, FcyR expression appeared to be associated with expression of the 
alarmms S100A8 and S100A9 and disease outcome The research described m this 
thesis has touched on multiple aspects m experimental arthritis m an attempt to 
broaden our understanding of FcyR-mediated joint destruction and to clarify their 
association with the expression and function of the alarmms S100A8 and S100A9 
Fey receptors and bone erosion 
First, we studied the involvement of FcyRs in osteoclast-mediated bone loss m 
arthritis In Chapter 2, we demonstrated that bone erosion levels and the expression 
of RANKL and cathepsm Κ were increased m FcyRIIB-deficient mice with antigen-
induced arthritis (AIA) RANKL is a key osteoclastogemc factor, committing precursor 
cells toward osteoclast differentiation and stimulating mature osteoclasts to 
produce the bone resorbmg protease cathepsm Κ * Differentiation and activation of 
osteoclasts is blocked by ORG, a naturally occurring soluble decoy receptor for 
RANKL that prevents RANKL from binding to its receptor RANK The balance between 
RANKL and ORG expression therefore determines the degree of osteoclast-mediated 
bone resorption Opposed to increased RANKL expression, OPG expression was 
not altered m FcyRIIB-deficient mice (Chapter 2), thus tipping the balance m favor of 
bone resorption 
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Additional support for the involvement of FcyRMB in bone destruction came from the 
detection of high FcyRMB expression on osteoclasts, whereas activating FcyR levels 
were low (Chapters 2 and 3) FcyRMB is an inhibitory, ITIM-bearmg receptor, 
recruiting the intracellular adaptor protein SHIP upon immune complex ligation It 
is known that, m addition to M-CSF and RANKL, co-stimulatory signaling via ITAM-
and ITIM-bearmg adaptors and receptors is essential for osteoclastogenesis 89 
Among the receptors and adaptor proteins identified thus far, SHIP has been 
described as anti-osteoclastogemc and recently it was shown that human OIP-1 can 
inhibit osteoclastogenesis of murine progenitors via FcyRMB and downstream 
phosphorylation of SHIP 10 However, despite high FcyRMB expression on mature 
osteoclasts, immune complex stimulation did not affect their bone resorptive 
capacity (Chapter 3) This may be due to the absence of activating FcyRs on mature 
osteoclasts Normally, co-expression and co-crosslmkmg of activating and inhibitory 
FcyRs upon immune complex binding is required for FcyRMB to exert its inhibitory 
effect " OIP-1, on the other hand, was demonstrated to solely bind and signal via 
FcyRMB 10 
Compared to the lack of effect on mature osteoclasts, immune complexes strongly 
inhibited the differentiation of precursor cells towards functional osteoclasts, which 
was mediated by activating FcyRs, highly expressed on progenitor cells, and not by 
FcyRMB (Chapters) This finding seems to contradict previous research describing the 
FcRy-cham, needed for the expression and function of the osteoclast receptor 
OSCAR, as pro-osteoclastogemc An explanation may be the occurrence of 
competition between receptors for common subumts and downstream mediators, 
as was previously demonstrated for the ITIM-bearmg receptor Ly49Q and its 
downstream mediator SHP-1 12 Both activating FcyRs and OSCAR need the FcRy-
cham for their expression and function Hence, rapid down-regulation of activating 
FcyRs during osteoclast differentiation (Chapters 2 and 3) might be beneficial for 
osteoclastogenesis by favoring the expression and function of OSCAR 
The situation m vivo is more complex We postulate that uncontrolled inflammation 
and concomitant production of osteoclast regulatory factors will overrule the 
inhibitory effects of immune complexes on osteoclastogenesis FcyRs are well-
appreciated regulators of inflammatory responses m autoimmune diseases like RA 
During AIA, bone destruction and RANKL expression were increased in FcyRIIB-
deficient mice but unaltered in FcRy-cham ' mice Moreover, bone destruction 
levels strongly correlated with inflammation severity (Chapter 2) In the absence of 
FcyRMB, negative regulation of activating FcyRs is lost and immune complex 
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clearance is impaired , enabling continuous activation of inflammatory mediators, 
such as macrophages and PMNs, via activating FcyRs 1 4 1 6 Subsequent production of 
chemokmes, cytokines, and osteoclast regulatory factors attracts new osteoclast 
precursors to the joint and stimulates their differentiation and activation Even 
though immune complexes inhibit osteoclastogenesis, differentiation is not 
completely blocked (Chapter 3) and will be even further driven due to enhanced 
RANKL production (Chapter 2) Resident osteoclasts present prior to arthritis onset 
become activated by RANKL and pro-inflammatory cytokines, because mature 
osteoclasts are not susceptible to immune complex regulation (Chapter 3) 
Moreover, Τ cells and Τ cell-derived cytokines play an important role m the AIA 
model and substantial evidence exists for their involvement in bone destruction 19 
Activated Thl7 cells, for instance, are considered an osteoclastogenic Τ cell subset as 
they express significant amounts of RANKL and TNFa, and the Th-17 cytokines IL-17 
and IL-22 both stimulate osteoclastogenesis 2 0 2 2 Altogether, the total amount and 
activity of osteoclasts within the joint will increase and lead to enhanced bone 
degradation In FcRy-cham mice, the presence of FcyRIIB prevents amplification of 
inflammation, thereby inhibiting influx and differentiation of osteoclast precursors 
and activation of resident osteoclasts 
Dysregulation of Fey receptors 
The findings m Chapters 2 and 3 once again underline the importance of coordinated 
expression of activating and inhibitory FcyRs m arthritis Characterizing factors m 
arthritis that modulate this expression balance is therefore important One factor 
already known is the Thl cytokine IFNy, aggravating severe cartilage destruction in 
immune complex-mediated arthritis (ICA) due to enhanced expression of FcyRI m 
conjunction with an increased activation state of macrophages 23 Another potential 
candidate is the Thl7 cytokine IL-17, expressed m RA synovium and an important 
mediator of inflammation, cartilage, and bone destruction m experimental arthritis 
IL-17 aggravates cartilage destruction particularly m immune complex-mediated 
arthritis models 
In Chapter 4, we showed that, similar to IFNy, IL-17-mediated amplification of 
cartilage destruction during ICA depended on the presence of activating FcyRs 
However, m contrast to IFNy, which directly up-regulated FcyR expression on 
macrophages and PMNs, IL-17 amplified cartilage destruction by increasing the local 
amount of FcyR-bearmg neutrophils via induction of the chemokmes KC and MIP-2 
(Chapter 4) These neutrophil attracting chemokmes act in strong synergy with each 
other , explaining the magnitude of the PMN influx In addition, we showed that 
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PMNs strongly adhered to the cartilage surface when activating FcyRs were present 
(Chapter 4). Activated PMNs can be potent mediators of MMP-mediated cartilage 
destruction in arthritis, but only when adhering to the cartilage surface 
Normally, PMNs do not adhere to cartilage because the proteoglycans in intact 
cartilage matrix prevent PMN adhesion . IL-17 can make the cartilage surface more 
prone to neutrophil adherence by induction of PG depletion, but PG depletion alone 
is insufficient for PMN adherence 30. Adherence is facilitated by retention of immune 
complexes in the surface layer of the cartilage 28, which, in the ICA model, is 
established by the highly cationic antigen PLL-lysozyme . In human RA, 
autoantibodies targeted against cartilage matrix components and penetration of IgG 
into the articular cartilage are found as well 32'33. A crucial role for activating FcyRs 
was demonstrated by the absence of PMN adherence in arthritic FcRy-chain" " mice, 
despite the presence of PG depletion and immune complexes in the cartilage surface 
(Chapter 4). 
Besides Τ cell cytokines, triggering of the innate immune receptor TLR4, an 
important mediator of arthritis development3'''35, was shown to potentiate arthritis 
onset through FcyR regulation . Its endogenous ligands, the alarmins S100A8 and 
S100A9, are strongly up-regulated in RA synovial fluid and significantly correlate with 
arthritis severity and joint destruction 37. We have found that their expression is 
associated with the expression of FcyRs and the activation state of macrophages in 
AIA mice 13'23'38. in vitro, S100A8, and to a lesser extent S100A9 and the S100A8/A9 
heterodimer, were found to up-regulate activating FcyRI and FcyRIV on macrophages 
through TLR4 activation (Chapter 5). In vivo, S100A8 up-regulated FcyRs in normal 
synovium, while FcyR expression in arthritic synovium of S100A9 mice was 
reduced (Chapter 5). Besides showing the ability of S100A8 and S100A9 to regulate 
FcyR expression, this study also confirms that S100A8 is the most active of these two 
alarmins. 
Alarmins as destructive mediators of inflammatory arthritis 
Based on our findings in Chapter 5, and on the association of S100A8 and S100A9 
expression with arthritis severity, active involvement of these proteins in the 
development of joint inflammation and destruction in arthritis was studied more 
closely in Chapters 6 to 8. To this end, we used SIOOAS'^ mice, which also lack 
S100A8 protein expression, probably due to rapid degradation of S100A8 as its 
binding partner S100A9 is absent39'40. 
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Induction of Β and Τ cell-mediated immune responses is required for AIA 
development and CD8+ Τ cells may be one of the subsets involved. Approximately 
40% of Τ cells in RA synovium are CD8+ 4 1 and S100A8 and S100A9 have been shown 
to be crucial for the development of autoreactive CD8+ Τ cells " , suggesting their 
potential involvement in the generation of an immunological response against the 
mBSA antigen After AIA induction, SIOOAS''' mice developed reduced levels of 
inflammation. However, upon immunization with mBSA, S100A9~~ mice displayed 
normal cellular and humoral responses (Chapter 6), indicating that the observed 
differences m inflammation are mainly caused by local effects on innate immunity 
S100A8 and S100A9 are expressed by activated macrophages and neutrophils m 
synovial tissue of RA patients 4 3 and in the inflamed synovium of AIA mice (Chapter 
6) After secretion they drive inflammation by stimulating the production of pro­
inflammatory cytokines by macrophages 44 Besides inflammation, PG depletion was 
reduced and MMP-mediated cartilage destruction (VDIPEN) was absent (Chapter 6). 
Cartilage destruction m RA is strongly driven by inflammation. Activated 
macrophages in inflamed synovium are a major source of catabohc cytokines and 
cartilage-degrading proteases. Articular chondrocytes respond to cytokines by 
increasing their production of proteases 4 5 Potentially, S100A8 and S100A9 can 
influence the production of catabohc factors in both macrophages and chondrocytes. 
Due to their small size, S100A8 and S100A9 can easily penetrate into the cartilage 
matrix and stimulate chondrocytes A6, whereas activated chondrocytes may also 
produce these proteins themselves. Evidence supporting these ideas was obtained 
by the detection of abundant expression of S100A8 and S100A9 in activated 
chondrocytes of arthritic mice and even in human chondrocytes, m PG-depleted 
areas of RA cartilage (Chapters 6 and 7) Furthermore, pro-inflammatory cytokines 
were shown to induce expression of S100A8 and S100A9 in murine chondrocytes 
(Chapter 7). 
In arthritic synovium of S100A9" ~ mice MMP expression was reduced, whereas 
injection of S100A8 into naive knee joints of wild type mice induced inflammation 
and expression of S100A8, S100A9, cytokines, MMPs, and aggrecanases, which 
correlated with enhanced PG depletion and aggrecanase-mduced neoepitopes 
(NITEGE) within the cartilage (Chapter 6). In addition, S100A8- and S100A8/A9-
stimulated macrophages up-regulated MMPs m vitro (Chapter 6), while stimulation 
of murine chondrocytes resulted m up-regulation of MMPs and aggrecanases m 
conjunction with increased pericellular VDIPEN and NITEGE expression (Chapter 7) 
The effects of S100A8 on chondrocytes were compared with those of IL-1, as this 
cytokine is known for its dominant role m mediating cartilage destruction by 
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stimulating MMP production in chondrocytes . S100A8 enhanced the stimulatory 
effect of IL-1 on MMP and aggrecanase expression by chondrocytes, resulting in 
enhanced NITEGE expression and loss of proteoglycans from patellar cartilage 
(Chapter 7). 
Although TLR4 is expressed on chondrocytes, its activation suppresses proteoglycan 
synthesis **, and even though S100A8 signals through TLR4 in phagocytes , blocking 
TLR4 did not attenuate SlOOAS-induced VDIPEN and NITEGE expression. On 
chondrocytes, signaling via carboxylated glycans, expressed on RAGE and other 
receptors 49'5C, appeared to be more important. Inhibition of binding to carboxylated 
glycans abrogated the induction of VDIPEN and NITEGE, but RAGE was not involved. 
This suggests that another, yet unknown receptor expressing carboxylated glycans is 
involved, which is a current subject of investigation in our laboratory. 
Finally, we demonstrated in Chapter 8 that S100A8 and S100A9 are also involved in 
osteoclast-mediated bone loss in experimental arthritis. Bone erosions and 
cathepsin Κ expression were suppressed in S100A9~ ~ mice after AIA induction. 
Osteoclasts have been demonstrated to prominently express both S100 proteins , 
but a crucial role for their intrinsic expression was excluded as bone marrow-derived 
precursors from S100A9" " mice developed normally into functional osteoclasts 
(Chapters). However, during arthritis S100A8 and S100A9 are strongly produced and 
secreted by activated macrophages and PMNs, and thus might affect differentiation 
of infiltrated osteoclast precursor cells. We demonstrated that addition of S100A8, 
but not S100A9 or the heterodimer complex, to osteoclastogenesis cultures resulted 
in stimulation of osteoclast formation and bone resorption. Expression of osteoclast 
markers and the bone-degrading enzyme cathepsin Κ were not affected by S100A8 
and thus could not explain the stimulatory effect on bone resorption (Chapters). 
Actin ring formation is highly characteristic for osteoclasts and is a prerequisite for 
bone resorption 52. The hypothesis that S100A8 might play a role in this process was 
supported by the marked change in osteoclast morphology upon S100A8 stimulation 
(Chapter 8) and a study demonstrating a regulatory role for S100A8 in microtubule 
reorganization . S100A8-stimulated osteoclasts contained significantly more actin 
rings per cell, despite similar cell size as unstimulated osteoclasts (Chapter 8), 
suggesting that S100A8 enhances the bone resorptive capacity per osteoclast. 
Also in osteoclasts we investigated the receptor involved and showed that the 
stimulatory effects of S100A8 were abrogated in absence of TLR4, while sustained 
when RAGE signaling was blocked (Chapters). 
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Future perspectives 
IgG-contammg immune complexes play an important role in mediation of 
inflammation and cartilage destruction in experimental arthritis via activation of 
FcyRs, and they are thought to play a crucial role in RA pathogenesis . Our studies 
have demonstrated that FcyRs are also involved in mediation of bone destruction, 
primarily by modulating inflammation severity, overruling the inhibitory effects of 
immune complexes on osteoclastogenesis of precursor cells (Chapters 2 and 3). 
Therefore, it may seem surprising that one of the successful anti-mflammatory 
treatments for autoimmune diseases is high-dose intravenous IgG (IVIG) therapy. It 
has become clear that the paradoxical pro- and anti-mflammatory activities of IgG 
depend on sialylation of the attached sugar moiety 55 In addition, IVIG treatment 
was shown to increase expression of the inhibitory FcyRIIB on the surface of murine 
macrophages 56. These properties make it an attractive target to selectively 
potentiate its anti-mflammatory activities. For future research it would be 
interesting to determine if sialylated IgGs display a stronger inhibitory potential on 
osteoclastogenesis of precursor cells than the immune complexes we have currently 
used, and to investigate whether the anti-mflammatory activity of IVIG can 
ameliorate bone pathology in experimental arthritis 
The intriguing inhibitory effect of human OIP-1 on the formation and function of 
osteoclasts via FcyRIIB also provides an interesting area for future investigations 
However, OIP-1, also known as thymic shared antigen-1 (TSA-1), has been suggested 
to play a role m the pathogenesis of systemic lupus erythematosus (SLE) . Both RA 
and SLE are chronic autoimmune diseases with symptoms that often overlap, which 
forms a major concern for its usability despite its beneficial effect on osteoclastic 
bone destruction. Although the physiologic function of OIP-1 is incompletely 
understood it may represent an alternative pathway for Τ cell activation OIP-1 is 
expressed during early development and activation of Τ cells and plays a regulatory 
role m thymocyte differentiation Whether it plays a role in experimental arthritis 
remains to be elucidated. 
Current approaches to the treatment of bone loss include bisphosphonates, RANKL 
inhibitors (Denosumab), and cathepsm Κ inhibitors (Odanacatib) Despite effectively 
blocking pathological bone loss, these drugs do not interfere with inflammatory 
processes, which makes them highly applicable in a broad range of bone diseases 
5 8 5 9
 For RA however, this implicates that combination therapy remains required to 
block inflammation and concomitant cartilage destruction as well It would therefore 
be desirable to inhibit mediators that drive multiple pathological processes m 
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arthritis Our studies suggest that the TLR4 hgand S100A8 might be an interesting 
target, as it modulates the expression of FcyRs, inflammation, cartilage, and bone 
destruction m experimental arthritis (Chapters 5 to 8), but further validation is 
needed 
One option to inhibit the activities of S100A8 would be to inhibit TLR4 activation, 
which has been shown to be effective for treating sepsis and colitis , and it 
suppresses the severity of experimental arthritis and IL-1 expression in arthritic 
joints 62 However, an undesirable side effect might be a potential increase in the 
susceptibility to infections, as TLR4 plays such a dominant role m host defense We 
therefore suggest that specific inhibition of S100A8 is preferable This might be 
established by knockdown of S100A8 expression with RNA interference, an effective 
strategy for post-transcriptional gene silencing, using short interfering RNAs (siRNA) 
encapsulated in liposomes that selectively target tissue resident and circulating 
monocytes 63 The great advantage of this approach is the specific targeting of the 
major producers and effector cells of S100A8, monocytes/macrophages, which are 
crucial mediators of inflammation and cartilage destruction, and the precursor cells 
for osteoclast formation Systemic administration of liposomes containing anti-
cytokme siRNAs has been demonstrated to efficiently reduce the severity of murine 
collagen-induced arthritis Whether this method is also applicable for effective 
inhibition of S100A8-mediated joint pathology is currently being investigated 
Concluding remarks 
Our aim was to broaden our understanding of FcyR-mediated joint destruction in 
arthritis and to further explore their association with the expression and function of 
the alarmms S100A8 and S100A9 We have demonstrated the involvement of FcyRs 
in osteoclast-mediated bone destruction and we have provided substantial evidence 
supporting a direct role for S100A8 and S100A9 m FcyR regulation and the 
pathogenesis of arthritis However, our understanding of their inflammatory and 
destructive mechanisms is far from complete Our data suggests that particularly 
S100A8 is a promising target for therapeutic treatment, but additional research is 
needed to validate its role m arthritis pathology Moreover, based on the fact that 
S100A8 mediates most of its effects through TLR4 activation and multiple TLR4 
ligands have been shown to be present in the arthritic joint, it cannot yet be 
excluded that other TLR4 ligands might play a more dominant role Therefore, the 
potential value of targeting S100A8 m order to prevent or inhibit inflammation and 
joint destruction in arthritis needs to be demonstrated m experimental models 
2 0 6 
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Reumatoide artritis (RA) is een chronische ontstekmgsziekte die vooral de 
gewrichten aantast Op den duur leiden de gewrichtsontstekingen tot onherstelbare 
schade aan kraakbeen en bot, met als gevolg een verlies van de gewrichtsfunctie 
waardoor RA patiënten ernstig beperkt worden m hun dagelijks functioneren 
Hoewel de exacte oorzaak van RA nog altijd onbekend is, is het wel duidelijk dat het 
immuunsysteem een zeer belangrijke rol speelt RA is een auto-immuunziekte, wat 
inhoudt dat het immuunsysteem lichaamseigen stoffen (auto-antigenen) als 
hchaamsvreemd beschouwd Hierdoor komt een afweerreactie tot stand waarbij 
antistoffen (antilichamen) tegen auto-antigenen aangemaakt worden. Deze 
antihchamen vormen samen met de auto-antigenen immuuncomplexen die het 
immuunsysteem kunnen activeren via Fcy receptoren (FcyRs) FcyRs zijn onder meer 
aanwezig op het celoppervlak van macrofagen en polymorphonucleaire leukocyten 
(PMNs), twee typen ontstekingscellen die een belangrijke rol spelen m RA. Binding 
van immuuncomplexen aan de activerende FcyRI, FcyRIII en/of FcyRIV leidt tot de 
productie van ontstekingsmediatoren (cytokmen, chemokmen en alarmines) en 
enzymen die het gewrichtskraakbeen afbreken. Binding aan de inhiberende FcyRIIB 
daarentegen remt de werking van de activerende FcyRs 
Uit onderzoek is gebleken dat immuuncomplexen en FcyRs een belangrijke rol 
spelen bij de ontwikkeling van ontsteking en kraakbeenschade tijdens experimentele 
artritis. Daarnaast is de expressie van FcyRs gecorreleerd met de expressie van de 
alarmines S100A8 en S100A9. Deze alarmines worden voornamelijk door 
macrofagen en PMNs geproduceerd en uitgescheiden bij ontsteking of 
weefselschade met als doel het immuunsysteem te "alarmeren" Ze komen voor in 
homodimeer (S100A8 of S100A9) en heterodimeer (S100A8/A9) formatie, welke 
mogelijk van elkaar verschillen qua functie en activiteit. S100A8 en S100A9 komen 
verhoogd tot expressie m het serum en de gewrichten van RA patiënten en hun 
spiegels zijn gecorreleerd met het ontstaan van gewrichtsschade Hoe ZIJ 
gewrichtsschade veroorzaken is echter met bekend 
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Het doel van dit proefschrift was om meer inzicht te verkrijgen m FcyR-gemedieerde 
gewrichtsschade en om de associatie tussen de expressie en activatie van FcyRs en 
S100A8 en S100A9 tijdens experimentele artritis te onderzoeken 
RA wordt gekenmerkt door de aanwezigheid van een verhoogd aantal en een 
verhoogde activiteit van osteoclasten die bot afbreken. Daarom hebben WIJ m de 
hoofdstukken 2 en 3 de rol van FcyRs bij het ontstaan van botschade tijdens 
experimentele artritis onderzocht In hoofdstuk 2 hebben WIJ aangetoond dat in het 
antigeen-gemduceerde artritis model (AIA) de ontsteking, kraakbeenschade, 
boterosies en de expressie van RANKL en cathepsme K, markers voor osteoclast 
differentiatie en activiteit, sterk verhoogd waren m FcyRIIB deficiente muizen 
(FcyRIIB~/~ en FcyRI/ll/llf ") In muizen die alleen activerende FcyRs missen (FcRy-
cham-''-) was de ontsteking en botschade vergelijkbaar met controle dieren, terwijl 
ernstige kraakbeenschade vrijwel volledig afwezig was. Deze studie laat zien dat 
activerende FcyRs direct betrokken zijn bij de ontwikkeling van kraakbeenschade en 
indirect bij de ontwikkeling van botschade, via het reguleren van de ontsteking 
Bovendien staat de ontwikkeling van ontsteking los van de ontwikkeling van 
kraakbeenschade. 
Naar aanleiding van deze resultaten, en omdat osteoclasten m vergelijking met 
macrofagen nauwelijks activerende FcyRs tot expressie brengen terwijl de expressie 
van FcyRIIB vergelijkbaar is, hebben wij m hoofdstuk 3 de rol van FcyRIIB m 
osteoclast differentiatie en activatie onderzocht. Ondanks de hoge FcyRIIB expressie 
bleek stimulatie van osteoclasten met immuuncomplexen geen effect te hebben op 
de mate van botresorptie Immuuncomplexen bleken wel de differentiatie van 
voorlopercellen uit het beenmerg naar osteoclast sterk te remmen. Met behulp van 
FcyRIIB" en FcRy-cham" " beenmergcellen is vervolgens aangetoond dat deze 
remming via activerende FcyRs verloopt, welke op voorlopercellen hoog tot 
expressie komen. In het AIA model lijkt het remmende effect van immuuncomplexen 
echter teniet gedaan te worden door de sterke ontsteking waarbij tal van factoren 
vrij komen die de osteoclast differentiatie en activiteit juist stimuleren Dit 
benadrukt wederom de sterke samenhang tussen de ontwikkeling van ontsteking en 
de ontwikkeling van botschade tijdens artritis 
De expressie balans tussen activerende en mhiberende FcyRs is cruciaal voor een 
gecontroleerde immuunrespons maar m RA patiënten is deze balans verstoord. Het 
is daarom belangrijk om de factoren te karakteriseren die tijdens RA aanwezig zijn en 
de expressie van FcyRs reguleren lnterferon-y (IFNy) is een cytokine dat door Τ 
helper 1 (Thl) cellen wordt geproduceerd, terwijl interleukine-17 (IL-17)wordt 
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geproduceerd door Thl7 cellen. Beide cytokinen komen verhoogd tot expressie 
tijdens RA en spelen een belangrijke rol bij de ontwikkeling van immuuncomplex-
gemedieerde kraakbeenschade in experimentele artritis. In hoofdstuk 4 hebben wij 
onderzocht hoe deze cytokinen kraakbeenschade verergeren door middel van 
adenovirale overexpressie in het kniegewricht in het immuuncomplex-geinduceerde 
artritis model (ICA). Overexpressie van IFNy verhoogde de expressie van FcyRI en 
FcyRIV op zowel macrofagen als PMNs, terwijl het geen effect had op het aantal en 
de samenstelling van deze cellen in het kniegewricht. Overexpressie van IL-17 
daarentegen had geen directe invloed op de FcyR expressie, maar zorgde wel voor 
een zeer sterke toename van het aantal PMNs in het kniegewricht. In beide gevallen 
waren activerende FcyRs nodig voor het ontwikkelen van ernstige kraakbeenschade 
aangezien chondrocytdood, kraakbeenerosie en MMP-ge'mduceerde kraakbeen­
schade (VDIPEN expressie) volledig afwezig waren in FcRy-chain" " muizen. 
Naast Τ cel cytokinen beïnvloedt ook activatie van Toll-like receptor 4 (TLR4) de 
expressie van FcyRs. Recent is aangetoond dat de alarmines S100A8 en S100A9 
endogene liganden zijn voor TLR4 op fagocyten. In hoofdstuk 5 hebben wij 
aangetoond dat deze alarmines een belangrijke rol spelen bij de regulatie van FcyRs 
tijdens experimentele artritis. Injectie van S100A8 in een kniegewricht zonder artritis 
resulteerde in verhoogde expressie van FcyRI en FcyRIV in het synovium. Uit in vitro 
studies bleek dat deze toename het sterkst was na stimulatie met S100A8 en dat 
alleen op macrofagen de FcyR expressie beïnvloed werd en niet op PMNs. Met 
behulp van TLR4" " macrofagen is aangetoond dat deze regulatie via TLR4 verloopt. 
In S100A9"/~ muizen (tevens deficiënt voor S100A8) met AIA bleek de FcyR expressie 
verlaagd ten opzichte van controle muizen met AIA. Dit correleerde bovendien met 
een afname in VDIPEN expressie. 
In de hoofdstukken 6 tot en met 8 hebben we de rol van deze alarmines bij de 
ontwikkeling van kraakbeen- en botschade in experimentele artritis verder 
onderzocht. 
AIA inductie in S100A9 muizen resulteerde m een significante afname in 
ontsteking en kraakbeenschade ten opzichte van controle dieren (hoofdstuk 6). Dit 
betrof zowel de mildere vorm van kraakbeenschade (aggrecanase geïnduceerde 
NITEGE expressie) als de ernstige vorm (VDIPEN). De afname in NITEGE en VDIPEN 
expressie correleerde met verlaagde synoviale expressie van aggrecanases en 
MMPs. Injectie van S100A8 in een kniegewricht zonder artritis daarentegen 
resulteerde in verhoogde synoviale expressie van pro-inflammatoire cytokinen, 
aggrecanases en MMPs. Dit ging bovendien gepaard met een toename in ontsteking, 
depletie van proteoglycanen en verhoogde NITEGE expressie. 
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In hoofdstuk 7 hebben we aangetoond dat zowel in experimentele artritis als ook in 
RA, S100A8 en S100A9 door kraakbeencellen (chondrocyten) tot expressie worden 
gebracht. Deze expressie kan geïnduceerd worden door chondrocyten te stimuleren 
met pro-inflammatoire cytokinen. Stimulatie van chondrocyten met S100A8 
resulteerde in verhoogde expressie van IL-6, MMPs en aggrecanases. Daarbij nam 
tevens de expressie van NITEGE en VDIPEN op de pericellulaire matrix van 
chondrocyten toe. De toename in kraakbeenafbraak werd bovendien versterkt 
wanneer chondrocyten tegelijkertijd werden gestimuleerd met S100A8 en IL-lß, een 
cytokine dat erom bekend staat de expressie van MMPs te induceren. 
In hoofdstuk 8 hebben we aangetoond dat alarmines ook een belangrijke bijdrage 
leveren aan de ontwikkeling van botschade in experimentele artritis. In S100A9" " 
muizen met AIA waren de mate van boterosie en het aantal osteoclasten sterk 
gereduceerd. De intrinsieke productie van S100A8 en S100A9 door beenmergcellen 
bleek echter geen belangrijke rol te spelen bij osteoclast differentiatie aangezien 
S100A9 beenmergcellen probleemloos tot functionele osteoclasten uitrijpten. 
Echter, tijdens een ontsteking worden alarmines vooral door macrofagen en PMNs 
geproduceerd en uitgescheiden, waardoor zij mogelijk de differentiatie en activiteit 
van osteoclasten van buiten af kunnen beïnvloeden. Externe stimulatie van 
beenmergcellen met S100A8 resulteerde in een sterke toename van het aantal 
osteoclasten, het aantal actine ringen per osteoclast en de botresorptie. De vorming 
van actine ringen is zeer typerend voor osteoclasten en cruciaal voor het effectief 
resorberen van bot. Een toename in het aantal actine ringen per osteoclast wijst er 
daarom mogelijk op dat de afbraak activiteit per cel toeneemt. De toename in 
osteoclast differentiatie en activiteit was volledig afwezig in gestimuleerde TLR4" " 
beenmergcellen en wederom bleek S100A8 meer potent dan S100A9 en S100A8/A9. 
Deze bevindingen laten zien dat de alarmines S100A8 en S100A9 een belangrijke 
rol spelen in het ontstaan van ontsteking en gewrichtsschade in experimentele 
artritis. Tevens is gebleken dat S100A8 de meest actieve vorm van de verschillende 
formaties is. 
Samengevat verschaffen de studies beschreven in dit proefschrift ons meer inzicht in 
de mechanismen van FcyR-gemedieerde gewrichtsschade en tonen zij aan dat 
S100A8 en S100A9 een belangrijke rol spelen bij de ontwikkeling van experimentele 
artritis. Aanvullend onderzoek blijft nodig om het belang van deze factoren in RA aan 
te tonen, maar vooralsnog lijken met name de alarmines een veelbelovend nieuw 
target in de behandeling van RA. 
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leven Nu is er eindelijk weer tijd om samen leuke dingen te doen en van het leven 
te gemeten' 
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